Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
42529215	p-fsh	U/l (u/l)	6336	8358	0.00%
42529215	p-fsh	— (—)	1733	2089	100.00%	Distribution not available
42529215	p-fsh	U/L (u/l)	12	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility

972

1392

4.39

308.92

1.4

1.3

13.26

31.42

u/l

49.18

861

1108

Disorders of other endocrine glands

1113

3268

3.46

303.52

1.7

1.3

17.41

25.63

u/l

16.03

960

2656

Hypopituitarism

321

307

11.51

297.08

1.8

1.3

14.54

22.02

u/l

2.99

258

256

Exclusions for E4_PCOS_BROAD

576

1241

4.91

249.62

1.9

1.3

17.56

25.17

u/l

6.84

484

1027

Female infertility, associated with anovulation

454

805

6.23

248.52

1.4

1.3

9.31

25.32

u/l

29.51

404

645

Female infertility, cervical, vaginal, other or unspecified origin

825

1370

4.02

241.99

1.3

14.75

31.87

u/l

38.98

723

1089

Medical observation and evaluation for suspected diseases and conditions

1132

1814

3.25

231.09

1.4

1.3

23.19

26.22

u/l

1.83

882

1533

General examination and investigation of persons without complaint and reported diagnosis

1103

1814

3.21

223.05

1.4

1.3

25.35

26.22

u/l

0.31

914

1533

Irregular menses

1550

4770

2.52

223.05

1.5

1.3

20.24

29.16

u/l

22.85

1313

3881

Depression

1841

5435

2.30

215.20

1.4

1.3

22.76

26.52

u/l

4.75

1422

4568

Examination and observation for other reasons

1007

1812

3.19

207.75

1.4

1.3

22.06

26.25

u/l

3.06

803

1531

Mood [affective] disorders

1878

5458

2.24

203.55

1.4

1.3

22.72

26.47

u/l

4.85

1458

4585

Mood disorders

1879

5459

2.23

202.89

1.4

1.3

22.71

26.47

u/l

4.88

1459

4585

Anxiety disorders, excluding more controls

1550

4218

2.39

194.33

1.4

1.3

25.27

27.39

u/l

1.47

1225

3564

Polycystic ovarian syndrome, consortium definition

1849

4859

2.24

191.98

1.5

1.3

20.52

29.50

u/l

25.10

1566

3956

Hypogonadotropic hypogonadism

142

23.06

190.75

1.5

1.4

4.40

13.58

u/l

3.54

Mood disorders, excluding more controls

1652

4260

2.31

189.25

1.4

1.3

23.54

27.25

u/l

4.08

1280

3599

Neurotic, stress-related and somatoform disorders

1739

5495

2.22

187.23

1.4

1.3

24.46

26.27

u/l

1.33

1383

4569

Anxiety disorders

1743

5496

2.21

186.54

1.4

1.3

24.42

26.31

u/l

1.42

1386

4571

Recurrent or chronic depression

850

1904

3.17

184.80

1.4

1.3

25.35

28.83

u/l

1.91

673

1637

L02BG Aromatase inhibitors

594

1625

3.72

181.87

1.4

1.3

37.67

39.70

u/l

0.61

556

1301

Amenorrhoea

320

546

6.37

181.64

1.8

1.3

12.61

25.41

u/l

11.43

294

426

Polycystic ovarian syndrome, broad definition

589

1689

3.79

175.90

1.4

1.3

8.97

20.25

u/l

31.71

526

1377

Medicines for HER+ breast cancer

768

2496

2.95

158.78

1.4

1.3

35.76

38.09

u/l

0.93

719

1981

Hypothyroidism, other/unspecified

1633

5209

2.09

150.91

1.5

1.3

24.66

25.75

u/l

0.61

1334

4298

Non-small cell lung cancer, including Hilmo

196

216

8.71

149.26

1.3

26.79

35.80

u/l

2.27

191

149

Hypothyreosis and Thyroxine purchase for inclusion criteria

1679

5454

2.05

146.22

1.5

1.3

24.82

25.89

u/l

0.61

1371

4492

Hypothyroidism, levothyroxine purchases

648

1096

3.41

146.18

1.5

1.2

18.43

20.26

u/l

0.70

538

925

Hypothyroidism and >3 levothyroxin purchases

648

1096

3.41

146.18

1.5

1.2

18.43

20.26

u/l

0.70

538

925

Hypothyroidism (congenital or acquired)

648

1099

3.39

145.29

1.5

1.2

18.14

20.23

u/l

0.85

537

927

Disorders of the thyroid gland

1651

5335

2.03

141.59

1.5

1.3

23.41

25.36

u/l

1.51

1331

4403

Lung cancer and mesothelioma

233

292

6.91

139.79

1.3

1.2

26.92

36.01

u/l

2.97

226

232

Ovarian dysfunction

409

1077

4.15

138.71

1.6

1.3

14.34

19.43

u/l

3.45

374

894

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

327

696

4.66

135.96

1.6

1.3

33.71

33.28

u/l

0.07

313

508

Anxiety (asthma-related co-morbidities)

1298

4642

2.16

134.76

1.4

1.3

20.64

26.79

u/l

9.38

1025

3902

Special screening examination for infectious and parasitic diseases

600

1433

3.13

129.85

1.4

1.3

16.97

23.40

u/l

4.56

424

1206

Malignant neoplasm of respiratory system and intrathoracic organs

229

299

6.47

128.34

1.3

25.18

32.48

u/l

2.00

222

206

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

251

362

5.80

126.26

1.3

26.40

32.94

u/l

1.87

243

255

Endocrine, nutritional and metabolic diseases

1432

3485

2.10

125.61

1.5

1.3

19.64

26.45

u/l

11.94

1198

2873

Malignant neoplasm of bronchus and lung, including Hilmo

218

280

6.60

124.95

1.3

27.90

35.81

u/l

2.07

212

194

Oxycodone

532

1465

3.15

123.05

1.5

1.3

30.04

32.40

u/l

0.76

472

1184

Malignant neoplasm of bronchus and lung

199

237

7.15

122.49

1.3

26.51

36.17

u/l

2.61

194

163

Pain in joint

967

2517

2.39

121.52

1.4

1.3

23.62

25.56

u/l

0.93

760

2121

Benzodiazepine use

1652

5883

1.92

121.25

1.4

1.3

24.83

25.54

u/l

0.34

1281

4912

Polycystic ovarian syndrome

324

798

4.48

120.87

1.5

1.3

7.41

17.99

u/l

18.90

291

673

Headache

1233

4597

2.10

120.03

1.5

1.3

23.75

25.03

u/l

0.65

993

3760

All anxiety disorders

1332

5149

2.04

119.50

1.4

1.3

20.37

25.60

u/l

7.37

1051

4275

Hypothyroidism, strict autoimmune

1326

4276

2.06

118.64

1.4

1.3

24.58

25.87

u/l

0.68

1074

3535

Other nutritional deficiencies

1306

5991

2.02

118.01

1.4

1.3

17.86

27.11

u/l

28.55

1055

4947

Pain and other conditions associated with female genital organs and menstrual cycle

522

1439

3.13

116.37

1.3

19.78

29.63

u/l

7.70

420

1144

Noninflammatory disorders of female genital tract

772

1495

2.64

110.91

1.4

1.3

18.48

30.27

u/l

16.25

671

1195

Excessive, frequent and irregular menstruation

734

1494

2.68

110.15

1.4

1.3

20.32

30.29

u/l

10.90

594

1194

Follow-up examination after treatment for conditions other than malignant neoplasms

682

1731

2.66

109.02

1.3

27.93

27.13

u/l

0.22

549

1460

Obesity and other hyperalimentation

1242

5946

2.00

108.54

1.4

1.3

17.52

27.33

u/l

32.35

1001

4906

Obesity

1239

5936

2.00

108.54

1.4

1.3

17.51

27.31

u/l

32.14

999

4898

Other special examinations and investigations of persons without complaint or reported diagnosis

866

1815

2.44

107.91

1.4

1.3

23.11

26.22

u/l

1.76

712

1533

Other antidepressants

1462

3847

1.96

107.23

1.4

1.3

23.40

26.03

u/l

2.14

1161

3239

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

675

2743

2.52

105.00

1.7

1.3

22.99

29.64

u/l

5.42

554

2231

Behavioural syndromes associated with physiological disturbances and physical factors

1514

5568

1.86

101.63

1.4

23.39

26.27

u/l

2.69

1230

4590

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

222

473

4.81

97.02

1.5

1.3

34.17

28.94

u/l

1.25

209

348

Exclusions for E4_PCOS_CONSORTIUM

1512

5208

1.84

95.69

1.5

1.3

22.89

26.82

u/l

4.77

1264

4234

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

232

523

4.53

94.45

1.5

1.3

35.26

34.23

u/l

0.15

223

373

Sleep disorders

1458

5538

1.83

93.85

1.4

1.3

23.57

26.38

u/l

2.48

1179

4565

Male infertility

12.43

93.09

1.4

1.3

11.92

10.38

u/l

0.28

Other specific joint derangements/joint disorders

1357

4555

1.88

92.34

1.4

1.3

24.20

23.36

u/l

0.39

1070

3805

Depression or dysthymia

847

2058

2.27

92.27

1.4

1.3

25.88

28.06

u/l

0.95

672

1771

Other soft tissue disorders, not elsewhere classified

1471

4590

1.84

92.25

1.4

1.3

23.13

23.79

u/l

0.31

1179

3830

Obesity due to excess calories

977

4870

2.04

92.18

1.4

17.80

27.16

u/l

23.41

777

3995

Any gastric operation

1283

3366

1.93

90.10

1.4

1.3

23.08

22.70

u/l

0.15

1082

2720

GASTRO-related operations

1283

3366

1.93

90.10

1.4

1.3

23.08

22.70

u/l

0.15

1082

2720

Insomnia

1453

5694

1.79

87.52

1.4

23.47

26.03

u/l

2.16

1183

4698

Anaemias

470

1054

2.92

87.50

1.4

1.2

23.32

20.70

u/l

0.84

386

887

Low back pain

1269

4622

1.87

87.30

1.4

1.3

24.54

24.42

u/l

0.04

1002

3848

Testicular dysfunction

14.49

86.52

1.5

1.2

17.44

11.48

u/l

1.20

Malignant neoplasm

1364

4385

1.84

86.17

1.4

1.3

34.75

26.39

u/l

13.75

1238

3426

Malignant neoplasm

1362

4377

1.84

86.16

1.4

1.3

34.69

26.48

u/l

13.26

1236

3418

Migraine

1119

4584

1.93

86.02

1.5

1.3

21.49

26.22

u/l

5.16

922

3800

Any event in cancer register

1516

5038

1.78

85.03

1.4

1.3

31.44

23.43

u/l

14.83

1336

3999

General symptoms and signs

1626

4687

1.75

84.44

1.4

1.3

25.41

24.75

u/l

0.31

1337

3833

Solid cancers, including Hilmo

1373

4432

1.83

84.13

1.4

1.3

34.14

26.23

u/l

12.60

1241

3462

Malignant neoplasm, including Hilmo

1401

4558

1.81

83.55

1.4

1.3

34.19

25.59

u/l

14.91

1262

3572

Lower back pain or/and sciatica

1639

5987

1.72

83.08

1.4

1.3

25.01

25.15

u/l

0.06

1317

4955

Malignant neoplasm, wide definition

1397

4555

1.80

82.56

1.4

1.3

34.19

25.67

u/l

14.59

1258

3569

Solid cancers

1319

4258

1.84

82.54

1.4

1.3

34.71

26.95

u/l

11.70

1201

3324

Malignant neoplasm of breast, HER-positive

620

1958

2.41

82.50

1.4

1.3

41.98

37.39

u/l

2.19

585

1496

Malignant neoplasm of breast, ER-positive, including Hilmo

621

1963

2.40

82.22

1.4

1.3

41.98

37.41

u/l

2.17

585

1500

Hypothyroidism, strict autoimmune, 3 medication purchases required

1398

5330

1.78

81.71

1.4

1.3

25.79

26.31

u/l

0.22

1128

4385

Any mental disorder

1498

4269

1.77

80.76

1.4

1.3

25.88

27.23

u/l

0.75

1179

3604

Caries of dentine

343

1086

3.10

79.56

1.4

1.3

22.26

26.64

u/l

1.64

281

926

Ovarian cyst

604

1435

2.45

78.20

1.3

24.47

31.24

u/l

4.66

511

1143

Chronic laryngitis and laryngotracheitis

272

802

3.49

76.42

1.4

1.3

31.63

31.31

u/l

0.04

210

675

Dorsalgia

1516

4684

1.73

76.31

1.4

1.3

23.23

24.17

u/l

0.50

1217

3904

Testicular hypofunction

14.35

76.23

1.5

1.2

18.98

10.88

u/l

1.82

Used for control exclusion in common control thyroid runs

1512

4442

1.73

75.35

1.5

1.3

20.91

24.73

u/l

4.56

1232

3693

Other anxiety disorders

988

4465

1.91

75.26

1.4

1.3

19.05

23.71

u/l

5.18

793

3701

Parasetamol

1070

2835

1.93

74.91

1.4

1.3

21.51

22.71

u/l

0.56

901

2343

Selective serotonin reuptake inhibitors

1318

3852

1.79

74.71

1.4

1.3

23.11

26.00

u/l

2.32

1059

3243

Persons encountering health services for examination and investigation

778

1815

2.17

74.53

1.4

1.3

22.83

26.22

u/l

1.94

631

1533

Depression medications

558

1126

2.53

74.41

1.4

1.2

19.54

20.00

u/l

0.12

464

951

Dental caries

369

1251

2.83

72.44

1.4

1.3

22.65

26.14

u/l

1.22

305

1075

Dysplasia of cervi uteri

473

1341

2.54

69.30

1.3

25.10

31.94

u/l

3.81

362

1066

Neurological diseases

1310

3791

1.75

67.92

1.4

1.3

20.72

24.40

u/l

3.85

1073

3169

Opioids

1510

4690

1.68

67.59

1.4

1.3

22.61

23.82

u/l

0.71

1232

3874

Continuous positive airway pressure

241

572

3.57

67.54

1.3

1.4

23.76

34.58

u/l

4.73

189

469

Neoplasms

1255

3786

1.76

66.36

1.4

1.3

19.81

19.18

u/l

0.30

1073

3015

Myalgia

485

2100

2.36

65.77

1.5

1.3

25.01

28.09

u/l

1.17

388

1726

Procreative management

603

2336

2.16

64.17

1.4

20.04

28.82

u/l

9.44

523

1838

Persons encountering health services in other circumstances

665

3250

2.05

64.17

1.4

22.64

25.97

u/l

1.86

580

2622

Menorrhagia

550

1337

2.33

63.77

1.3

25.19

33.00

u/l

5.01

450

1069

Thyrotropin deficiency

10.14

63.04

1.8

1.4

16.53

25.03

u/l

1.46

Genitourinary diseases

569

1251

2.30

62.64

1.4

1.3

18.07

23.36

u/l

3.69

484

1011

Dermatitis and eczema

1578

5847

1.61

62.26

1.4

1.3

25.06

25.31

u/l

0.11

1280

4826

Chronic diseases of tonsils and adenoids

1215

4510

1.72

61.79

1.4

1.3

25.33

25.56

u/l

0.08

975

3768

Other dorsopathies, not elsewhere classified

1471

4690

1.64

61.01

1.4

1.3

22.60

24.15

u/l

1.02

1185

3909

Psychiatric diseases

1207

3515

1.73

60.61

1.4

1.3

25.27

27.56

u/l

1.44

967

2976

Malignant neoplasm of breast

810

2745

1.94

60.53

1.4

40.80

34.60

u/l

4.69

761

2111

Malignant neoplasm of breast, HER2-negative

807

2739

1.93

60.08

1.4

40.81

34.66

u/l

4.60

759

2105

Nerve, nerve root and plexus disorders

1492

5586

1.62

60.06

1.4

1.3

26.44

26.05

u/l

0.16

1195

4609

Liquid cancers, including Hilmo

330

1078

2.73

60.05

1.5

1.3

33.93

29.48

u/l

1.42

296

813

Endometriosis

538

1399

2.27

59.55

1.3

24.53

31.86

u/l

4.72

457

1114

Other problems related to primary support group, including family circumstances

332

1232

2.73

59.47

1.5

1.4

20.54

21.25

u/l

0.16

286

1033

Abnormal findings on diagnostic imaging of lung

438

1782

2.35

59.32

1.4

1.3

30.16

33.88

u/l

1.47

382

1433

Malignant neoplasm of breast, HER2-negative, including Hilmo

826

2823

1.91

58.93

1.4

40.51

34.13

u/l

5.04

777

2171

Malignant neoplasm of breast, including Hilmo

826

2823

1.91

58.91

1.4

40.51

34.13

u/l

5.04

777

2171

Episodal and paroxysmal disorders

1556

4952

1.61

58.79

1.4

1.3

22.02

25.47

u/l

3.79

1254

4112

Sleep disorders (combined)

1476

4786

1.62

58.60

1.4

1.3

22.34

26.37

u/l

4.70

1166

3977

Acute upper respiratory infections

1449

5439

1.61

57.21

1.4

1.3

25.70

26.45

u/l

0.35

1159

4490

Other reaction to severe stress, and adjustment disorders

747

4017

1.89

56.44

1.4

1.3

24.28

24.69

u/l

0.13

613

3315

Codeine

1383

4625

1.63

56.18

1.4

1.3

23.35

24.05

u/l

0.33

1106

3816

Symptoms and signs involving the circulatory and respiratory systems

1524

4827

1.59

55.80

1.4

1.3

23.34

24.38

u/l

0.58

1251

3977

Pain in limb

1186

4535

1.68

55.62

1.4

1.3

24.59

24.01

u/l

0.24

950

3778

Soft tissue disorders

1437

4606

1.61

55.03

1.4

1.3

21.74

23.72

u/l

1.51

1164

3845

Mental and behavioural disorders due to tobacco

182

517

3.65

54.48

1.5

1.3

25.75

25.86

u/l

0.01

135

431

Smoking dependency

182

517

3.65

54.48

1.5

1.4

25.75

26.08

u/l

0.04

135

428

Abnormalities of breathing

1349

4822

1.61

53.38

1.4

1.3

25.62

24.39

u/l

0.63

1107

3972

Malignant melanoma

177

498

3.62

53.33

1.5

1.3

31.37

32.13

u/l

0.10

165

365

Migraine, single triptan purchase ok & required. ICD-code if available is included

1272

5362

1.62

53.15

1.4

24.74

26.53

u/l

1.08

1051

4385

Triptan medication for migraine, single purchase ok

1272

5362

1.62

53.15

1.4

24.74

26.53

u/l

1.08

1051

4385

Neurological diseases, wide definition

531

1224

2.21

53.05

1.4

1.3

19.09

23.48

u/l

2.31

445

1028

Other and unspecified disorders of skin and subcutaneous tissue

132

305

4.50

52.69

1.4

28.76

28.06

u/l

0.07

110

252

Sciatica+with lumbago

770

3780

1.82

51.52

1.4

1.3

27.37

28.30

u/l

0.32

636

3116

Other symptoms and signs involving the digestive system and abdomen

298

1161

2.62

50.98

1.4

1.3

30.65

32.64

u/l

0.40

239

951

Pain, not elsewhere classified

465

2199

2.15

50.77

1.6

1.3

25.84

25.94

u/l

0.02

396

1780

Hyperfunction of pituitary gland

156

422

3.91

50.69

2.0

1.3

13.40

24.20

u/l

6.06

142

354

Carpal tunnel syndrome

872

4361

1.75

50.66

1.4

1.3

29.09

30.82

u/l

0.79

711

3585

Persons encountering health services in other circumstances, wide

1490

4938

1.56

50.38

1.4

1.3

24.70

27.03

u/l

1.81

1238

4012

Substance abuse, excluding more controls

685

3091

1.87

49.30

1.4

1.3

22.61

25.67

u/l

1.57

518

2601

Malignant melanoma, including Hilmo

189

584

3.29

49.19

1.5

1.3

31.48

31.53

u/l

0.01

177

427

Benign neoplasm: Pituitary gland, craniopharyngeal duct

132

324

4.27

48.90

2.2

1.3

16.26

23.78

u/l

2.37

122

269

Malignant neoplasm of urinary organs, including Hilmo

183

5.38

48.87

1.3

35.51

31.39

u/l

0.41

127

Substance use, excluding alcohol

344

1463

2.40

48.75

1.4

22.59

22.91

u/l

0.06

259

1218

Dorsopathies

1438

4695

1.56

48.53

1.4

1.3

22.05

24.13

u/l

1.63

1173

3913

Personality disorders, excluding more controls

490

2406

2.07

48.24

1.5

1.3

20.74

23.37

u/l

1.10

383

2033

Unspecified urinary incontinence

152

418

3.74

47.68

1.5

1.3

29.99

32.37

u/l

0.32

108

348

Other joint disorders

1368

4576

1.57

47.63

1.4

1.3

20.93

23.29

u/l

1.86

1096

3822

Acute upper respiratory infections of multiple and unspecified sites

1158

5294

1.61

47.61

1.4

1.3

22.68

26.20

u/l

3.19

935

4365

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1431

4937

1.55

47.28

1.3

24.37

27.03

u/l

2.23

1200

4011

Caries of enamel

1367

5806

1.55

47.27

1.4

1.3

24.44

26.28

u/l

1.22

1103

4802

Oligomenorrhoea

109

237

4.87

47.25

1.3

9.28

24.91

u/l

10.09

195

Dental pulpitis, including avohilmo

1417

5941

1.54

47.06

1.4

1.3

22.92

25.33

u/l

2.06

1158

4888

Malignant melanoma of skin, including Hilmo

164

481

3.47

46.45

1.5

1.3

31.25

31.41

u/l

0.02

156

351

Hyperprolactinaemia

134

350

4.11

46.09

1.9

1.3

13.49

24.82

u/l

5.64

121

290

Codeine or tramadol medication

1563

5663

1.51

45.90

1.4

1.3

24.10

25.24

u/l

0.68

1254

4678

Malignant melanoma of skin

142

383

3.78

45.65

1.6

1.3

30.62

32.11

u/l

0.18

134

280

First line medication for Crohn's disease

1527

5463

1.51

45.40

1.5

1.3

25.06

23.94

u/l

0.65

1273

4455

Sleep apnoea, including avohilmo

1338

5268

1.55

44.96

1.4

25.67

28.43

u/l

2.28

1066

4322

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

703

3445

1.79

44.43

1.4

28.44

31.39

u/l

1.50

596

2792

Hypertrichosis

118

293

4.46

44.00

1.5

1.4

9.75

20.92

u/l

5.31

248

Abnormalities of heart beat

512

2574

1.95

43.07

1.4

23.88

27.45

u/l

1.54

420

2118

Fever of other and unknown origin

730

3645

1.75

42.64

1.5

1.3

28.74

25.06

u/l

2.16

640

2967

Any reimbursement code in KELA

1021

3139

1.65

42.54

1.4

1.3

22.58

21.27

u/l

0.61

865

2511

Generalized anxiety disorder

390

1851

2.15

42.47

1.5

1.4

20.55

18.63

u/l

0.60

306

1543

Other diseases of intestines

1544

5829

1.49

42.29

1.4

1.3

25.17

24.08

u/l

0.61

1251

4814

Unknown and unspecified causes of morbidity

135

375

3.71

41.82

1.3

26.50

25.29

u/l

0.15

129

312

Other menopausal disorders

440

1167

2.14

41.77

1.5

1.3

33.86

35.89

u/l

0.49

347

950

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

162

5.27

41.36

1.3

35.42

31.12

u/l

0.39

113

Hirsutism in women

107

259

4.60

41.35

1.6

1.4

9.46

20.20

u/l

4.77

220

Fibromyalgia

251

1004

2.59

41.21

1.4

27.24

31.57

u/l

1.06

195

824

Malignant neoplasm of urinary organs

152

5.41

41.10

1.3

38.82

32.78

u/l

0.58

104

Symptoms and signs involving the skin and subcutaneous tissue

1012

6070

1.59

41.08

1.4

1.3

25.49

26.75

u/l

0.59

838

4970

Somatoform disorder

303

1318

2.35

40.97

1.5

1.3

28.28

27.13

u/l

0.22

244

1087

Dermatitis

846

5066

1.65

40.25

1.4

1.3

26.61

27.60

u/l

0.37

696

4159

Bronchitis

1487

6078

1.48

40.20

1.4

1.3

23.45

25.71

u/l

1.86

1220

5003

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

520

2750

1.90

40.01

1.4

1.3

18.79

23.96

u/l

3.64

396

2314

Other intervertebral disc disorders

1079

4116

1.57

39.19

1.4

1.3

27.82

26.70

u/l

0.49

860

3398

Other disorders of skin and subcutaneous tissue, not elsewhere classified

195

702

2.83

39.05

1.5

1.4

27.74

28.63

u/l

0.13

169

579

Fentanyl

104

254

4.15

38.27

1.5

1.3

39.67

33.02

u/l

0.84

207

Other and unspecified dermatitis

726

4339

1.69

38.19

1.4

1.3

26.33

28.01

u/l

0.68

596

3569

Complications of procedures, not elsewhere classified

1086

5724

1.54

37.74

1.4

1.3

27.45

26.32

u/l

0.50

924

4661

Non-selective monoamine reuptake inhibitors

394

1880

2.03

37.30

1.4

1.3

31.50

36.08

u/l

1.68

305

1545

Complications of surgical and medical care, not elsewhere classified

1310

5931

1.48

36.97

1.4

1.3

28.56

25.65

u/l

2.23

1113

4827

Other diseases of upper respiratory tract

1315

4606

1.50

36.96

1.4

1.3

26.13

25.39

u/l

0.32

1053

3844

Substance abuse

685

3776

1.70

36.53

1.4

22.61

23.94

u/l

0.49

518

3114

Malignant neoplasm of kidney, except renal pelvis

143

5.25

36.39

1.3

37.49

31.38

u/l

0.59

Cervicobrachial syndrome

353

1713

2.09

36.26

1.5

1.3

31.90

32.81

u/l

0.18

288

1387

Other headache syndromes

675

4032

1.69

35.26

1.4

1.3

24.97

28.53

u/l

2.01

543

3334

Endometriosis of pelvic peritoneum

295

1230

2.22

34.58

1.4

1.3

29.10

33.10

u/l

1.06

254

983

Autoimmune diseases

1435

5045

1.45

34.56

1.4

1.3

22.65

24.27

u/l

1.08

1156

4183

Mental and behavioural disorders due to psychoactive substance use

703

3913

1.66

34.18

1.4

22.77

24.03

u/l

0.46

533

3225

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1332

5900

1.46

34.14

1.4

1.3

22.67

26.14

u/l

3.40

1077

4866

Vasomotor and allergic rhinitis

638

3713

1.70

34.09

1.4

1.3

23.94

24.89

u/l

0.29

497

3088

Migraine without aura

497

2769

1.83

34.08

1.5

1.3

21.52

24.53

u/l

1.38

412

2280

Inflammatory diseases of female pelvic organs

1194

5553

1.49

34.01

1.4

1.3

25.27

27.38

u/l

1.28

951

4600

Gastro-oesophageal reflux disease

858

4621

1.58

33.59

1.4

1.3

27.66

29.53

u/l

0.83

662

3818

Bipolar affective disorders

354

1772

2.04

33.56

1.5

1.3

17.73

23.53

u/l

3.78

277

1467

Irritable bowel syndrome

463

2533

1.85

33.47

1.4

1.3

25.08

27.33

u/l

0.74

381

2079

ILD medications: prednisolone, methylprednisolone, prednisone

1437

5595

1.44

33.26

1.4

1.3

25.41

24.70

u/l

0.34

1191

4589

Panic disorder

324

1578

2.10

33.22

1.5

1.3

19.69

19.60

u/l

0.02

253

1314

Other/unspecified dorsalgia

504

2797

1.80

33.11

1.4

1.3

23.68

27.98

u/l

2.17

398

2295

Tramadol

1012

3991

1.53

33.08

1.4

1.3

27.62

26.89

u/l

0.26

829

3262

Sleep apnoea

1166

4975

1.49

33.07

1.4

25.88

30.30

u/l

4.64

932

4069

Triptan medication for migraine, min. 3 purchases

1131

5739

1.49

32.91

1.4

1.3

22.32

26.40

u/l

4.24

947

4688

Oedema, not elsewhere classified

360

1778

2.00

32.71

1.5

1.3

26.98

29.18

u/l

0.62

302

1443

Use of hypnotics and sedatives

1377

5495

1.44

32.64

1.4

1.3

27.05

26.70

u/l

0.13

1086

4533

Follow-up care involving plastic surgery

103

287

3.77

32.14

1.2

1.3

33.14

30.24

u/l

0.31

233

Excluding asthma or asthma-COPD overlap

1006

3303

1.54

31.79

1.4

1.3

24.86

26.96

u/l

1.15

814

2750

Dentofacial anomalies [including malocclusion]

1132

6062

1.47

31.69

1.5

1.3

24.09

26.03

u/l

1.18

925

4981

Certain infectious and parasitic diseases

1322

4603

1.45

31.29

1.4

1.3

25.94

25.73

u/l

0.08

1076

3804

Hypothyroidism, drug reimbursement

249

757

2.34

31.13

1.5

1.2

31.75

26.79

u/l

1.23

201

620

Diseases of the ear and mastoid process

1577

5680

1.40

30.98

1.4

1.3

24.54

25.15

u/l

0.29

1271

4688

Antihypertensive medication - note that there are other indications

1093

3851

1.50

30.66

1.4

1.3

18.30

22.09

u/l

3.83

897

3203

Arthropathies

1300

4577

1.44

30.50

1.4

1.3

20.40

23.29

u/l

2.66

1050

3823

Impingement syndrome of shoulder

255

1168

2.21

30.40

1.4

1.3

34.90

36.60

u/l

0.29

197

956

Missing teeth due to accident, extraction or parodontitis

597

3206

1.67

30.18

1.4

1.3

29.82

32.06

u/l

0.85

459

2639

ILD medications

1475

5698

1.40

29.88

1.4

1.3

25.02

24.34

u/l

0.33

1214

4677

Tonsillectomy and adenotomy

1108

5322

1.46

29.33

1.4

21.20

23.70

u/l

1.86

918

4372

Benign neoplasm of other and unspecified endocrine glands

183

739

2.52

29.31

2.0

1.3

19.70

29.65

u/l

4.33

165

607

Other pulmonary diagnosis

991

3303

1.51

29.27

1.4

1.3

24.49

26.96

u/l

1.48

800

2750

Cervicalgia

278

1338

2.11

29.27

1.4

28.84

31.62

u/l

0.63

224

1092

Acute sinusitis

826

4933

1.54

29.00

1.3

23.42

25.82

u/l

1.33

661

4066

Convalescence

110

341

3.34

28.98

1.4

23.10

28.18

u/l

0.86

279

Obesity, other/unspecified

607

3733

1.65

28.94

1.5

1.4

15.67

28.72

u/l

33.09

504

3044

1425

5165

1.41

28.92

1.4

1.3

26.11

26.37

u/l

0.10

1152

4260

Unspecified/other endometriosis

208

879

2.38

28.85

1.4

1.3

20.04

27.69

u/l

2.86

183

698

COPD differential diagnosis

997

3339

1.51

28.81

1.4

1.3

25.21

26.86

u/l

0.80

804

2776

Shoulder lesions

872

3425

1.53

28.66

1.4

1.3

30.16

29.61

u/l

0.17

700

2825

ILD differential diagnosis

995

3338

1.50

28.52

1.4

1.3

25.25

26.86

u/l

0.76

802

2776

Benign neoplasms

1308

5041

1.42

28.51

1.4

1.3

22.05

22.71

u/l

0.32

1080

4134

Contraceptive management

585

2462

1.68

28.42

1.4

30.32

29.97

u/l

0.08

473

1951

Diseases of oesophagus, stomach and duodenum

1370

5800

1.40

28.23

1.4

1.3

26.31

26.03

u/l

0.11

1077

4807

Symptoms and signs involving the digestive system and abdomen

1146

3965

1.46

28.13

1.4

1.3

24.07

25.29

u/l

0.59

949

3276

Medical treatment for female infertility

633

3943

1.63

28.04

1.3

1.4

15.39

24.56

u/l

16.51

555

3202

Polyp of the female genital tract

404

1224

1.89

28.02

1.4

1.3

31.06

35.31

u/l

1.51

330

982

Oxicams

231

564

2.35

28.01

1.4

1.3

22.03

26.58

u/l

1.18

189

465

Disorders of thyroid, IBD co-morbidities

302

1017

2.06

27.85

1.5

1.3

27.71

26.83

u/l

0.15

242

848

Other maternal disorders predominantly related to pregnancy

1092

4739

1.46

27.75

1.4

25.72

29.22

u/l

2.85

914

3879

Abdominal and pelvic pain

1140

3965

1.45

27.55

1.4

1.3

24.00

25.29

u/l

0.63

940

3276

Persons encountering health services for specific procedures and health care

1421

6079

1.39

27.47

1.4

1.3

28.17

24.33

u/l

4.07

1201

4960

Hyperkinetic disorders, excluding more controls

283

1309

2.06

27.38

1.4

1.3

12.78

14.23

u/l

0.45

214

1127

Complications of medical and surgical care

930

5689

1.48

27.34

1.4

1.3

27.27

27.77

u/l

0.17

767

4652

L01XE Protein kinase inhibitors

166

4.33

27.12

1.6

1.3

35.50

33.29

u/l

0.19

133

Diseases of the skin and subcutaneous tissue

1230

4351

1.43

27.05

1.4

1.3

24.28

25.05

u/l

0.34

1003

3578

Gastrointestinal diseases

878

2906

1.52

26.97

1.4

1.3

22.57

23.09

u/l

0.18

728

2421

Disorders of skin appendages

762

4995

1.53

26.80

1.4

20.56

24.88

u/l

3.74

639

4093

Personality disorders

490

2914

1.71

26.72

1.5

1.4

20.74

22.48

u/l

0.62

383

2413

KRA_PSY_EATING, excluding more controls

220

999

2.24

26.60

1.5

1.4

13.64

16.21

u/l

0.94

192

858

Disorders of adult personality and behaviour

518

3133

1.68

26.48

1.5

1.4

20.54

22.31

u/l

0.66

405

2601

Adenomyosis (Endometriosis of uterus)

194

845

2.33

26.20

1.4

1.3

21.64

35.64

u/l

7.33

169

686

Hyperhidrosis

245

3.67

26.01

1.7

1.3

27.84

22.52

u/l

0.69

209

COPD/asthma/ILD related infections

1312

4722

1.40

25.94

1.3

1.4

26.20

26.46

u/l

0.10

1069

3891

COPD/asthma related infections

1312

4722

1.40

25.94

1.3

1.4

26.20

26.46

u/l

0.10

1069

3891

Hernia of abdominal wall, postoperative

189

813

2.33

25.78

1.3

26.13

29.85

u/l

0.73

152

645

Disorders of synovium and tendon

704

3894

1.54

25.34

1.4

1.3

26.98

26.79

u/l

0.05

557

3231

Other medical care

448

2191

1.73

25.30

1.5

1.3

29.72

28.67

u/l

0.27

402

1756

Persistent mood disorders

263

1311

2.03

25.28

1.4

1.3

23.67

27.56

u/l

1.14

203

1086

Problems related to lifestyle

165

682

2.47

25.23

1.5

1.3

15.03

22.10

u/l

3.14

140

564

Asthma (only as main-diagnosis)

871

3277

1.49

25.02

1.4

1.3

23.41

26.89

u/l

2.47

721

2727

Disease of hard tissues of teeth, NOS

513

1588

1.70

24.98

1.4

1.3

26.78

27.52

u/l

0.17

395

1358

Endometriosis of ovary

257

1199

2.05

24.91

1.4

1.3

24.44

34.02

u/l

4.54

231

960

Conjunctivitis (acute, non atopic), including avohilmo

1254

5476

1.39

24.76

1.4

1.3

28.08

24.91

u/l

2.47

999

4538

Supervision of high-risk pregnancy

531

1938

1.68

24.75

1.3

1.4

23.46

30.73

u/l

5.08

452

1519

Asthma (mode)

931

3338

1.47

24.62

1.4

1.3

22.63

26.86

u/l

3.71

771

2776

Oral corticosteroids

1349

5789

1.37

24.61

1.4

1.3

25.89

25.50

u/l

0.16

1132

4723

Uterine polyps

374

1197

1.85

24.40

1.4

1.3

31.42

35.53

u/l

1.36

307

968

Poisoning by drugs, medicaments and biological substances

404

2340

1.75

24.31

1.4

20.15

23.57

u/l

1.40

303

1931

Diseases of the musculoskeletal system and connective tissue

751

2464

1.54

24.14

1.4

1.3

19.63

22.90

u/l

2.08

627

2075

Asthma (only as main-diagnosis), excluding more controls

864

3236

1.48

24.02

1.4

1.3

23.33

26.81

u/l

2.46

716

2692

Infections with a predominantly sexual mode of transmission

600

3845

1.58

24.00

1.4

20.99

22.18

u/l

0.43

464

3183

Asthma, excluding more controls

921

3236

1.47

23.93

1.4

1.3

22.49

26.81

u/l

3.84

762

2692

Postpartum care and examination

425

1547

1.77

23.81

1.4

22.07

25.55

u/l

1.30

359

1225

Asthma

926

3277

1.47

23.77

1.4

1.3

22.43

26.89

u/l

4.09

765

2727

Malaise and fatigue

554

2726

1.61

23.68

1.4

1.3

26.12

27.29

u/l

0.35

461

2220

Lumbar disc prolapse

783

3906

1.49

23.68

1.4

1.3

27.66

27.71

u/l

0.01

633

3217

Nonorganic sleeping disorders, excluding more controls

335

1854

1.83

23.54

1.5

1.3

20.43

24.59

u/l

1.69

273

1564

Migraine without aura and triptan purchases

420

2491

1.72

23.44

1.5

1.4

21.94

23.93

u/l

0.67

345

2031

Endometriosis of intestine

170

4.18

23.38

1.3

25.03

24.96

u/l

0.01

140

Infections with a predominantly sexual mode of transmission, including avohilmo

772

4806

1.49

23.15

1.4

19.68

21.36

u/l

0.87

609

3980

Dysphagia

242

1208

2.02

23.12

1.4

1.3

30.19

30.99

u/l

0.13

197

994

Complications of labour and delivery

1025

4024

1.43

23.06

1.3

1.4

27.55

28.75

u/l

0.51

861

3274

Symptoms and signs involving the urinary system

751

3804

1.50

23.05

1.5

1.3

26.68

28.33

u/l

0.66

609

3124

Bacterial infection, other or unspecified

456

2312

1.67

23.04

1.4

28.52

28.94

u/l

0.09

392

1898

Localized swelling, mass and lump of skin and subcutaneous tissue

386

2238

1.74

23.04

1.4

25.42

28.86

u/l

1.26

320

1833

Chronic periodontitis, complicated

544

3349

1.59

23.02

1.3

28.31

32.30

u/l

2.17

425

2736

Pain in thoracic spine

230

1132

2.06

22.99

1.4

24.70

29.73

u/l

1.52

191

932

Inflammatory bowel disease treatment related agents

1447

6000

1.34

22.84

1.4

1.3

25.08

24.78

u/l

0.12

1218

4904

Chronic apical periodontitis

1417

5927

1.35

22.76

1.4

1.3

25.16

24.83

u/l

0.14

1134

4910

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

464

1373

1.71

22.68

1.4

1.3

21.71

23.41

u/l

0.53

387

1146

Tobacco use

100

340

3.03

22.62

1.4

1.3

15.28

20.59

u/l

1.24

282

Persons encountering health services in circumstances related to reproduction

634

2758

1.55

22.48

1.4

25.40

28.94

u/l

1.85

533

2200

Pain associated with micturition

162

700

2.35

22.46

1.4

1.3

24.86

27.84

u/l

0.52

127

591

Specific personality disorders

429

2584

1.68

22.42

1.5

1.4

20.27

22.16

u/l

0.64

337

2134

Failed induction of labour

193

914

2.19

21.87

1.3

1.4

12.21

18.89

u/l

3.22

158

742

1764

0.26

21.76

1.4

18.31

20.63

u/l

0.25

1454

Allergic rhinitis

555

3539

1.57

21.64

1.4

22.85

23.56

u/l

0.20

435

2911

Cervical disc disorders

361

2091

1.74

21.61

1.5

1.3

31.73

33.82

u/l

0.52

286

1709

Other enthesopathies

391

2318

1.70

21.55

1.5

1.3

26.44

32.86

u/l

3.35

304

1906

Pain (limb, back, neck, head abdominally)

749

2518

1.50

21.42

1.4

1.3

22.51

25.49

u/l

1.65

621

2124

Any operation in hilmo

6.19

21.33

1.5

1.4

18.08

25.98

u/l

0.61

Phobic anxiety disorders

258

1356

1.93

21.32

1.5

1.4

18.49

19.00

u/l

0.10

205

1132

L02BA Anti-estrogens

270

1445

1.90

21.27

1.5

1.4

35.86

37.44

u/l

0.31

254

1163

Functional dyspepsia

358

2081

1.74

21.26

1.4

23.59

29.84

u/l

3.09

270

1733

Diseases of pulp and periapical tissues, including avohilmo

1245

4748

1.36

21.26

1.4

1.3

22.82

24.53

u/l

1.09

1006

3964

Diseases of external ear

399

2391

1.68

21.12

1.4

22.98

27.06

u/l

1.60

297

1979

Postmenopausal bleeding

304

848

1.90

21.07

1.5

1.3

41.90

44.90

u/l

0.70

252

695

Symptoms and signs concerning food and fluid intake

121

470

2.61

21.01

1.5

1.3

21.10

25.47

u/l

0.82

397

Atopic dermatitis

951

5429

1.40

20.96

1.4

1.3

21.76

25.36

u/l

2.92

765

4471

Diseases of the respiratory system

783

2674

1.48

20.80

1.4

1.3

24.74

26.91

u/l

1.00

629

2228

Pleural effusion

102

366

2.81

20.71

1.4

1.3

24.22

29.23

u/l

0.95

303

Corticotropin deficiency

6.79

20.63

2.5

1.5

43.23

24.75

u/l

1.39

Bacterial infection, other or unspecified, including avohilmo

523

2737

1.57

20.60

1.4

27.76

28.32

u/l

0.14

452

2242

Other disorders of adrenal gland

233

3.36

20.48

1.9

1.3

30.14

26.38

u/l

0.37

191

Schizophrenia or delusion, excluding more controls

359

2083

1.72

20.42

1.5

1.3

21.88

25.35

u/l

1.28

276

1747

Poisoning by medicine

359

2116

1.72

20.39

1.4

19.70

23.58

u/l

1.56

275

1743

Intestinal infectious diseases, including avohilmo, including avohilmo

1378

5797

1.33

20.34

1.4

1.3

24.33

26.24

u/l

1.26

1110

4791

Any death

398

1661

1.68

20.05

1.4

1.3

30.16

33.54

u/l

1.19

356

1336

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

410

2518

1.66

20.04

1.4

19.29

23.38

u/l

1.96

308

2094

Factors influencing health status and contact with health services

207

489

2.14

19.76

1.3

1.4

20.93

28.99

u/l

2.93

170

404

Primary ovarian failure

206

3.58

19.75

2.1

1.3

42.22

24.54

u/l

4.01

174

Disturbances of skin sensation

453

2860

1.60

19.61

1.4

1.3

22.77

26.04

u/l

1.39

369

2315

Other diseases of lip and oral mucosa

507

3282

1.56

19.56

1.4

1.3

30.05

29.17

u/l

0.22

403

2688

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

520

3401

1.55

19.29

1.4

18.79

22.54

u/l

2.21

396

2815

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

288

1622

1.80

19.29

1.4

20.57

23.24

u/l

0.71

212

1341

Visual disturbances and blindness

585

3914

1.50

19.20

1.4

25.81

27.56

u/l

0.62

482

3199

Other functional intestinal disorders

503

2957

1.55

19.10

1.5

1.3

22.70

29.08

u/l

4.54

415

2435

Otitis externa

304

1743

1.76

19.04

1.5

1.3

22.68

25.83

u/l

0.89

234

1447

Spinal instabilities

157

3.84

18.97

1.5

1.4

30.00

31.07

u/l

0.07

129

Pain in throat and chest

1064

4637

1.36

18.94

1.4

1.3

25.79

25.13

u/l

0.26

858

3817

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

699

4761

1.45

18.94

1.4

27.13

28.51

u/l

0.49

577

3879

Adrenocortical insufficiency

190

3.53

18.93

2.0

1.3

33.33

28.78

u/l

0.42

152

Soft tissue disorders related to use, overuse and pressure

282

1583

1.80

18.92

1.4

1.3

29.15

33.71

u/l

1.44

229

1307

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

986

5620

1.37

18.89

1.4

1.3

25.52

27.05

u/l

0.74

806

4602

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

588

3815

1.49

18.74

1.4

1.3

24.61

27.47

u/l

1.25

472

3154

Diseases of male genital organs

214

527

2.05

18.57

1.4

1.3

11.01

10.03

u/l

0.41

171

440

Obesity related asthma

438

2778

1.59

18.55

1.4

1.3

19.70

31.50

u/l

15.56

355

2248

Other predominantly sexually transmitted diseases, not elsewhere classified

349

2100

1.69

18.51

1.3

1.4

21.47

21.20

u/l

0.06

270

1746

Exposure to other specified factors

1036

6622

1.35

18.22

1.3

1.4

22.15

25.32

u/l

2.63

809

5495

Other diseases of hard tissues of teeth

485

1591

1.59

18.21

1.4

1.3

27.79

27.60

u/l

0.04

387

1361

Rotator cuff syndrome

611

2841

1.49

18.16

1.4

1.3

31.12

32.62

u/l

0.48

497

2347

Migraine with aura

471

3065

1.55

17.90

1.5

1.3

19.45

24.77

u/l

3.56

387

2526

False labour

771

3390

1.43

17.88

1.4

23.66

27.21

u/l

2.14

634

2785

Melanocytic naevi, other sites/unspecified

140

630

2.27

17.84

1.5

1.4

25.91

25.49

u/l

0.05

119

530

Artrosis, including avohilmo

1038

4200

1.36

17.83

1.4

1.3

26.44

27.16

u/l

0.28

830

3481

Other shoulder lesions

146

668

2.22

17.82

1.5

1.3

25.58

29.87

u/l

0.84

120

551

Coxibs

262

738

1.87

17.78

1.4

17.47

21.65

u/l

1.48

218

623

Visual disturbances

552

3721

1.49

17.63

1.4

1.3

25.64

27.55

u/l

0.68

457

3035

Other abnormal uterine and vaginal bleeding

260

1033

1.83

17.37

1.4

1.3

25.78

35.23

u/l

4.63

223

828

Alcohol use disorder, ICD-based

384

2398

1.61

17.33

1.4

22.00

24.73

u/l

0.93

293

1973

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

364

2249

1.63

17.24

1.4

22.04

34.10

u/l

12.45

279

1816

Glucagon-like peptide-1 (GLP-1) analogues

364

2249

1.63

17.24

1.4

22.04

34.10

u/l

12.45

279

1816

Seborrhoeic dermatitis

113

471

2.43

17.10

1.6

1.4

21.18

24.54

u/l

0.57

390

Viral hepatitis, IBD co-morbidity

276

2.92

17.04

1.4

1.3

16.11

29.16

u/l

2.80

234

Excessive attrition of teeth

867

6307

1.37

17.02

1.4

23.75

25.56

u/l

0.89

690

5199

Trochanteric bursitis

179

900

2.01

17.00

1.4

31.07

36.70

u/l

1.39

141

729

Cough

458

2791

1.54

16.85

1.4

28.76

29.01

u/l

0.05

375

2294

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

125

550

2.31

16.79

1.5

1.4

29.83

26.53

u/l

0.44

103

458

Arthrosis

837

3307

1.39

16.78

1.4

1.3

27.96

29.68

u/l

0.74

662

2728

Polyuria

185

945

1.97

16.73

1.4

1.3

24.73

26.78

u/l

0.34

142

781

Emotionally unstable personality disorder

264

1517

1.77

16.68

1.5

1.4

18.62

20.52

u/l

0.52

202

1260

Suicide or other Intentional self-harm

361

2248

1.62

16.64

1.5

1.4

21.15

25.28

u/l

1.67

262

1856

Cardiovascular diseases

1054

4189

1.34

16.63

1.4

1.3

21.35

u/l

0.00

882

3456

Deforming dorsopathies

314

1885

1.68

16.62

1.4

1.3

27.89

29.73

u/l

0.42

248

1555

Pollen allergy

361

2222

1.62

16.51

1.5

1.4

18.49

20.50

u/l

0.64

280

1852

Lateral epicondylitis

196

1029

1.93

16.48

1.4

26.04

34.63

u/l

3.03

151

840

Cardiovascular diseases (excluding rheumatic etc)

1102

4772

1.33

16.40

1.4

23.05

22.74

u/l

0.12

915

3945

Autoimmune diseases related-to ILD

1025

6462

1.33

16.39

1.4

25.50

25.44

u/l

0.02

833

5318

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

640

4495

1.43

16.26

1.4

26.16

29.07

u/l

1.38

524

3657

Temporomandibular joint disorders, including avohilmo

799

5662

1.38

16.23

1.5

1.3

24.61

24.75

u/l

0.04

663

4647

Cystitis

1119

5060

1.32

16.18

1.4

1.3

27.81

25.85

u/l

1.09

911

4185

Urticaria and erythema

539

3684

1.48

16.17

1.5

1.4

24.15

26.38

u/l

0.79

439

3020

Other pleural conditions

230

3.03

16.12

1.4

1.3

24.67

29.47

u/l

0.63

186

Gastroduodenal ulcer

153

738

2.08

16.05

1.4

1.3

26.98

30.45

u/l

0.72

125

613

Mental and behavioural disorders due to alcohol, excluding acute intoxication

401

2553

1.57

16.05

1.4

22.29

24.70

u/l

0.78

303

2100

Kela-code for severe mental illness

455

3010

1.52

16.02

1.5

1.3

20.67

24.70

u/l

2.08

344

2472

All influenza

250

1425

1.77

16.00

1.3

26.74

24.15

u/l

0.57

210

1176

Dyshidrosis [pompholyx]

134

3.87

15.98

1.3

1.4

26.17

18.81

u/l

0.78

111

Injuries to the ankle and foot

1004

6486

1.33

15.95

1.4

22.72

25.03

u/l

1.46

808

5353

Other complications of surgical and medical care, not elsewhere classified

137

641

2.17

15.86

1.4

35.07

27.29

u/l

1.54

119

523

Concussion

616

3333

1.44

15.86

1.4

1.3

21.48

24.91

u/l

1.93

492

2796

Gastric ulcer

113

487

2.34

15.82

1.4

1.3

27.80

30.40

u/l

0.38

406

Other and unspecified urticaria

308

1875

1.66

15.63

1.4

22.97

25.66

u/l

0.74

250

1558

Postpartum haemorrhage due to anatomy

303

1849

1.68

15.52

1.3

1.4

17.31

19.09

u/l

0.51

249

1538

Other diseases of the digestive system

215

1182

1.83

15.52

1.4

1.3

21.90

26.26

u/l

1.30

177

970

Haemorrhoids and perianal venous thrombosis

303

1823

1.66

15.47

1.4

1.3

28.03

29.77

u/l

0.40

244

1522

Type 2 diabetes

1240

5565

1.29

15.46

1.4

1.3

21.77

28.06

u/l

10.81

1003

4581

Assault

199

1075

1.88

15.36

1.4

19.76

20.67

u/l

0.17

151

897

Preterm labour and delivery

436

2890

1.53

15.36

1.4

29.72

32.10

u/l

0.72

362

2316

Spondylolisthesis/Spondylolysis

187

992

1.90

15.20

1.4

1.3

31.57

35.36

u/l

0.76

151

806

Allergic contact dermatitis

231

1314

1.79

15.10

1.4

1.3

27.85

28.74

u/l

0.15

187

1089

Mouth breathing

376

2415

1.56

15.04

1.3

1.4

23.55

28.51

u/l

2.32

318

1983

Benign neoplasm: Colon

361

2154

1.58

14.98

1.4

1.3

32.08

34.58

u/l

0.65

282

1758

Fitting and adjustment of other devices

235

1174

1.77

14.97

1.3

27.32

31.33

u/l

1.09

207

930

Chronic rhinitis, nasopharyngitis and pharyngitis

416

2744

1.53

14.88

1.4

1.3

24.96

28.78

u/l

1.67

331

2254

Nausea and vomiting

279

1635

1.68

14.73

1.5

1.4

21.80

24.94

u/l

0.97

235

1345

Cerebral cysts

388

2.48

14.70

1.4

23.38

21.33

u/l

0.22

328

Urticaria

464

3142

1.49

14.68

1.5

1.4

23.23

25.54

u/l

0.77

376

2574

Infections of the skin and subcutaneous tissue

687

4904

1.39

14.68

1.5

1.3

23.53

24.39

u/l

0.32

569

4023

Other otitis externa (chronic)

377

2.49

14.58

1.5

1.3

23.38

26.05

u/l

0.31

314

Mental and behavioural disorders due to sedatives or hypnotics

100

426

2.39

14.56

1.3

1.4

22.09

21.58

u/l

0.05

354

Finngen Rheumatological endpoints

1265

5624

1.28

14.54

1.4

24.45

24.32

u/l

0.05

1018

4667

Other sexually transmitted chlamydial diseases

150

754

2.04

14.53

1.3

1.4

11.51

14.64

u/l

1.00

108

648

Complications associated with artificial fertilization

178

3.31

14.52

1.4

1.3

8.47

23.50

u/l

6.66

147

Post-traumatic stress disorder

194

1062

1.86

14.51

1.5

1.4

16.85

18.54

u/l

0.41

167

887

Otitis externa, unspecified

168

876

1.95

14.50

1.4

1.3

20.67

24.56

u/l

0.90

138

733

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

398

2622

1.54

14.50

1.4

20.37

19.13

u/l

0.36

310

2188

Vocal cord dysfunction

184

863

1.90

14.48

1.5

1.3

28.40

31.92

u/l

0.67

149

716

Malignant neoplasm of breast, HER-negative

197

1035

1.85

14.46

1.3

38.88

37.21

u/l

0.26

183

791

Migraine with aura and triptan purchases

354

2277

1.58

14.44

1.5

1.4

19.73

22.85

u/l

1.17

285

1865

Eating disorder

220

1252

1.79

14.43

1.5

1.4

13.64

16.18

u/l

0.95

192

1067

Hypo-osmolality and hyponatraemia

121

555

2.18

14.35

1.6

1.4

40.41

32.92

u/l

1.23

462

Spontaneous abortion

807

4009

1.36

14.33

1.3

25.44

27.62

u/l

1.02

670

3301

Other and unspecified drugs and medicaments

113

511

2.25

14.30

1.4

31.36

26.34

u/l

0.70

427

Use of pramipexole

189

1027

1.86

14.27

1.3

30.38

32.42

u/l

0.33

152

833

Disturbance of activity and attention

277

1643

1.67

14.22

1.4

12.81

14.23

u/l

0.44

208

1410

Family history of malignant neoplasm

219

1254

1.78

14.08

1.4

28.69

27.76

u/l

0.14

198

1026

Mycoses, including avohilmo

1111

6584

1.29

14.07

1.4

1.3

23.73

25.16

u/l

0.77

877

5454

Disorders of mineral metabolism

383

2.44

14.06

1.3

1.4

31.85

28.75

u/l

0.30

317

Single delivery by caesarean section

429

1623

1.53

13.92

1.4

20.96

23.53

u/l

0.91

369

1318

Autism spe, excluding more controls

166

3.29

13.91

1.4

14.30

13.23

u/l

0.09

151

Misadventures to patients during surgical and medical care

165

867

1.93

13.89

1.4

26.42

28.68

u/l

0.39

140

709

Hyperkinetic disorders

284

1706

1.65

13.82

1.4

12.74

14.36

u/l

0.53

215

1462

Other and unspecified polyneuropathies, also in other diseases

130

628

2.09

13.82

1.5

1.4

34.40

28.25

u/l

0.99

104

524

Dental operations

469

1618

1.50

13.74

1.4

1.3

26.71

28.48

u/l

0.52

388

1358

Other disorders of lacrimal gland

436

2955

1.49

13.73

1.5

1.4

31.49

31.58

u/l

0.02

353

2412

Type 2 diabetes, definitions combined, including avohilmo

1163

5254

1.28

13.71

1.4

1.3

22.57

29.05

u/l

10.49

940

4323

Injuries to the wrist and hand

1230

6434

1.27

13.70

1.4

23.48

25.33

u/l

1.17

992

5314

Disorders of lacrimal system

511

3512

1.44

13.66

1.5

1.3

30.17

31.34

u/l

0.31

414

2845

Other and unspecified nerve root and plexus disorders, also in other diseases

240

1419

1.71

13.63

1.5

1.3

26.99

30.34

u/l

0.79

185

1166

Mental and behavioural disorders due to opioids

284

2.68

13.54

1.4

1.3

18.00

15.24

u/l

0.32

241

Diabetes mellitus

1283

5869

1.27

13.54

1.4

1.3

21.53

26.97

u/l

8.62

1042

4840

FESS (DNB20)

166

883

1.91

13.52

1.4

1.3

24.83

26.60

u/l

0.28

135

726

Use of disulfiram, acamprosate or naltrexone

434

2.32

13.49

1.3

1.4

23.94

25.92

u/l

0.25

352

Epilepsy

297

1851

1.61

13.48

1.4

1.3

24.01

27.53

u/l

1.14

238

1538

Wide developmental disorders, excluding more controls

201

2.99

13.43

1.5

1.4

12.66

13.40

u/l

0.07

178

Perineal laceration during delivery

427

2332

1.50

13.42

1.3

1.4

15.56

19.02

u/l

1.86

361

1904

Dyspnoea

1015

5670

1.30

13.37

1.4

1.3

28.14

26.80

u/l

0.60

831

4642

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

410

2402

1.50

13.32

1.4

12.70

14.26

u/l

0.66

317

2035

COPD (mode)

143

556

2.01

13.28

1.3

26.16

33.88

u/l

2.06

115

457

Maternal care related to the fetus and amniotic cavity and possible delivery problems

842

3718

1.34

13.27

1.4

26.78

29.15

u/l

1.15

690

3060

Follow-up examination after treatment for malignant neoplasms

246

2.75

13.20

1.4

1.3

34.89

37.70

u/l

0.22

221

Anomalies of dental arch relationship, including avohilmo

312

1792

1.59

13.18

1.5

1.4

19.96

21.95

u/l

0.56

248

1509

Other disorders of fluid, electrolyte and acid-base balance

223

1224

1.72

13.15

1.6

1.3

32.27

30.99

u/l

0.19

181

1008

Injuries to the neck

316

2021

1.58

13.13

1.5

1.4

22.02

22.67

u/l

0.14

267

1660

Malignant neoplasm of breast, ER-negative, including Hilmo

216

1173

1.74

12.98

1.3

38.11

36.66

u/l

0.23

202

898

Other follicular disorders

127

626

2.07

12.97

1.4

21.80

23.20

u/l

0.20

108

530

Other diseases of urinary system

1186

5250

1.27

12.95

1.4

1.3

25.47

25.22

u/l

0.09

952

4347

Dislocation, sprain and strain of joints and ligaments at neck level

253

1541

1.66

12.94

1.4

1.3

21.55

22.49

u/l

0.19

213

1262

Spondylopathies

773

3409

1.35

12.86

1.4

1.3

29.72

30.43

u/l

0.22

620

2803

Other diseases of anus and rectum

261

1594

1.64

12.85

1.4

1.3

28.17

30.10

u/l

0.38

208

1326

Chronic sinusitis

507

3576

1.42

12.84

1.4

1.3

27.49

28.44

u/l

0.25

411

2941

Assault by bodily force

120

581

2.10

12.84

1.5

1.4

20.39

20.81

u/l

0.05

491

Alcohol use disorder, Swedish definition

490

3116

1.44

12.84

1.4

21.95

24.99

u/l

1.36

376

2556

Dissociative [conversion] disorders

328

2.51

12.81

1.4

1.3

23.00

17.62

u/l

0.70

281

Liquid cancers

165

839

1.87

12.79

1.4

1.3

31.83

28.88

u/l

0.49

141

626

Unspecified mental disorder

504

3560

1.42

12.76

1.5

1.4

21.54

24.32

u/l

1.19

379

2922

Abnormal findings in secretions and smears from cervix uteri vagina vulva

949

5410

1.30

12.68

1.4

1.3

25.62

27.49

u/l

0.96

777

4435

Eating disorders

226

1345

1.71

12.65

1.5

1.4

13.46

17.10

u/l

1.73

197

1147

Ethmoidectomy

167

910

1.86

12.64

1.4

1.3

24.68

26.89

u/l

0.37

136

746

Candidiasis, including avohilmo

419

2868

1.47

12.64

1.4

23.65

24.52

u/l

0.21

322

2373

Maternal care for other known or suspected fetal problems

656

3021

1.38

12.59

1.4

18.77

24.81

u/l

5.71

532

2496

Mental and behavioural disorders due to alcohol

465

3086

1.44

12.56

1.4

22.02

23.98

u/l

0.67

354

2547

Other skin changes

182

1019

1.80

12.54

1.5

1.3

29.48

28.40

u/l

0.16

159

840

Chronic periodontitis, including avohilmo

1112

5592

1.27

12.48

1.3

1.4

30.08

27.16

u/l

2.02

875

4599

Other diseases of pleura

250

1320

1.65

12.46

1.4

1.3

25.03

29.87

u/l

1.66

209

1066

Implicit viral Sepsis, including avohilmo

257

1580

1.63

12.43

1.4

1.3

24.09

26.10

u/l

0.43

208

1309

Polyneuropathies and other disorders of the peripheral nervous system

150

795

1.90

12.30

1.5

1.3

34.88

28.50

u/l

1.16

120

651

Endometriosis diagnosis and infertility diagnosis occurring together

248

1529

1.66

12.27

1.4

18.70

26.47

u/l

4.25

220

1251

Early lumbar disc prolapse, operated

178

1001

1.81

12.23

1.6

1.4

18.95

24.11

u/l

1.57

147

824

Periodontitis

1111

5603

1.27

12.08

1.3

1.4

29.91

27.13

u/l

1.88

876

4610

Weight loss

424

2.24

12.00

1.6

1.4

24.22

25.43

u/l

0.14

353

Haemorrhage in early pregnancy

540

3798

1.40

11.97

1.4

24.30

27.80

u/l

1.80

458

3099

Inflammatory disease of uterus

288

1850

1.58

11.94

1.4

22.25

24.52

u/l

0.57

231

1530

Other disorders of patella

262

1643

1.61

11.93

1.4

1.3

27.98

28.83

u/l

0.14

199

1356

Gingivitis and periodontal diseases

1063

4309

1.28

11.92

1.4

1.3

27.07

26.14

u/l

0.38

843

3573

Obsessive-compulsive disorder

129

661

1.99

11.86

1.4

1.3

13.38

16.16

u/l

0.62

102

572

Convulsions, not elsewhere classified

235

1416

1.65

11.84

1.4

1.3

20.17

19.79

u/l

0.07

185

1170

Certain infectious and parasitic diseases, including avohilmo

813

3086

1.32

11.84

1.3

26.16

26.67

u/l

0.16

672

2592

Diseases of the digestive system

372

2497

1.49

11.84

1.4

23.93

27.06

u/l

1.06

307

2053

Deviated nasal septum

262

1643

1.60

11.76

1.3

21.85

26.85

u/l

1.79

213

1362

Anorexia (incl.atypical)

122

616

2.02

11.73

1.6

1.4

9.50

17.48

u/l

5.40

108

527

Hypertrophy of breast in women and men

337

2247

1.52

11.71

1.4

27.42

32.03

u/l

1.74

277

1821

Dermatitis due to substances taken internally

318

2.44

11.61

1.4

28.59

25.10

u/l

0.36

262

Subjective visual disturbances

293

1899

1.56

11.53

1.5

1.4

26.88

26.92

u/l

0.01

240

1561

Covid-19 suspected case

337

2253

1.51

11.53

1.3

1.4

25.06

22.67

u/l

0.67

278

1861

Disorders of calcium metabolism

278

2.52

11.41

1.3

1.4

32.40

28.72

u/l

0.30

234

Rheumatism, unspecified

155

853

1.84

11.40

1.4

1.3

27.45

37.07

u/l

2.90

120

703

Monoamine oxidase A inhibitors

116

581

2.02

11.32

1.4

1.3

24.04

32.39

u/l

1.83

473

Intracranial trauma

676

3419

1.34

11.31

1.4

1.3

21.21

24.61

u/l

2.04

541

2867

Osteopathies and chondropathies

543

3617

1.38

11.31

1.5

1.3

29.69

29.56

u/l

0.03

441

2960

Social phobias

151

828

1.85

11.29

1.4

17.99

17.21

u/l

0.11

112

707

Acetic acid derivatives and related substances

231

712

1.69

11.24

1.3

16.53

22.15

u/l

2.33

191

597

Caries of dentine, including avohilmo

724

2782

1.33

11.19

1.3

25.93

27.20

u/l

0.46

591

2340

Diabetes, varying definitions

1253

5875

1.24

11.14

1.4

1.3

21.65

26.99

u/l

8.17

1021

4841

Premenstrual syndrome

127

3.38

11.13

1.4

1.2

6.59

24.29

u/l

7.65

106

Postmenopausal atrophic vaginitis

273

933

1.61

11.12

1.4

1.3

42.39

42.25

u/l

0.02

231

762

Acute suppurative otitis media

427

2799

1.43

11.11

1.5

1.4

15.25

16.98

u/l

0.78

346

2324

Spondylosis

469

2605

1.41

11.09

1.4

1.3

33.13

34.83

u/l

0.48

367

2132

Other postsurgical states

337

2.35

11.08

1.4

23.58

27.85

u/l

0.60

281

Other disorders of the genitourinary system

117

593

1.99

11.05

1.5

1.4

34.14

36.34

u/l

0.26

484

Alcohol dependence

203

1217

1.68

11.01

1.4

23.24

24.92

u/l

0.32

155

1004

Vitamin D deficiency

113

3.48

10.95

1.6

1.4

27.40

22.91

u/l

0.31

Diseases of oral cavity, salivary glands and jaws

444

1592

1.44

10.94

1.4

1.3

26.13

27.58

u/l

0.39

366

1362

Other symptoms and signs involving cognitive functions and awareness

340

2031

1.49

10.88

1.4

24.11

31.26

u/l

3.92

262

1679

Nonorganic sleeping disorders

335

2266

1.49

10.86

1.5

1.4

20.43

23.93

u/l

1.32

273

1863

Lesion of ulnar nerve

139

751

1.87

10.85

1.5

1.3

25.43

30.64

u/l

1.16

114

621

Postpartum haemorrhage

570

3484

1.37

10.81

1.3

1.4

21.18

26.65

u/l

3.86

475

2812

Transport accidents

615

3826

1.34

10.81

1.4

19.88

25.37

u/l

4.77

487

3222

Endometriosis of rectovaginal septum and vagina

472

2.11

10.70

1.6

1.3

33.60

31.91

u/l

0.17

380

All influenza (not pneumonia)

144

790

1.84

10.70

1.3

1.4

23.89

21.81

u/l

0.32

126

662

Other noninflammatory disorders of uterus, except cervix

196

769

1.71

10.69

1.4

1.3

33.07

42.46

u/l

3.15

166

623

Fenamates

154

575

1.84

10.68

1.4

1.3

24.22

25.68

u/l

0.20

125

476

Internal derangement of knee

404

2808

1.43

10.66

1.4

1.3

27.29

28.41

u/l

0.27

325

2324

Diaphragmatic hernia

271

1757

1.55

10.64

1.5

1.3

34.82

34.18

u/l

0.10

221

1441

Gonarthrosis

649

2744

1.34

10.60

1.4

1.3

32.25

33.07

u/l

0.23

512

2262

Other disorders of urethra and urinary system

897

4906

1.28

10.57

1.4

1.3

26.57

26.40

u/l

0.05

719

4056

Non-invasive ventilation

1458

0.47

10.57

1.2

1.3

28.38

30.50

u/l

0.24

1216

Other specified/unspecified soft tissue disorders

201

2.73

10.50

1.7

1.4

24.76

31.88

u/l

0.86

170

Diseases of middle ear and mastoid

788

4998

1.29

10.49

1.4

16.71

21.46

u/l

5.49

642

4133

Other noninflammatory disorders of vulva and perineum

128

682

1.90

10.49

1.4

1.3

27.44

33.31

u/l

1.36

114

541

Car occupant injured in other and unspecified transport accidents

260

1680

1.56

10.47

1.4

20.30

22.51

u/l

0.59

205

1389

Hypertrophic disorders of skin

485

2.08

10.40

1.5

1.4

21.07

22.81

u/l

0.25

411

Corns and callosities

291

2.41

10.38

1.3

21.92

28.83

u/l

0.93

240

Other sleep disorders

122

642

1.92

10.36

1.4

1.3

18.88

26.55

u/l

2.29

546

Benign neoplasm: Caecum

316

2.33

10.31

1.3

30.67

34.64

u/l

0.42

262

Other abnormal products of conception

744

3766

1.31

10.28

1.4

1.3

22.63

26.34

u/l

2.36

629

3084

Early onset COPD, excluding more controls

127

677

1.88

10.28

1.3

24.27

33.39

u/l

2.41

556

Other disorders of skin and subcutaneous tissue

724

4712

1.30

10.20

1.4

1.3

27.22

29.60

u/l

1.16

603

3819

Unspecified misadventure during surgical and medical care

282

2.42

10.15

1.5

1.4

25.85

28.29

u/l

0.23

229

Sacroiliitis, not elsewhere classified

437

2.13

10.11

1.3

1.4

17.74

23.57

u/l

1.15

366

Inflammatory disease of cervix uteri

391

2.19

10.07

1.4

29.18

33.32

u/l

0.52

329

Atypical facial pain

340

2.28

10.05

1.5

1.4

27.49

31.20

u/l

0.43

289

Later onset COPD, excluding more controls

147

2.76

10.03

1.2

27.74

35.46

u/l

0.95

116

Other eating disorders

116

610

1.95

10.01

1.5

1.4

13.03

15.60

u/l

0.58

104

524

Codes for special purposes

613

4609

1.32

10.01

1.4

25.31

24.00

u/l

0.46

518

3781

Type 2 diabetes, strict (exclude DM1)

1115

5246

1.24

10.00

1.4

1.3

22.26

29.30

u/l

11.92

907

4312

Type 2 diabetes, definitions combined

1113

5236

1.24

9.99

1.4

1.3

22.25

29.31

u/l

11.97

905

4302

Iron deficiency anaemia

410

2864

1.41

9.99

1.4

27.08

27.37

u/l

0.05

333

2350

Primary amenorrhea

3.96

9.99

1.7

1.5

15.20

11.85

u/l

0.29

Propionic acid derivatives

241

754

1.62

9.98

1.4

17.71

21.22

u/l

1.15

208

639

Diseases of the eye and adnexa

1110

4485

1.24

9.98

1.4

1.3

23.37

23.42

u/l

0.02

909

3720

Provisional assignment of new diseases of uncertain etiology

612

4604

1.32

9.97

1.4

25.31

24.01

u/l

0.45

518

3777

Erosion and ectropion of cervix uteri

105

3.41

9.91

1.3

40.08

36.88

u/l

0.15

Other and unspecified local infections of skin and subcutaneous tissue

108

556

1.97

9.83

1.3

1.4

22.14

24.59

u/l

0.38

465

Spinal stenosis

302

1490

1.50

9.75

1.4

1.3

33.36

37.59

u/l

1.36

248

1202

Autism

210

2.64

9.74

1.4

14.05

13.37

u/l

0.06

183

Focal epilepsy, strict definition

181

1090

1.67

9.73

1.4

24.06

25.73

u/l

0.30

150

908

Lesion of lateral popliteal nerve

198

2.67

9.71

1.4

1.3

25.84

29.35

u/l

0.30

164

Other disorders of optic [2nd] nerve and visual pathways

358

2.21

9.68

1.8

1.3

18.91

23.20

u/l

0.68

294

Benign neoplasm of colon, rectum, anus and anal canal

429

2607

1.40

9.67

1.5

1.3

32.68

34.27

u/l

0.40

339

2122

Asthma, including avohilmo

1359

6190

1.21

9.67

1.4

1.3

21.83

25.56

u/l

4.60

1112

5103

Infections, IBD-co-morbidities

159

640

1.76

9.66

1.4

1.3

30.83

31.08

u/l

0.03

136

532

Systemic connective tissue disorders

348

2425

1.44

9.66

1.4

27.27

30.17

u/l

0.83

288

1989

Other local infections of skin and subcutaneous tissue

111

582

1.93

9.58

1.3

1.4

22.97

24.90

u/l

0.28

483

Female genital prolapse

303

1123

1.51

9.56

1.4

1.3

34.95

37.47

u/l

0.51

231

907

Focal epilepsy

204

1272

1.61

9.55

1.4

1.3

23.64

25.49

u/l

0.38

166

1052

Other disorders of breast

228

1464

1.58

9.55

1.5

1.4

26.68

28.92

u/l

0.47

194

1204

Abnormal weight loss

366

2.18

9.54

1.6

1.3

27.05

25.41

u/l

0.16

304

Hypertrophic scar

447

2.08

9.54

1.5

1.4

20.41

22.73

u/l

0.35

379

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

585

4388

1.32

9.50

1.4

22.51

23.25

u/l

0.22

469

3615

Flat foot [pes planus] (acquired)

111

584

1.92

9.49

1.5

1.3

31.39

36.92

u/l

0.88

482

Fibroblastic disorders

177

1067

1.67

9.48

1.4

1.3

29.45

33.01

u/l

0.67

137

880

Superficial injury of wrist and hand

280

1882

1.50

9.42

1.3

1.4

21.51

23.13

u/l

0.40

223

1564

Elevated blood glucose level

428

2.08

9.40

1.4

1.3

17.53

24.70

u/l

1.48

357

Schizophrenia, schizotypal and delusional disorders

360

2538

1.43

9.40

1.5

1.4

21.95

24.26

u/l

0.72

276

2083

GI-bleeding

190

1168

1.63

9.39

1.5

1.3

21.89

26.03

u/l

1.18

157

956

Psychotic depression

324

2.25

9.37

1.6

1.3

17.79

27.02

u/l

1.80

269

Asthma-related infections

648

4873

1.30

9.35

1.4

21.83

26.48

u/l

3.81

536

3988

Asthma, hospital admission 2, infections

648

4873

1.30

9.35

1.4

21.83

26.48

u/l

3.81

536

3988

Disorders of continuity of bone

127

703

1.83

9.29

1.4

1.3

23.93

27.40

u/l

0.57

103

579

Schizophrenia or delusion

359

2538

1.42

9.24

1.5

1.4

21.88

24.21

u/l

0.73

276

2083

Premature rupture of membranes

521

2771

1.35

9.24

1.4

16.22

24.58

u/l

9.71

410

2293

Impotence

3.56

9.22

1.2

11.43

11.97

u/l

0.06

Paracetamol or NSAID medication

151

426

1.80

9.22

1.4

1.3

17.03

19.84

u/l

0.61

133

358

544

4076

1.33

9.22

1.4

21.30

25.77

u/l

3.08

455

3343

Heartburn

126

697

1.83

9.21

1.3

26.64

27.88

u/l

0.14

100

564

Malignant neoplasm of tongue, including Hilmo

4.33

9.15

1.4

1.3

37.27

34.66

u/l

0.12

Sexual dysfunction

3.59

9.15

1.3

1.4

11.79

19.92

u/l

1.05

Disorders of vestibular function (Vertigo)

418

2955

1.38

9.14

1.4

29.79

32.84

u/l

1.03

342

2401

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

392

2822

1.40

9.11

1.4

23.56

24.75

u/l

0.31

316

2321

Symptoms and signs involving cognition, perception, emotional state and behaviour

1104

6036

1.23

9.09

1.4

25.36

26.43

u/l

0.50

902

4959

Benign neoplasm: Sigmoid colon

116

627

1.86

9.09

1.5

1.3

27.30

33.27

u/l

1.27

510

Deep endometriosis

165

993

1.69

9.07

1.5

1.4

26.64

24.12

u/l

0.42

139

834

Ovarian hyperstimulation (induction)

226

2.55

9.02

1.5

1.4

8.60

22.69

u/l

6.50

189

Abnormal results of function studies

490

1.98

9.00

1.5

1.4

19.71

27.09

u/l

1.45

405

Pulmonary heart disease

190

1182

1.61

8.99

1.5

1.3

28.77

31.20

u/l

0.51

172

955

Pulmonary embolism

190

1182

1.61

8.99

1.5

1.3

28.77

31.20

u/l

0.51

172

955

Thyroiditis, ILD-related definition

170

1034

1.67

8.92

1.5

1.4

26.95

25.95

u/l

0.14

138

848

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

871

6377

1.25

8.92

1.4

22.23

24.65

u/l

1.57

722

5237

Wide developmental disorders

261

2.38

8.91

1.5

1.4

12.41

12.61

u/l

0.02

229

Enthesopathies of lower limb, excluding foot

256

1710

1.51

8.89

1.5

1.3

29.92

32.17

u/l

0.45

211

1394

Postprocedural disorders of nervous system

140

811

1.76

8.88

1.5

1.4

18.86

24.23

u/l

1.45

119

677

Sequelae of injuries of neck and trunk

157

2.80

8.78

1.3

20.40

23.29

u/l

0.25

133

Other systemic involvement of connective tissue (FG)

270

1794

1.49

8.75

1.4

27.22

30.77

u/l

0.94

231

1491

Other septicaemia, including avohilmo

240

1485

1.52

8.73

1.5

1.3

33.37

27.20

u/l

1.72

194

1225

Focal epilepsy, mode (most common among epilepsy diagnosis)

174

1069

1.64

8.71

1.4

1.3

24.30

25.50

u/l

0.21

145

888

Other septicaemia

234

1448

1.53

8.70

1.5

1.4

33.35

27.16

u/l

1.67

189

1193

Dental caries, including avohilmo

618

2417

1.31

8.68

1.3

26.62

28.06

u/l

0.47

500

2050

Autism spe

217

2.51

8.65

1.4

14.30

13.00

u/l

0.11

188

548

3628

1.32

8.63

1.4

21.98

24.30

u/l

1.01

423

2980

Chromosomal abnormalities, not elsewhere classified

159

2.79

8.59

1.7

1.4

25.79

16.09

u/l

1.34

134

Other sexually transmitted chlamydial diseases, including avohilmo

195

1241

1.59

8.56

1.3

1.4

11.39

13.06

u/l

0.52

145

1070

Thyrotoxicosis, other and/or unspecified

244

1630

1.51

8.51

1.4

1.3

31.83

30.20

u/l

0.30

197

1332

Diabetes mellitus in pregnancy

814

4138

1.26

8.48

1.4

17.82

26.18

u/l

15.05

682

3382

Nutritional anaemias

446

3157

1.35

8.45

1.4

27.07

27.83

u/l

0.17

363

2579

Symptoms and signs involving the nervous and musculoskeletal systems

588

4545

1.30

8.43

1.5

1.3

27.00

27.43

u/l

0.11

500

3703

Intracranial injury

566

4054

1.31

8.39

1.4

18.53

24.62

u/l

6.08

450

3346

Diabetes medication

1226

5958

1.20

8.39

1.4

1.3

21.00

27.11

u/l

10.85

992

4916

Vitamin deficiency, wide

238

2.39

8.37

1.5

1.3

25.66

24.70

u/l

0.07

196

Vitamin deficiency

238

2.39

8.37

1.5

1.3

25.66

24.70

u/l

0.07

196

Other noninfective gastroenteritis and colitis

250

1682

1.49

8.37

1.6

1.4

26.84

25.82

u/l

0.19

207

1391

Hypercalcemia

144

2.82

8.36

1.5

1.3

29.52

31.03

u/l

0.08

117

Hidradenitis suppurativa

355

2.14

8.35

1.3

1.4

23.42

21.64

u/l

0.23

301

Unspecified haematuria

248

1350

1.50

8.29

1.4

1.3

28.51

26.64

u/l

0.37

211

1112

Agranulocytosis

109

597

1.84

8.28

1.4

33.92

29.51

u/l

0.68

489

Hypermobility syndrome

119

673

1.81

8.28

1.4

26.67

22.70

u/l

0.55

100

569

Brachial plexus disorders

155

941

1.67

8.26

1.5

1.4

23.72

28.58

u/l

1.11

132

777

Cutaneous abscess, furuncle and carbuncle

292

2034

1.44

8.23

1.5

1.4

21.99

24.21

u/l

0.68

256

1672

Ganglion

274

1887

1.46

8.22

1.4

26.82

29.40

u/l

0.61

215

1551

Maltreatment syndromes

480

1.95

8.20

1.7

1.4

15.39

20.44

u/l

1.13

406

Other systemic involvement of connective tissue

274

1888

1.46

8.17

1.4

26.93

29.53

u/l

0.62

234

1549

Diseases of salivary glands

370

2689

1.38

8.17

1.4

28.00

28.51

u/l

0.10

297

2193

Fissure and fistula of anal and rectal regions

238

1595

1.50

8.17

1.4

25.81

28.92

u/l

0.71

194

1330

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

4.61

8.15

1.4

40.92

37.85

u/l

0.12

Superficial injury of head

226

1498

1.52

8.12

1.4

22.43

25.71

u/l

0.97

182

1238

Spontaneous rupture of synovium and tendon

331

2.14

8.09

1.4

28.89

36.03

u/l

1.02

280

Cervical polyps

119

675

1.78

8.09

1.4

1.3

34.00

40.32

u/l

1.18

101

539

Special screening examination for other diseases and disorders

515

1.90

8.08

1.5

1.3

18.23

28.47

u/l

2.98

442

Care involving use of rehabilitation procedures

654

4627

1.27

8.07

1.5

1.3

28.45

28.47

u/l

0.01

547

3733

Radial styloid tenosynovitis [de Quervain]

504

1.92

8.05

1.3

24.15

29.49

u/l

0.80

418

Early lumbar disc prolapse operation

181

1150

1.60

8.03

1.6

1.3

18.90

23.10

u/l

1.20

149

946

Suppurative and unspecified otitis media

520

3523

1.31

8.03

1.4

15.63

18.32

u/l

1.68

420

2920

Mycoses

285

1987

1.44

8.00

1.4

23.50

25.88

u/l

0.65

227

1634

500

3396

1.32

7.99

1.4

22.06

24.03

u/l

0.74

385

2793

Cellulitis

209

1370

1.54

7.98

1.5

1.4

24.55

25.25

u/l

0.12

166

1132

Injury, poisoning and certain other consequences of external causes

662

2591

1.29

7.95

1.3

23.69

24.50

u/l

0.25

546

2159

Sequelae of external causes of morbidity and mortality

224

1492

1.51

7.93

1.5

1.3

28.31

27.79

u/l

0.08

197

1225

Open wound of wrist and hand

475

3477

1.33

7.92

1.4

22.50

22.52

u/l

0.00

386

2862

Malignant neoplasm of tongue

4.70

7.91

1.4

37.73

37.18

u/l

0.02

Primary_lymphoid and hematopoietic malignant neoplasms

136

805

1.70

7.88

1.5

1.3

30.74

28.09

u/l

0.39

118

665

Other arthrosis

496

2516

1.33

7.87

1.4

1.3

31.06

34.07

u/l

1.05

386

2076

Implicit viral Sepsis

154

946

1.64

7.76

1.4

24.24

24.36

u/l

0.01

128

782

Diplopia

121

698

1.75

7.75

1.4

25.42

28.05

u/l

0.38

103

568

Other noninflammatory disorders of vagina

532

1.87

7.72

1.3

28.01

35.44

u/l

1.32

428

Extrapyramidal and movement disorders

289

2034

1.43

7.69

1.3

1.4

31.84

30.35

u/l

0.28

227

1660

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

365

2.05

7.68

1.2

1.3

32.58

31.74

u/l

0.07

297

Viral Sepsis

154

950

1.63

7.64

1.4

24.24

24.55

u/l

0.04

128

786

Falls/tendency to fall

1320

5576

1.19

7.64

1.4

23.57

24.78

u/l

0.66

1033

4660

Non-Hodgkin lymphoma, all, including Hilmo

286

2.18

7.63

1.5

1.3

31.75

31.19

u/l

0.04

204

Other symptoms and signs involving the circulatory and respiratory systems

327

2.10

7.57

1.3

1.4

32.63

24.92

u/l

0.92

267

Agoraphobia

296

2.18

7.53

1.5

1.3

20.62

17.71

u/l

0.34

251

Syncope and collapse

346

2095

1.38

7.53

1.3

23.27

25.30

u/l

0.56

280

1725

Pulmonary heart disease, diseases of pulmonary circulation

194

1267

1.54

7.52

1.5

1.3

28.77

31.25

u/l

0.53

175

1025

Other enthesopathy of foot (+metatarsalgia)

127

750

1.71

7.51

1.5

1.4

25.41

31.70

u/l

1.35

618

Algoneurodystrophy

271

2.23

7.47

1.7

1.3

30.24

24.68

u/l

0.65

224

Supplementary factors related to causes of morbidity and mortality classified elsewhere

322

2324

1.39

7.46

1.4

23.20

24.81

u/l

0.35

251

1923

Other epidermal thickening

226

2.34

7.44

1.4

1.3

23.51

23.05

u/l

0.03

184

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

496

1.88

7.43

1.4

1.3

13.33

17.18

u/l

1.02

424

Other peripheral vertigo

425

1.95

7.43

1.5

1.4

33.22

31.50

u/l

0.15

356

Anti-inflammatory and antirheumatic products, non-steroids

227

754

1.52

7.42

1.4

17.48

21.22

u/l

1.27

195

639

Mixed and other personality disorders

121

709

1.73

7.41

1.4

1.3

22.33

23.94

u/l

0.22

596

External causes of morbidity and mortality

796

3214

1.25

7.38

1.3

22.99

24.88

u/l

0.91

651

2717

Acute generalized exanthematous pustulosis

259

2.24

7.36

1.5

1.3

25.05

25.63

u/l

0.05

213

Asthma, unspecified (mode)

552

3095

1.29

7.36

1.4

1.3

23.92

28.08

u/l

2.42

442

2570

Accidents

977

4030

1.22

7.36

1.4

23.59

25.60

u/l

1.15

795

3400

Iron deficiency anaemia secondary to blood loss (chronic)

126

746

1.70

7.36

1.4

29.41

28.88

u/l

0.05

104

617

Other (not insulin) diabetes medications

1098

5380

1.20

7.33

1.4

21.01

29.17

u/l

17.14

886

4427

Hernia of abdominal wall

380

2823

1.35

7.32

1.3

1.4

22.62

28.08

u/l

2.89

304

2318

Injuries to the knee and lower leg

1362

6257

1.18

7.30

1.4

25.23

24.81

u/l

0.17

1105

5169

Cholecystectomy

765

5265

1.24

7.29

1.4

1.3

26.82

30.51

u/l

2.52

619

4290

Metatarsalgia

116

675

1.74

7.26

1.5

1.4

25.98

32.18

u/l

1.20

561

Meralgia paraesthetica

180

2.49

7.22

1.8

1.3

24.38

29.95

u/l

0.46

147

Disorders of breast

762

5447

1.24

7.22

1.4

1.3

27.80

28.96

u/l

0.43

647

4438

Secondary malignant neoplasm of other and unspecified sites

4.56

7.21

1.5

1.2

39.49

34.53

u/l

0.20

Acne vulgaris

143

881

1.64

7.20

1.4

9.47

14.32

u/l

2.47

125

757

Generalized skin eruption due to drugs and medicaments

224

2.32

7.15

1.5

1.3

26.72

23.50

u/l

0.29

183

Radiculopathy

120

707

1.71

7.14

1.6

1.4

34.57

33.07

u/l

0.20

102

586

Asthma, unspecified (mode), excluding more controls

548

3056

1.29

7.14

1.4

1.3

23.96

27.99

u/l

2.30

440

2537

Other external causes of accidental injury

974

4030

1.21

7.13

1.4

24.28

25.60

u/l

0.61

792

3400

Enlarged lymph nodes

147

914

1.62

7.11

1.3

22.09

25.51

u/l

0.75

130

750

Sequelae of injuries of head

263

2.20

7.09

1.2

1.4

18.44

22.64

u/l

0.57

213

Implicit Sepsis

644

3775

1.26

7.08

1.4

1.3

24.97

27.94

u/l

1.47

522

3090

Other disorders of amniotic fluid and membranes

324

2287

1.39

7.07

1.3

1.4

20.00

23.66

u/l

1.50

264

1896

Disorders of psychological development

156

913

1.60

7.05

1.6

1.3

12.26

13.30

u/l

0.21

129

792

Diseases of inner ear

467

3438

1.30

6.99

1.4

1.3

29.65

32.10

u/l

0.85

385

2785

Cervicocranial syndrome

119

705

1.70

6.99

1.6

1.3

25.62

31.52

u/l

1.08

580

Drug-induced neutropenia

338

2.04

6.97

1.4

39.78

31.71

u/l

1.08

277

Plantar fascial fibromatosis

121

721

1.70

6.97

1.4

32.95

33.92

u/l

0.11

100

586

Viral hepatitis, including avohilmo

514

1.83

6.97

1.4

1.3

18.88

20.46

u/l

0.16

426

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1023

6665

1.20

6.96

1.4

1.3

25.15

24.94

u/l

0.07

825

5501

Other diseases of blood and blood-forming organs, wide

186

1228

1.52

6.94

1.4

1.3

29.92

28.61

u/l

0.21

161

994

Diseases of pulp and periapical tissues and dental caries

533

2115

1.30

6.94

1.3

26.15

27.54

u/l

0.42

438

1803

Hypertrophy of breast

303

2199

1.39

6.92

1.4

28.68

32.41

u/l

1.14

252

1785

Other disorders of penis

153

2.56

6.90

1.4

1.3

8.32

11.66

u/l

0.85

123

Nontoxic single thyroid nodule

416

1.92

6.88

1.3

23.86

30.15

u/l

0.81

344

Other specified/unspecified dorsopathies

166

2.51

6.88

1.4

35.53

30.62

u/l

0.32

144

Gestational diabetes (for exclusion)

878

4993

1.22

6.88

1.4

16.37

25.80

u/l

22.98

726

4091

Examination and encounter for administrative purposes

184

2.41

6.84

1.5

1.3

30.02

24.88

u/l

0.35

167

Acne

179

1173

1.53

6.81

1.4

10.36

14.40

u/l

2.12

157

1006

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

784

5577

1.23

6.79

1.3

1.4

22.84

28.16

u/l

5.32

666

4557

Other and unspecified nail disorders

138

2.67

6.78

1.4

1.3

24.65

25.28

u/l

0.04

117

Candidiasis

172

1124

1.54

6.78

1.4

1.3

26.20

26.24

u/l

0.00

134

936

Other and unspecified iron deficiency

320

2341

1.37

6.77

1.4

25.78

26.53

u/l

0.14

259

1936

Other symptoms and signs involving the urinary system

404

1.92

6.75

1.5

1.3

24.56

23.30

u/l

0.13

336

Salpingitis and oophoritis

221

1523

1.46

6.73

1.5

1.3

35.46

36.04

u/l

0.09

173

1249

Other extrapyramidal and movement disorders in other diseases

210

1431

1.48

6.73

1.3

30.39

29.70

u/l

0.09

157

1176

Hypertensive diseases (excluding secondary)

759

3590

1.23

6.72

1.4

26.46

28.10

u/l

0.67

600

2932

Bulimia nervosa (incl. atypical)

472

1.87

6.72

1.4

14.48

16.98

u/l

0.49

406

Acute bronchitis

372

2739

1.34

6.70

1.4

23.94

25.95

u/l

0.62

320

2241

Impacted teeth

331

2094

1.37

6.69

1.4

13.00

12.98

u/l

0.01

297

1779

Septicaemia

259

1670

1.42

6.67

1.5

1.3

31.58

27.37

u/l

1.06

211

1375

Sequelae of other external causes

310

2.06

6.67

1.5

1.3

24.49

25.68

u/l

0.10

251

Colonic or urogenital fistula

254

1800

1.42

6.61

1.4

26.62

27.84

u/l

0.22

208

1480

Stomatitis and related lesions

222

1537

1.45

6.58

1.4

24.45

24.58

u/l

0.02

181

1279

Pregnancy with abortive outcome

971

4219

1.20

6.54

1.4

1.3

25.16

26.95

u/l

0.90

801

3480

Overjet

182

2.41

6.53

1.5

21.23

16.87

u/l

0.32

158

Pediculosis, acariasis and other infestations

354

1.97

6.51

1.6

1.3

18.78

20.95

u/l

0.31

292

Scabies

293

2.08

6.50

1.6

1.3

18.52

19.95

u/l

0.17

241

Injuries to the thorax

343

2556

1.35

6.49

1.4

24.28

26.82

u/l

0.72

254

2114

Bruxism

197

2.37

6.48

1.7

1.4

21.63

21.91

u/l

0.02

163

Other other unspecified disorders of the circulatory system

141

2.59

6.48

1.3

1.4

35.25

32.09

u/l

0.19

114

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.66

6.47

1.3

22.07

35.54

u/l

0.98

Ovarian dysfunction, other/unspecified

3.68

6.45

1.9

1.4

30.51

20.02

u/l

0.87

Osteoporosis

134

765

1.62

6.44

1.5

1.3

44.47

37.17

u/l

1.11

101

621

Other and unspecified follicular disorders

261

2.14

6.43

1.4

1.3

20.42

20.73

u/l

0.02

213

Asthma-related pneumonia

285

2062

1.38

6.42

1.4

22.87

28.46

u/l

2.48

233

1693

Dizziness and giddiness

776

4963

1.22

6.41

1.4

26.24

28.64

u/l

1.20

638

4069

Other and unspecified tonsillitis

459

2962

1.29

6.40

1.4

15.72

17.61

u/l

0.83

374

2464

Additional codes for the location of defect, injury or illness

322

2.01

6.39

1.3

28.73

25.26

u/l

0.32

262

Ocular pain

119

724

1.66

6.39

1.4

23.27

24.59

u/l

0.16

607

Postpartum hemorraghe, all women as controls

570

4458

1.26

6.32

1.3

1.4

21.18

24.01

u/l

1.38

475

3639

malignant neoplasm of male genital organs, including Hilmo

178

2.10

6.31

1.3

12.74

9.58

u/l

0.92

116

Benign neoplasm: Descending colon

204

2.28

6.31

1.6

1.3

28.85

32.06

u/l

0.23

166

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

481

3735

1.28

6.30

1.4

21.34

21.60

u/l

0.07

413

3073

Type of accident

289

2112

1.38

6.29

1.4

21.88

24.72

u/l

0.73

223

1746

Family history of certain disabilities and chronic diseases leading to disablement

525

1.78

6.29

1.5

1.4

13.39

20.09

u/l

2.52

450

Asthma-related pneumonia or sepsis

285

2070

1.38

6.28

1.4

22.87

28.38

u/l

2.43

233

1700

Asthma, hospital admissions 3, pneumonia

285

2070

1.38

6.28

1.4

22.87

28.38

u/l

2.43

233

1700

Congenital malformations, deformations and chromosomal abnormalities

786

6167

1.21

6.27

1.4

22.87

24.03

u/l

0.50

656

5053

Ventral hernia

192

1305

1.48

6.26

1.3

27.22

30.07

u/l

0.55

155

1078

Torsion of ovary, ovarian pedicle and fallopian tube

187

2.36

6.25

1.6

1.2

23.75

27.52

u/l

0.31

153

Schizoaffective disorder

570

1.74

6.23

1.4

19.87

24.04

u/l

0.70

473

Other symptoms and signs involving the nervous and musculoskeletal systems

453

3536

1.29

6.21

1.5

1.4

27.60

27.16

u/l

0.09

389

2856

Benign neoplasm of mouth and pharynx

496

1.79

6.20

1.3

1.4

24.92

29.22

u/l

0.64

404

malignant neoplasm of male genital organs

172

2.10

6.18

1.3

12.23

9.61

u/l

0.72

111

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

963

4722

1.19

6.18

1.4

25.64

26.46

u/l

0.33

789

3891

963

4722

1.19

6.18

1.4

25.64

26.46

u/l

0.33

789

3891

Gluteal tendinitis

279

2.08

6.16

1.5

1.4

31.26

32.85

u/l

0.11

233

Ectopic pregnancy

274

1997

1.39

6.15

1.4

1.3

27.58

31.61

u/l

1.30

233

1624

Small fibre neuropathy

2.87

6.13

1.6

1.4

41.62

27.25

u/l

1.00

Diseases of the myoneural junction and muscle

476

1.80

6.11

1.4

1.3

23.73

26.67

u/l

0.37

393

Viral hepatitis

478

1.80

6.07

1.4

1.3

18.75

20.57

u/l

0.18

395

Heart failure, not strict

508

2691

1.27

6.06

1.5

1.3

29.62

33.64

u/l

1.76

414

2191

Intestinal infectious diseases

1035

6528

1.18

6.05

1.5

1.3

21.91

25.14

u/l

2.72

863

5363

Other CVD

551

1.73

6.04

1.4

1.3

32.49

30.22

u/l

0.22

451

Unspecified maternal hypertension

192

2.36

6.03

1.2

1.4

20.27

20.36

u/l

0.01

160

Other and unspecified epidermal thickening

153

2.47

6.00

1.5

1.3

22.32

20.87

u/l

0.11

125

DVT of lower extremities and pulmonary embolism

267

1932

1.38

6.00

1.5

1.4

28.39

31.13

u/l

0.75

234

1562

Other disorders of conjunctiva

101

598

1.70

5.99

1.4

1.3

33.47

31.26

u/l

0.22

483

Leisure time condition

173

1164

1.50

5.98

1.4

21.88

23.64

u/l

0.26

127

968

Implicit fungal Sepsis, including avohilmo

310

1.99

5.93

1.4

1.3

28.16

26.46

u/l

0.14

261

Assault by unspecified means

130

2.60

5.93

1.4

20.30

19.51

u/l

0.05

111

Benign neoplasm: Rectum

100

592

1.70

5.92

1.5

1.4

33.74

32.93

u/l

0.08

485

Mixed hyperlipidaemia

101

2.80

5.90

1.2

1.3

19.88

27.85

u/l

0.65

Other contact dermatitis

579

1.71

5.90

1.4

27.97

26.61

u/l

0.15

489

Vulvovaginal ulceration/inflammation in other diseases

139

899

1.57

5.88

1.4

20.04

22.82

u/l

0.49

114

764

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

3.54

5.88

1.3

16.73

34.28

u/l

1.59

Haemorrhage from respiratory passages

203

1246

1.45

5.87

1.5

1.3

27.00

28.10

u/l

0.19

178

1032

Other viral hepatitis, including avohilmo

462

1.80

5.84

1.5

1.3

16.44

19.41

u/l

0.35

386

Disorders of conjunctiva

994

6538

1.18

5.83

1.4

1.3

25.06

25.29

u/l

0.08

807

5389

Recurrent dislocation of patella

100

599

1.70

5.78

1.3

20.33

21.15

u/l

0.10

512

Volume depletion

265

2.05

5.77

1.4

1.3

25.08

26.03

u/l

0.06

226

COPD, hospital admission 2, with asthma infections

125

676

1.60

5.73

1.2

1.3

25.45

31.47

u/l

1.44

107

543

Complications of internal orthopaedic prosthetic devices, implants and grafts

115

713

1.62

5.71

1.3

32.39

35.86

u/l

0.46

572

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

152

1001

1.52

5.71

1.4

19.90

20.98

u/l

0.17

120

848

Spondylopathies (FG)

162

1088

1.50

5.69

1.3

1.4

21.20

24.60

u/l

0.79

134

902

Other specified and unspecified personality disorders

123

779

1.60

5.67

1.5

1.3

21.27

23.39

u/l

0.32

650

Medical abortion

914

4174

1.19

5.55

1.4

1.3

27.97

27.14

u/l

0.29

719

3440

Benign thyroid growths and nodules

288

1993

1.35

5.55

1.3

29.85

35.64

u/l

1.98

234

1633

Abnormal findings on diagnostic imaging of other body structures

125

798

1.58

5.54

1.5

1.3

28.14

31.02

u/l

0.42

108

641

SLE (Finngen)

217

2.16

5.52

1.3

23.11

23.38

u/l

0.02

181

Vasomotor rhinitis (mode)

427

1.80

5.48

1.5

1.4

29.02

28.01

u/l

0.08

356

Disorders of parathyroid gland

121

759

1.58

5.46

1.6

1.3

35.10

36.44

u/l

0.15

102

607

Other and unspecified mononeuropathies, also in other diseases

112

2.63

5.41

1.3

44.32

30.76

u/l

0.58

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.96

5.41

1.2

22.01

32.89

u/l

0.87

Autoimmune diseases excluding thyroid diseases

1076

4995

1.17

5.39

1.4

1.3

25.45

24.25

u/l

0.58

882

4141

Noninfective enteritis and colitis

481

3847

1.25

5.39

1.5

1.4

25.84

25.72

u/l

0.03

399

3147

Sequelae of injuries, of poisoning and of other consequences of external causes

225

1623

1.39

5.38

1.4

24.40

27.23

u/l

0.65

179

1338

Abnormal findings on examination of urine, without diagnosis

206

2.16

5.37

1.3

34.54

22.43

u/l

1.17

168

Superficial injury of ankle and foot

165

1127

1.48

5.37

1.5

1.4

16.44

21.49

u/l

1.84

138

940

Other and unspecified myopathies

266

2.01

5.36

1.4

1.3

21.69

25.14

u/l

0.33

214

Benign neoplasm: Ascending colon

415

1.79

5.34

1.5

1.3

36.57

33.46

u/l

0.26

340

Papilloedema, unspecified

162

2.34

5.34

1.8

1.4

10.03

19.44

u/l

2.38

138

Benign neoplasm: Rectum, anus and anal canal

112

703

1.60

5.32

1.5

1.3

34.04

32.84

u/l

0.13

574

Oter anti-inflammatory and antirheumatic agents, non-steroids

124

427

1.60

5.32

1.5

1.3

29.91

32.38

u/l

0.30

355

Other bursopathies

565

1.67

5.32

1.4

1.3

30.05

31.53

u/l

0.15

471

Congenital iodine-deficiency syndrome/hypothyroidism

125

2.52

5.32

1.5

1.3

23.28

23.86

u/l

0.04

103

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

446

1.77

5.31

1.4

26.15

28.03

u/l

0.21

373

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

491

1.73

5.31

1.4

19.91

20.65

u/l

0.07

417

Familial hypercholesterolemia

365

1.84

5.31

1.4

29.07

29.32

u/l

0.02

309

Trigger finger

144

959

1.51

5.29

1.4

33.07

33.87

u/l

0.09

112

784

Chronic viral hepatitis

360

1.86

5.27

1.4

1.3

10.57

19.83

u/l

4.09

297

Oral leukoplakia, including avohilmo

2.86

5.27

1.3

29.83

30.80

u/l

0.04

Other acute lower respiratory infections

493

3777

1.25

5.26

1.4

22.40

23.60

u/l

0.39

419

3094

Implicit bacterial Sepsis

213

1304

1.40

5.26

1.4

1.3

27.79

28.01

u/l

0.03

171

1070

LSIL lesion of the cervix uteri, vagina or vulva

287

2165

1.34

5.26

1.4

27.25

25.73

u/l

0.34

234

1779

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

418

1.79

5.26

1.2

1.4

29.47

31.76

u/l

0.24

340

Emotional disorders starting during childhood or adolecense, excluding more controls

342

1.87

5.24

1.5

1.4

5.71

10.07

u/l

4.88

310

Umbilical hernia

232

1691

1.38

5.22

1.4

18.96

24.06

u/l

2.31

182

1405

Female infertility, tubal origin

458

1.75

5.18

1.4

20.25

35.46

u/l

3.90

374

Fracture of skull and facial bones

181

1266

1.44

5.17

1.5

1.4

24.16

24.98

u/l

0.12

156

1037

Thyrotoxicosis

283

2131

1.34

5.17

1.4

32.75

30.60

u/l

0.45

231

1734

Alcohol abuse, main dg, excluding more controls

120

772

1.56

5.16

1.3

20.04

22.72

u/l

0.41

647

Nail disorders

495

1.71

5.15

1.3

1.4

22.56

25.46

u/l

0.37

414

Transplanted organ and tissue status

421

1.77

5.12

1.4

33.23

25.76

u/l

0.97

352

Asthma, hospital admissions , main diagnosis only

901

6686

1.17

5.12

1.4

22.99

25.51

u/l

1.70

744

5497

Bell's palsy

108

680

1.60

5.11

1.5

1.3

28.08

28.59

u/l

0.05

561

Retention of urine

173

966

1.45

5.11

1.5

1.3

24.14

24.32

u/l

0.02

138

795

Disorders of optic nerve and visual pathways

118

760

1.57

5.10

1.6

1.4

21.43

24.28

u/l

0.48

101

630

Otalgia

596

1.64

5.09

1.4

23.75

24.89

u/l

0.13

501

Malignant neoplasm of corpus uteri

217

2.09

5.09

1.4

1.3

41.99

44.07

u/l

0.14

156

Allergic asthma (mode), excluding more controls

295

2186

1.32

5.07

1.4

1.3

19.55

24.58

u/l

2.29

251

1812

Noninfectious colitis NAS

138

921

1.51

5.04

1.6

1.4

26.73

25.57

u/l

0.15

113

760

COPD related to multimorbidity

142

800

1.50

5.04

1.3

25.48

32.57

u/l

1.96

114

643

Allergic asthma (mode)

295

2189

1.32

5.03

1.4

1.3

19.55

24.62

u/l

2.32

251

1818

Open wound of head

402

2983

1.27

5.02

1.3

1.4

26.35

25.77

u/l

0.13

315

2448

Other chronic obstructive pulmonary disease, including avohilmo

259

1581

1.35

4.98

1.3

27.16

33.11

u/l

2.28

208

1282

Speech and linguistic disorders, excluding more controls

489

1.68

4.98

1.7

1.4

12.75

13.48

u/l

0.11

432

Chronic lower respiratory diseases

1353

6244

1.14

4.97

1.4

21.70

25.46

u/l

4.66

1116

5138

Other benign neoplasms of skin

314

2414

1.31

4.95

1.4

30.55

30.80

u/l

0.04

243

1977

Other viral hepatitis

434

1.75

4.94

1.4

1.3

15.88

20.02

u/l

0.51

360

Fracture of rib(s), sternum and thoracic spine

183

1294

1.42

4.93

1.3

26.84

27.43

u/l

0.08

132

1057

Diabetic retinopathy

138

1264

0.67

4.90

1.3

1.4

27.09

21.06

u/l

1.11

1041

Explicit Sepsis

315

2205

1.30

4.89

1.5

1.4

28.60

26.01

u/l

0.64

257

1813

Other female pelvic inflammatory diseases

199

1434

1.40

4.87

1.6

1.4

30.52

30.15

u/l

0.05

158

1186

Superficial injury of shoulder and upper arm

119

776

1.54

4.86

1.3

1.4

19.60

24.85

u/l

1.25

641

Benign neoplasm of other and unspecified female genital organs

263

1.97

4.86

1.4

1.3

29.91

29.65

u/l

0.02

221

Urinary track infection

1003

4319

1.17

4.85

1.4

1.3

27.66

26.98

u/l

0.25

826

3564

Other and unspecified effects of external causes

352

2756

1.28

4.85

1.4

20.15

23.64

u/l

1.35

295

2273

Nontoxic multinodular goitre

148

1010

1.47

4.85

1.3

29.97

35.26

u/l

1.00

110

830

Necrosis of pulp, including avohilmo

708

5890

1.19

4.84

1.4

23.28

26.82

u/l

2.47

564

4823

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

256

1.97

4.84

1.4

40.62

35.44

u/l

0.45

215

Other bacterial diseases

881

4979

1.17

4.83

1.4

1.3

28.49

28.35

u/l

0.04

733

4048

Benign neoplasm: Stomach

370

1.80

4.83

1.5

1.3

33.07

33.96

u/l

0.07

303

Alcoholic liver disease

277

1.92

4.81

1.3

1.4

26.87

26.48

u/l

0.02

226

Early onset COPD

127

841

1.52

4.81

1.3

24.27

31.35

u/l

1.68

672

Presence of other devices

148

995

1.47

4.80

1.3

31.45

29.47

u/l

0.28

128

818

Impacted cerumen

378

1.78

4.79

1.5

1.3

33.26

27.26

u/l

0.55

317

Nonsuppurative otitis media

282

1860

1.32

4.76

1.4

15.52

15.11

u/l

0.09

225

1571

Pure hypercholesterolaemia

379

3038

0.79

4.76

1.3

29.86

34.25

u/l

1.69

311

2482

Other chronic obstructive pulmonary disease

181

1047

1.42

4.75

1.3

25.44

31.89

u/l

2.03

146

845

Anankastic personality disorder

359

1.81

4.74

1.5

1.3

24.89

22.20

u/l

0.23

306

Undetermined asthma

120

788

1.53

4.73

1.4

1.3

25.78

28.66

u/l

0.44

660

Viral and other specified intestinal infections, including avohilmo

360

2727

1.28

4.73

1.5

1.4

16.42

18.25

u/l

0.65

300

2268

Malignant neoplasm of corpus uteri, including Hilmo

258

1.95

4.72

1.4

1.3

42.44

42.46

u/l

0.00

188

Implicit bacterial Sepsis, including avohilmo

244

1510

1.35

4.71

1.4

1.3

27.80

27.50

u/l

0.04

198

1246

Undetermined asthma, excluding more controls

120

789

1.53

4.71

1.4

1.3

25.78

28.70

u/l

0.45

660

Abnormal involuntary movements

118

774

1.53

4.71

1.3

26.21

26.19

u/l

0.00

100

639

Diarrhoea and gastroenteritis of presumed infectious origin

771

5845

1.18

4.70

1.5

1.3

21.65

23.94

u/l

1.29

646

4793

Ménière disease

418

1.74

4.69

1.5

1.4

31.55

32.82

u/l

0.11

348

Cardiac murmurs and other cardiac sounds

618

1.60

4.66

1.3

1.4

22.94

20.42

u/l

0.36

518

Abrasion of teeth

407

3259

1.25

4.66

1.5

1.3

34.69

31.44

u/l

0.93

330

2652

Puerperal sepsis

144

988

1.47

4.64

1.4

1.3

32.11

33.56

u/l

0.20

116

812

Other specified disorders of external ear

115

2.46

4.64

1.5

1.3

16.90

24.75

u/l

0.54

malignant neoplasm of female genital organs, including Hilmo

124

784

1.51

4.64

1.4

1.3

44.87

34.67

u/l

2.31

108

606

Spondyloarthritis

173

1227

1.42

4.63

1.3

1.4

23.05

24.70

u/l

0.29

143

1015

Malignant neoplasm of skin

275

1407

1.33

4.63

1.5

1.3

33.80

34.83

u/l

0.19

240

1049

All dysplastic lesions of the cervix uteri, vagina or vulva

597

4858

1.21

4.62

1.4

24.90

25.55

u/l

0.19

467

3983

Malignant neoplasm of skin, including Hilmo

308

1585

1.30

4.61

1.4

1.3

34.50

34.34

u/l

0.03

271

1185

Acute and transient psychotic disorders

125

835

1.51

4.60

1.5

1.3

26.21

26.39

u/l

0.02

681

Pruritus

132

892

1.49

4.59

1.5

1.3

22.70

27.45

u/l

1.10

102

747

Scoliosis

566

1.62

4.59

1.4

19.06

20.30

u/l

0.14

485

COPD, early/later onset

181

1082

1.41

4.58

1.3

25.44

31.12

u/l

1.68

146

872

Contusion of ankle

290

1.89

4.58

1.6

1.3

22.82

20.10

u/l

0.25

249

Malignant neoplasm of other and unspecified parts of tongue

4.60

4.58

1.4

42.81

31.26

u/l

0.46

Scabies, including avohilmo

208

1529

1.37

4.54

1.4

21.26

21.55

u/l

0.05

173

1271

Abnormal findings on diagnostic imaging of central nervous system

327

1.83

4.53

1.4

23.64

25.60

u/l

0.17

272

Benign lipomatous neoplasm

243

1828

1.33

4.52

1.4

30.71

31.74

u/l

0.18

202

1495

Dependent personality disorder

117

2.45

4.52

1.4

1.3

22.21

25.54

u/l

0.24

LSIL lesion of the cervix uteri

240

1809

1.34

4.50

1.3

1.4

25.92

23.64

u/l

0.54

198

1489

Explicit Sepsis, including avohilmo

322

2278

1.28

4.49

1.5

1.4

28.61

25.86

u/l

0.71

263

1872

Diabetic retinopathy, excluding more controls

130

1067

0.68

4.47

1.4

26.72

20.60

u/l

1.12

878

Toxic effects of substances chiefly nonmedicinal as to source

114

752

1.53

4.46

1.5

1.4

21.57

21.83

u/l

0.03

628

Benign paroxysmal vertigo

234

1755

1.34

4.45

1.3

1.4

27.72

32.45

u/l

1.46

187

1442

Other and unspecified visual disturbances

101

649

1.57

4.45

1.5

1.4

26.43

27.34

u/l

0.10

536

Other disorders of eye and adnexa

161

1138

1.42

4.44

1.4

1.3

22.68

26.22

u/l

0.71

132

936

Implicit Sepsis, including avohilmo

736

4460

1.18

4.43

1.4

25.41

27.72

u/l

1.10

595

3649

Tinnitus

199

1458

1.37

4.42

1.3

1.4

27.76

30.15

u/l

0.43

157

1190

Asthma and allergy, excluding more controls

187

1340

1.39

4.41

1.5

1.4

19.15

23.22

u/l

1.10

159

1127

Dystonia

323

1.82

4.39

1.4

1.3

36.49

26.15

u/l

1.27

265

Embedded and impacted teeth

412

2694

1.25

4.39

1.4

13.77

14.99

u/l

0.55

367

2235

Nummular dermatitis

323

1.81

4.37

1.5

1.4

29.54

26.83

u/l

0.22

264

Constipation

881

5140

1.16

4.37

1.5

1.3

27.62

29.31

u/l

0.75

686

4230

Asthma and allergy

187

1342

1.38

4.37

1.5

1.4

19.15

23.30

u/l

1.13

159

1127

Invasive ventilation

277

0.29

4.36

1.6

1.3

35.58

24.18

u/l

—

227

Hypoglycaemia, other or unspecified

353

1.77

4.35

1.5

1.4

21.00

21.82

u/l

0.07

292

Disorders of tooth development and eruption

171

992

1.41

4.35

1.4

1.3

21.10

23.55

u/l

0.48

143

850

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

310

1.83

4.34

1.3

1.4

31.45

30.82

u/l

0.05

256

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

551

1.61

4.34

1.6

1.4

32.81

25.86

u/l

0.97

458

Hyperparathyroidism

100

637

1.56

4.33

1.6

1.3

35.62

37.60

u/l

0.21

503

Diseases of liver

271

2087

1.30

4.28

1.3

1.4

26.27

30.84

u/l

1.36

207

1709

Acne, including avohilmo

363

2341

1.26

4.27

1.4

10.58

14.09

u/l

2.76

300

1971

Erosion of teeth , including avohilmo

364

2911

1.26

4.27

1.5

1.4

23.81

22.88

u/l

0.21

282

2406

Abnormalities of forces of labour

204

1514

1.36

4.27

1.3

1.4

30.56

32.97

u/l

0.47

167

1202

Xerosis cutis

3.09

4.26

1.5

1.4

25.68

26.48

u/l

—

Benign neoplasm: Transverse colon

319

1.80

4.23

1.2

1.3

32.08

31.02

u/l

0.08

265

Trigeminal neuralgia

364

1.75

4.23

1.4

23.99

31.13

u/l

0.88

302

Disturbances of smell and taste

220

1.98

4.23

1.3

1.4

37.52

31.81

u/l

0.39

190

Other specific arthropathies, wide

109

2.43

4.18

1.4

1.3

28.29

25.74

u/l

0.12

Other diseases of peritoneum

235

1.94

4.18

1.3

1.4

28.95

31.03

u/l

0.13

196

Biguanides

992

5217

1.15

4.16

1.4

1.3

20.14

29.81

u/l

23.66

800

4285

Autoimmune diseases excluding thyroid diseases, strict definition

1007

4771

1.15

4.16

1.4

1.3

25.30

24.22

u/l

0.47

821

3946

Status post-ami

394

1.62

4.15

1.2

1.4

35.75

26.14

u/l

1.36

319

Benign neoplasm: Lip

2.84

4.14

1.7

1.5

13.91

30.31

u/l

1.42

Gonarthrosis [arthrosis of knee](FG)

699

3411

1.18

4.14

1.4

33.01

33.81

u/l

0.23

547

2801

Scleritis and episcleritis

481

1.64

4.13

1.5

1.4

21.60

28.05

u/l

1.04

399

Excessive vomiting in pregnancy

148

1048

1.43

4.12

1.4

18.51

23.77

u/l

1.41

121

859

Disorders of lipoprotein metabolism and other lipidaemias

497

3646

0.83

4.10

1.3

29.16

33.51

u/l

2.10

396

2953

Persistent delusional disorders

330

1.77

4.10

1.5

1.4

28.94

27.77

u/l

0.08

266

COPD, hospital admissions

176

1074

1.38

4.09

1.3

25.21

31.20

u/l

1.81

144

866

Inflammatory diseases of prostate (prostatitis)

195

2.01

4.06

1.3

10.95

12.53

u/l

0.30

156

Episcleritis

422

1.68

4.06

1.5

1.4

23.52

26.91

u/l

0.38

347

Pediculosis, acariasis and other infestations, including avohilmo

224

1696

1.33

4.06

1.4

20.86

21.47

u/l

0.11

186

1403

Persons with potential health hazards related to communicable diseases

384

4677

0.81

4.05

1.4

20.06

20.90

u/l

0.24

348

3830

Superficial injury of abdomen, lower back and pelvis

160

1150

1.40

4.04

1.4

1.3

19.33

22.04

u/l

0.59

133

960

Other/unspecified synovitis and tenosynovitis

109

729

1.51

4.04

1.4

25.25

29.37

u/l

0.58

608

All dysplastic lesions of the cervix uteri

543

4484

1.20

4.03

1.3

1.4

23.51

24.30

u/l

0.24

422

3691

Specific development disorders of scholastic skills

340

1.75

4.03

1.7

1.3

11.73

12.87

u/l

0.15

297

Other bacterial diseases, including avohilmo

1070

5865

1.14

4.02

1.4

1.3

28.71

26.40

u/l

1.40

883

4796

conjunctival haemorrhage

274

1.84

4.00

1.4

1.3

39.29

32.03

u/l

0.54

229

Maternal care for known or suspected malpresentation of fetus

461

2710

1.22

3.99

1.3

1.4

21.68

24.86

u/l

1.41

379

2237

Sicca syndrome [Sjögren]

517

1.60

3.97

1.5

1.4

30.36

31.71

u/l

0.13

426

Anogenital herpesviral [herpes simplex] infection, including avohilmo

195

1454

1.35

3.97

1.5

1.4

18.97

19.24

u/l

0.05

164

1213

Foreign body on external eye

635

1.54

3.96

1.4

1.3

19.76

18.19

u/l

0.22

523

Use of interferon beta-1a

248

1.90

3.96

1.3

1.4

28.02

25.00

u/l

0.24

205

Mixed disorders of conduct and emotions, excluding more controls

144

2.19

3.96

1.5

1.3

7.24

9.28

u/l

0.43

132

Status epilepticus

112

2.34

3.93

1.4

23.22

23.43

u/l

0.01

malignant neoplasm of female genital organs

102

661

1.52

3.93

1.4

1.3

45.53

34.71

u/l

2.18

508

Chalazion

110

742

1.49

3.92

1.5

1.4

24.05

25.81

u/l

0.24

618

Malignant neoplasm of tonsil and base of tongue

3.83

3.91

1.3

31.16

39.11

u/l

0.41

Aplastic and other anaemias

262

1859

1.29

3.90

1.4

1.3

30.08

28.87

u/l

0.22

221

1527

Other and unspecified mood [affective] disorders

102

679

1.52

3.90

1.4

15.19

19.81

u/l

1.04

578

Effects of foreign body entering through natural orifice

193

1438

1.35

3.90

1.4

1.3

22.13

22.07

u/l

0.01

156

1197

Endometriosis ASRM stages 3,4

332

2661

1.26

3.89

1.4

25.27

27.62

u/l

0.66

289

2170

Hypokalaemia

535

1.58

3.88

1.5

1.4

21.83

30.73

u/l

1.54

441

Palmar fascial fibromatosis [Dupuytren]

313

1.76

3.88

1.5

1.4

20.77

30.09

u/l

1.31

268

Other disorders starting during childhood or adolecense, excluding more controls

313

1.75

3.87

1.5

1.4

9.51

10.68

u/l

0.22

278

Polyhydramnios

105

707

1.51

3.86

1.4

21.81

22.35

u/l

0.05

584

Disorders of eyelid, lacrimal system and orbit

909

5813

1.15

3.85

1.4

1.3

29.04

27.38

u/l

0.74

743

4760

Bacterial Sepsis

255

1629

1.30

3.85

1.4

1.3

26.70

27.10

u/l

0.06

207

1349

Benign neoplasm of other and ill-defined parts of digestive system

123

851

1.45

3.85

1.5

1.3

31.66

31.51

u/l

0.02

687

Collagenous colitis

529

1.58

3.85

1.5

1.4

23.59

28.64

u/l

0.82

440

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

118

812

1.47

3.85

1.3

1.4

21.00

29.21

u/l

2.23

101

664

Cardiac arrhythmias

783

4331

1.16

3.84

1.4

1.3

27.40

26.95

u/l

0.13

646

3559

Cholelithiasis

888

5280

1.15

3.83

1.4

1.3

27.24

29.24

u/l

1.06

716

4314

Dipeptidyl peptidase 4 (DPP-4) inhibitors

290

1786

1.28

3.83

1.3

25.82

36.22

u/l

6.31

217

1452

Conjunctivitis

917

6456

1.15

3.83

1.4

24.24

25.47

u/l

0.55

751

5318

Systemic lupus erythematosus

250

1.87

3.83

1.3

23.11

25.46

u/l

0.16

206

Autonomic disorders

133

2.22

3.83

1.6

1.3

33.01

22.58

u/l

0.78

112

Spirochaetal infections, other/unspecified

444

1.63

3.82

1.4

27.09

29.43

u/l

0.21

372

Moderate visual impairment, binocular

2.62

3.81

1.8

1.5

22.01

23.22

u/l

0.05

Cerebral palsy and other paralytic syndromes

650

1.52

3.80

1.7

1.4

25.83

26.34

u/l

0.05

539

Disorders of gallbladder, biliary tract and pancreas

1023

5599

1.14

3.78

1.4

1.3

27.33

27.93

u/l

0.23

823

4588

Peritonsillar abscess

240

1854

1.30

3.78

1.4

21.65

22.51

u/l

0.17

203

1537

Primary hyperparathyroidism

461

1.61

3.77

1.6

1.4

34.72

37.25

u/l

0.23

368

Postpartum hemorraghe, parous women as controls

570

4038

1.19

3.76

1.3

21.18

25.90

u/l

3.10

475

3301

Benign neoplasm: Colon, unspecified

115

789

1.46

3.76

1.4

1.3

28.65

33.14

u/l

0.69

642

Atopic dermatitis, strict definition with reimbursement

450

3586

1.21

3.76

1.4

1.3

20.51

22.47

u/l

0.69

361

2962

Acute laryngitis and tracheitis

154

1098

1.39

3.75

1.4

15.01

18.88

u/l

1.08

136

923

Thyroiditis

557

1.56

3.75

1.6

1.3

30.20

27.71

u/l

0.26

469

Ascites

237

1.87

3.74

1.3

33.20

35.52

u/l

0.18

193

!Aliquae complicationes praecoces traumatis

202

1.95

3.73

1.7

1.3

15.67

22.02

u/l

0.83

164

Early complications of trauma

202

1.95

3.73

1.7

1.3

15.67

22.02

u/l

0.83

164

Sudden idiopathic hearing loss

439

1.63

3.73

1.5

1.4

24.93

28.55

u/l

0.36

365

Dermatophytosis, including avohilmo

664

5582

1.17

3.71

1.4

24.82

25.40

u/l

0.18

530

4602

Injuries to the abdomen, lower back, lumbar spine and pelvis

331

2624

1.25

3.71

1.4

22.55

24.58

u/l

0.56

268

2157

Unspecified event, undetermined intent

155

2.10

3.70

1.3

1.4

16.43

20.10

u/l

0.38

131

Familial hypercholesterolemia, with ischemic heart disease

148

2.10

3.68

1.1

1.3

23.95

27.44

u/l

0.24

118

Other peripheral vascular diseases

536

1.56

3.66

1.4

18.15

26.20

u/l

1.73

449

Schizophrenia

148

1070

1.39

3.65

1.4

1.3

21.61

24.70

u/l

0.57

117

878

Appendectomy

764

6314

1.15

3.64

1.4

27.49

25.79

u/l

0.73

637

5170

Nontoxic goitre/thyroid nodule

242

1881

1.29

3.64

1.3

29.17

34.78

u/l

1.62

193

1545

Disorders of sclera, cornea, iris and ciliary body

542

4586

1.19

3.64

1.4

27.56

27.19

u/l

0.09

456

3719

Congenital malformations and deformations of the musculoskeletal system

112

768

1.46

3.62

1.4

22.04

19.59

u/l

0.33

662

Allergic urticaria

103

699

1.49

3.62

1.5

1.4

22.64

24.44

u/l

0.19

594

Restless leg syndrome

135

964

1.41

3.59

1.3

30.42

29.64

u/l

0.08

781

Onycholysis

3.16

3.58

1.5

1.4

27.02

27.10

u/l

—

Venous thromboembolism

366

2876

1.23

3.58

1.4

29.39

31.71

u/l

0.67

315

2328

Neuralgia and neuritis, unspecified

300

1.75

3.57

1.6

1.4

38.18

28.60

u/l

0.93

247

Paralytic strabismus

285

1.77

3.56

1.3

19.92

26.30

u/l

1.00

233

Acute pharyngitis

182

1352

1.34

3.56

1.4

15.53

17.11

u/l

0.35

149

1137

Sequelae with surgical and medical care as external cause

146

1058

1.39

3.55

1.4

1.3

31.58

28.34

u/l

0.52

127

865

Other abnormal findings in urine

2.85

3.54

1.4

42.74

23.38

u/l

1.13

Other disorders of bone

208

1592

1.31

3.54

1.4

26.00

25.78

u/l

0.03

170

1308

Emotional disorders and disorders of social functioning with onset specific to childhood

452

1.60

3.53

1.4

5.55

10.24

u/l

5.96

402

SLE, strict definition

250

1.83

3.53

1.3

23.11

26.50

u/l

0.25

208

SLE, ICD10

250

1.83

3.53

1.3

23.11

26.50

u/l

0.25

208

Other nonscarring hair loss

106

2.34

3.52

1.4

23.16

21.18

u/l

0.09

COPD

186

1133

1.34

3.51

1.3

25.82

32.19

u/l

1.98

149

919

Mental retardation, excluding more controls

172

1.98

3.51

1.7

1.3

12.84

19.57

u/l

1.11

151

Nonsuppurative otitis media, including avohilmo

398

2837

1.22

3.51

1.4

17.42

19.19

u/l

0.56

324

2351

Acute alcohol intoxication

176

1316

1.34

3.51

1.4

21.50

22.12

u/l

0.10

132

1101

Recurrent dislocation and subluxation of joint

590

1.52

3.51

1.3

18.62

26.40

u/l

2.22

496

Other and unspecified nonorganic psychotic disorders

222

1718

1.30

3.49

1.5

1.4

19.61

21.77

u/l

0.51

173

1417

Pregnancy hypertension

714

5536

1.16

3.49

1.3

1.4

22.81

27.71

u/l

4.26

602

4528

Achilles tendinitis

558

1.53

3.49

1.3

1.4

26.97

33.45

u/l

0.91

459

Benign neoplasm: Vulva

119

2.23

3.48

1.6

1.4

26.50

28.27

u/l

0.10

Other noninflammatory disorders of cervix uteri

215

1.88

3.46

1.3

42.54

41.14

u/l

0.08

182

Retained placenta and membranes, without haemorrhage

161

1194

1.36

3.44

1.5

1.4

31.92

31.39

u/l

0.07

141

970

Dermatophytosis

624

1.50

3.44

1.5

1.4

22.07

25.75

u/l

0.61

519

Raynaud syndrome

115

806

1.44

3.44

1.4

18.75

24.67

u/l

1.24

678

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

674

1.48

3.44

1.3

19.28

27.11

u/l

2.37

564

Injury of muscle and tendon at shoulder and upper arm level

208

1598

1.31

3.43

1.3

1.4

29.00

29.92

u/l

0.15

168

1305

therapeutic use

2.37

3.42

1.5

1.4

20.06

31.26

u/l

1.15

Orthopaedic devices associated with adverse incidents

3.56

3.41

1.1

1.4

24.63

36.98

u/l

—

Conductive hearing loss, unspecified

458

1.58

3.41

1.4

32.00

25.34

u/l

0.93

381

Abnormal findings on examination of blood, without diagnosis

299

2172

1.25

3.41

1.4

23.74

25.95

u/l

0.54

250

1789

Contact with and exposure to communicable diseases

339

4116

0.82

3.40

1.4

20.22

20.21

u/l

0.00

308

3377

Presence of other functional implants

218

1922

0.77

3.39

1.3

1.4

30.74

35.34

u/l

1.03

169

1566

Polyarthrosis

119

754

1.43

3.39

1.4

1.3

39.59

43.84

u/l

0.64

629

Cholelithiasis, broad definition with cholecystitis

910

5334

1.14

3.39

1.4

1.3

27.20

29.04

u/l

0.96

735

4355

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

313

1.71

3.37

1.3

1.4

18.67

26.08

u/l

1.13

264

Malignant neoplasm of tonsil and base of tongue, including Hilmo

2.86

3.37

1.4

1.2

29.56

34.11

u/l

0.25

Pneumothorax

217

1.85

3.36

1.5

1.3

31.75

22.17

u/l

0.96

176

Neuromuscular dysfunction of bladder

444

1.59

3.36

1.6

1.4

25.46

27.74

u/l

0.25

369

Fall on same level

1308

6266

1.11

3.35

1.4

25.45

24.52

u/l

0.44

1036

5211

Other anaemias

232

1696

1.28

3.34

1.5

1.3

28.73

29.25

u/l

0.08

195

1396

Colon adenocarcinoma

203

1.88

3.33

1.3

26.17

35.79

u/l

1.10

140

Melanocytic naevi

362

2981

1.22

3.33

1.4

23.99

25.87

u/l

0.55

312

2440

Statin medication

907

4497

1.14

3.32

1.4

1.3

27.21

26.21

u/l

0.40

743

3678

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

118

836

1.42

3.32

1.4

33.69

30.88

u/l

0.38

684

Labour and delivery complicated by umbilical cord complications

575

1.52

3.31

1.4

22.87

27.59

u/l

0.73

473

Lesion of radial nerve

155

2.02

3.31

1.4

1.3

36.08

29.02

u/l

0.52

128

Other and unspecified anaemias

228

1672

1.28

3.29

1.5

1.3

29.06

29.23

u/l

0.02

192

1376

Amputation

197

1.88

3.28

1.3

33.97

26.22

u/l

0.49

164

In situ neoplasms

349

2868

1.22

3.27

1.4

1.3

27.16

28.18

u/l

0.23

283

2356

Perforation of tympanic membrane

551

1.52

3.26

1.3

1.4

19.96

24.52

u/l

0.67

467

Unspecified kidney failure

219

1.83

3.26

1.9

1.3

21.74

27.41

u/l

0.51

180

Use of biperiden

249

1.78

3.25

1.4

31.01

28.83

u/l

0.16

201

Redundant prepuce, phimosis and paraphimosis

386

1.61

3.24

1.3

1.4

7.38

9.82

u/l

1.71

322

Outcome of delivery

226

1764

0.78

3.23

1.4

33.73

29.15

u/l

1.15

207

1388

Nasal polyp

123

882

1.40

3.22

1.5

1.4

22.09

28.05

u/l

1.42

102

745

Foreign body in alimentary tract

257

1.77

3.22

1.4

1.3

27.73

21.34

u/l

0.61

210

Conjunctivitis (acute, non atopic)

321

2609

1.23

3.22

1.4

24.16

25.19

u/l

0.23

267

2151

Pregnancy, childbirth and the puerperium

297

1242

1.25

3.22

1.4

20.70

20.94

u/l

0.05

255

1014

Degenerative diseases of the nervous system

431

0.53

3.20

1.3

1.2

49.21

35.59

u/l

0.68

354

Recurrent aphthous stomatitis , including avohilmo

132

960

1.38

3.20

1.4

24.49

25.26

u/l

0.09

104

807

Other disorders of glucose regulation and pancreatic internal secretion

442

1.57

3.19

1.5

1.4

20.49

23.16

u/l

0.28

373

Erysipelas

347

2457

1.22

3.19

1.4

26.26

30.20

u/l

1.59

283

2005

Other inflammation of eyelid

120

860

1.40

3.17

1.4

1.3

23.22

29.43

u/l

1.36

100

708

Viral infections characterized by skin and mucous membrane lesions

392

3268

1.20

3.15

1.5

1.4

22.16

25.86

u/l

1.50

322

2677

Juvenile cataract

4.20

3.14

1.9

1.4

16.23

33.79

u/l

—

Vestibular neuronitis

414

1.58

3.09

1.4

33.57

28.95

u/l

0.53

347

Obstructed labour due to maternal pelvic abnormality

175

1337

1.32

3.09

1.3

1.4

32.71

38.74

u/l

1.41

144

1062

Hypertension, essential

899

4496

1.13

3.09

1.4

28.10

30.48

u/l

1.25

706

3679

Ill-defined and unknown causes of mortality

180

1.90

3.09

1.3

17.57

25.07

u/l

0.90

146

Pregnancy examination and test

337

1714

1.23

3.08

1.5

1.4

22.89

27.40

u/l

1.73

284

1350

Striking against or struck by other objects

326

2675

1.22

3.08

1.4

20.38

21.43

u/l

0.28

264

2210

Congenital malformations of uterus and cervix

270

1.74

3.07

1.3

1.4

13.49

19.62

u/l

1.17

232

Zoster [herpes zoster], including avohilmo

411

3332

1.19

3.05

1.4

1.3

31.16

30.01

u/l

0.25

333

2727

Injury of muscle and tendon at wrist and hand level

691

1.44

3.05

1.3

1.4

25.46

25.22

u/l

0.02

569

Bacterial intestinal infections, IBD co-morbidities

125

909

1.38

3.04

1.4

32.70

28.03

u/l

0.75

108

754

Injuries to the head

1210

6468

1.11

3.04

1.4

22.93

25.37

u/l

1.90

979

5340

Burn and corrosion of wrist and hand

240

1.77

3.03

1.4

14.87

18.48

u/l

0.41

201

Viral and other specified intestinal infections

233

1805

1.26

3.03

1.5

1.4

13.78

15.34

u/l

0.49

200

1522

Artificial joint operation, meniscal resection

544

4043

0.86

3.02

1.3

1.4

33.79

32.47

u/l

0.39

442

3284

Panniculitis affecting regions of neck and back

182

1.89

3.02

1.6

1.4

27.06

31.39

u/l

0.26

150

ILD medications: immunosuppressive drugs

657

5188

1.15

3.02

1.4

1.3

27.34

26.00

u/l

0.46

547

4243

Colorectal cancer

506

1.50

3.01

1.4

1.3

35.64

33.65

u/l

0.18

361

Ankylosing spondylitis

505

1.51

3.01

1.3

23.14

27.05

u/l

0.56

424

Colorectal adenocarcinoma

372

1.60

3.01

1.4

1.3

33.90

34.91

u/l

0.08

260

Bitten or struck by other mammals

157

1187

1.33

3.00

1.4

1.3

22.00

24.19

u/l

0.42

130

992

Fall on and from stairs and steps

229

1817

1.26

3.00

1.3

1.4

22.01

27.28

u/l

1.65

174

1492

Event of undetermined intent

410

1.57

2.99

1.3

1.4

23.53

19.72

u/l

0.41

345

Contact with machinery

324

1.64

2.98

1.3

1.4

23.97

18.01

u/l

0.76

266

Chronic gastritis

135

997

1.36

2.98

1.6

1.4

33.75

33.42

u/l

0.03

111

833

Other infective otitis externa

340

1.63

2.98

1.4

24.99

25.31

u/l

0.03

279

Manic episode

176

1.90

2.97

1.4

1.3

27.41

19.53

u/l

0.60

148

Zoster [herpes zoster]

119

862

1.39

2.97

1.5

1.3

28.80

29.56

u/l

0.08

103

704

Other gastritis (incl. Duodenitis)

129

947

1.37

2.97

1.4

30.94

29.65

u/l

0.16

104

787

Arthropathies in other diseases classified elsewhere

162

1.93

2.96

1.3

22.50

27.49

u/l

0.44

140

Other obstetric trauma

107

765

1.42

2.96

1.4

26.37

24.96

u/l

0.16

619

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1019

6150

1.12

2.94

1.4

1.3

26.92

26.23

u/l

0.26

854

5027

Carcinoma in situ of breast, intraductal

500

1.51

2.94

1.3

1.4

38.95

39.80

u/l

0.07

407

Systemic lupus erythematosus, unspecified

221

1.79

2.92

1.4

24.21

26.82

u/l

0.16

188

Disorders of choroid and retina

438

3609

0.85

2.91

1.4

1.3

31.62

30.56

u/l

0.24

344

2938

Extreme obesity with alveolar hypoventilation

163

1.92

2.91

1.2

1.3

23.13

32.23

u/l

0.98

130

Endometriosis ASRM stages 1,2

299

2458

1.22

2.89

1.4

28.96

27.00

u/l

0.44

258

2017

Ehlers-Danlos syndrome, including avohilmo

172

1.92

2.88

1.3

1.4

28.82

19.45

u/l

0.81

144

Acute alcohol intoxication, ICD10

158

1202

1.32

2.88

1.3

1.4

20.97

21.46

u/l

0.07

115

1003

Periapical abscess

434

3687

1.18

2.88

1.3

1.4

25.47

29.53

u/l

2.00

348

3008

Burns and corrosions of external body surface, specified by site

683

1.43

2.88

1.5

1.4

20.53

21.21

u/l

0.08

576

Malignant neoplasm of colon, including Hilmo

380

1.58

2.87

1.3

28.03

33.87

u/l

0.68

271

Melanocytic naevi of trunk

124

911

1.37

2.87

1.4

21.88

25.31

u/l

0.63

112

757

Malignant neoplasm of larynx, including Hilmo

5.42

2.87

1.4

1.3

8.59

19.37

u/l

—

Hypoparathyroidism

136

2.00

2.86

1.8

1.3

35.59

30.03

u/l

0.29

111

Desensitization to allergens

586

1.47

2.86

1.5

1.3

18.47

19.28

u/l

0.09

496

Open bite

537

1.49

2.85

1.5

1.4

17.45

17.55

u/l

0.01

462

Disorders of ocular muscles, binocular movement, accommodation and refraction

569

4899

1.15

2.83

1.4

23.39

25.58

u/l

0.83

462

4004

Hypertensive diseases

926

4658

1.12

2.83

1.4

28.52

29.73

u/l

0.48

733

3818

Stenosis and insufficiency of lacrimal passages

464

1.52

2.82

1.4

23.75

29.64

u/l

0.87

389

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

253

1.71

2.81

1.5

1.3

24.86

30.95

u/l

0.65

209

Hypertension

925

4654

1.12

2.81

1.4

28.52

29.76

u/l

0.50

733

3814

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

432

1.53

2.81

1.3

1.4

26.00

28.49

u/l

0.22

351

Calcific tendinitis of shoulder

362

1.59

2.79

1.3

1.4

39.73

36.33

u/l

0.25

298

Diseases of peritoneum

474

1.51

2.77

1.3

1.4

27.96

29.45

u/l

0.12

396

Use of memantine

266

0.42

2.77

1.4

1.3

36.20

35.87

u/l

—

216

Use of other anti-dementia drugs

266

0.42

2.77

1.4

1.3

36.20

35.87

u/l

—

216

Sarcoidosis

100

715

1.41

2.74

1.5

1.3

29.62

30.46

u/l

0.08

571

Crossbite

482

1.48

2.73

1.6

1.5

16.77

17.40

u/l

0.08

418

Other and unspecified rosacea

100

716

1.41

2.73

1.4

31.77

29.46

u/l

0.25

593

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

263

1.68

2.73

1.4

1.3

24.93

28.75

u/l

0.33

212

Other symptoms and signs involving general sensations and perceptions

167

1.87

2.72

1.6

1.4

19.24

19.96

u/l

0.05

142

Inflammatory disorders of breast

104

752

1.40

2.71

1.6

1.4

16.70

22.58

u/l

1.51

630

Senile cataract

227

1718

0.80

2.70

1.3

37.91

37.55

u/l

0.05

178

1375

Maternal care for known or suspected fetal abnormality and damage

234

2443

0.81

2.70

1.4

17.10

24.02

u/l

3.57

182

2020

Enterocolitis due to Clostridium difficile

397

1.54

2.68

1.5

1.3

38.91

26.68

u/l

1.66

327

Malignant neoplasm of digestive organs

140

805

1.33

2.68

1.3

31.34

33.79

u/l

0.35

113

584

Type1 diabetes, definitions combined, early onset

607

0.59

2.67

1.3

1.4

13.29

15.39

u/l

0.24

523

LeFortI or BSSO operation

399

1.55

2.67

1.4

23.61

23.04

u/l

0.05

339

Other mental disorders due to brain damage and dysfunction and to physical disease

311

1.61

2.66

1.4

1.3

30.32

30.46

u/l

0.01

257

Osteoporosis with pathological fracture (FG)

154

1.89

2.65

1.6

1.3

60.39

46.87

u/l

0.62

128

Thyrotoxicosis with diffuse goitre

165

1281

1.30

2.64

1.3

29.02

29.84

u/l

0.11

133

1055

Lichen simplex chronicus and prurigo

281

1.65

2.64

1.3

32.10

29.60

u/l

0.19

230

Anogenital herpesviral [herpes simplex] infection

104

756

1.39

2.63

1.5

1.4

18.15

21.37

u/l

0.56

641

Benign neoplasm: Skin of other and unspecified parts of face

480

1.49

2.63

1.4

26.05

28.60

u/l

0.24

402

Condition for Implicit Sepsis (Organ dysfunction codes)

758

4658

1.13

2.63

1.4

25.52

27.67

u/l

1.01

611

3821

Prolonged pregnancy

230

2414

0.81

2.61

1.3

1.4

19.67

22.93

u/l

0.95

191

2008

Pedal cyclist injured in other and unspecified transport accidents

689

1.40

2.59

1.4

20.15

23.98

u/l

0.73

572

Chronic suppurative otitis media, including avohilmo

425

1.52

2.59

1.3

26.29

21.15

u/l

0.62

357

Other infectious diseases, including avohilmo

417

1.52

2.58

1.4

1.3

28.64

23.40

u/l

0.55

343

Duodenal ulcer

229

1.71

2.58

1.4

1.3

24.87

29.23

u/l

0.45

183

Congenital malformations of genital organs

151

1157

1.31

2.57

1.5

1.4

22.30

22.95

u/l

0.10

128

962

Disorders of optic nerve, not elsewhere classified

2.38

2.57

2.1

1.3

34.54

29.48

u/l

—

Alzheimer disease

325

0.53

2.56

1.4

1.2

44.29

36.59

u/l

0.33

265

Hypermetropia

426

1.51

2.56

1.5

1.4

16.61

22.11

u/l

1.11

355

Hydronephrosis

475

1.48

2.55

1.3

1.4

40.70

26.22

u/l

2.25

398

Other CVD (FINNGEN)

298

1.54

2.54

1.5

1.3

29.70

26.85

u/l

0.20

250

Other and unspecified injuries of lower leg

626

1.42

2.52

1.3

1.4

27.53

23.19

u/l

0.57

529

Visual impairment including blindness (binocular or monocular)

277

1.63

2.52

1.6

1.3

27.20

26.54

u/l

0.04

230

Diagnoses used for exclusion with ILD

150

1157

1.30

2.52

1.4

1.3

30.98

29.98

u/l

0.12

130

935

Speech therapy

114

1522

0.75

2.51

1.4

1.3

35.40

30.79

u/l

0.69

100

1241

Viral infections of the central nervous system, including avohilmo

511

1.46

2.49

1.5

1.4

19.11

23.90

u/l

0.88

425

Asthma mixed form (mode), excluding more controls

255

1.66

2.48

1.3

18.74

22.86

u/l

0.48

214

Congenital deformities of hip, including avohilmo

173

1.82

2.48

1.3

1.4

25.76

17.20

u/l

0.60

151

Later onset COPD

278

1.56

2.47

1.2

1.3

27.85

31.57

u/l

0.42

224

Ehlers-Danlos syndrome

131

1.97

2.46

1.4

28.61

20.30

u/l

0.56

113

Keratitis

334

2819

1.19

2.46

1.4

28.32

26.21

u/l

0.54

276

2308

Deep bite

117

767

1.35

2.46

1.4

16.39

20.80

u/l

1.13

657

Asthma (diagnoses ohter than nonallergic)

918

6687

1.11

2.45

1.4

22.35

25.58

u/l

2.66

750

5506

Asthma mixed form (mode)

256

1.65

2.45

1.3

18.74

23.09

u/l

0.51

215

Unspecific neurodegenerative disorder

496

0.63

2.45

1.4

1.3

35.32

34.49

u/l

0.05

417

Chronic pancreatitis

390

1.52

2.45

1.4

1.3

29.20

26.58

u/l

0.22

319

IBD (strict) with PSC

0.00

2.45

0.0

1.4

—

18.21

—

Other neurological diseases

531

3593

1.15

2.44

1.4

1.3

27.43

29.87

u/l

0.91

436

2924

Colitis, primary sclerosing, strict definition

0.00

2.44

0.0

1.4

—

19.77

—

Malignant neoplasm of colon

303

1.59

2.43

1.3

30.28

34.47

u/l

0.37

217

Certain disorders involving the immune mechanism

152

1182

1.29

2.43

1.5

1.3

29.96

28.21

u/l

0.25

133

965

Postpartum haemorrhage due to retained placenta

265

2200

1.21

2.41

1.3

21.62

25.24

u/l

1.14

222

1809

Alzheimer disease, including avohilmo

379

0.58

2.41

1.3

45.39

37.28

u/l

0.40

310

Carrier of infectious disease

175

1.80

2.40

1.4

18.44

18.95

u/l

0.03

150

Crohn disease

134

1027

1.31

2.40

1.4

1.3

22.53

23.60

u/l

0.17

116

852

Carcinoma in situ of cervix uteri, exocervix

2.17

2.39

1.3

1.5

12.74

23.93

u/l

1.41

Superficial injury of lower leg

273

2270

1.21

2.39

1.5

1.4

23.40

25.58

u/l

0.51

212

1868

Any dementia

489

0.64

2.39

1.3

39.46

34.47

u/l

0.29

407

Hordeolum and other deep inflammation of eyelid

377

1.52

2.38

1.5

1.4

27.58

23.98

u/l

0.34

321

Colorectal cancer, including Hilmo

580

1.40

2.38

1.4

1.3

34.47

34.02

u/l

0.04

417

Emotional disorders starting during childhood or adolescence

446

1.48

2.38

1.5

1.4

5.71

9.84

u/l

4.80

391

Malignant neoplasm of vulva, including Hilmo

2.65

2.37

1.8

1.3

41.90

37.08

u/l

0.19

Cluster headache, strict

259

1.64

2.37

1.3

1.4

24.88

23.21

u/l

0.14

225

Other neurotic disorders

168

1.80

2.37

1.6

1.3

24.53

24.83

u/l

0.02

138

Disorder of lipoprotein metabolism, unspecified

345

1.54

2.36

1.4

1.3

21.69

32.23

u/l

1.72

286

HSIL lesion of the cervix uteri

372

3186

1.17

2.36

1.4

21.11

23.96

u/l

1.05

278

2631

HSIL lesion of the cervix uteri, vagina or vulva

390

3353

1.17

2.36

1.4

21.75

24.44

u/l

0.99

293

2761

Anxious personality disorder

169

1.80

2.35

1.7

1.4

21.86

17.91

u/l

0.24

142

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

207

1.73

2.34

1.3

1.4

28.92

19.97

u/l

0.81

177

Other bacterial intestinal infections

122

926

1.32

2.34

1.4

1.3

33.21

28.24

u/l

0.80

105

766

Conduction disorders

144

892

1.30

2.33

1.3

20.23

27.37

u/l

2.02

112

728

Giant cell arteritis

2.10

2.33

1.4

1.3

29.32

34.12

u/l

0.28

Other conjunctival vascular disorders and cysts

2.06

2.33

1.5

1.4

32.07

27.33

u/l

0.25

Pneumonia due to other infectious organisms, not elsewhere classified

140

1.87

2.33

1.5

1.4

33.38

23.80

u/l

0.60

114

Parkinson's disease, excluding more controls

189

1.71

2.32

1.2

35.93

36.93

u/l

0.06

164

Other specified/unspecified systemic involvement of connective tissue

388

1.51

2.31

1.5

1.4

15.80

27.75

u/l

3.65

321

Malignant neoplasm of tonsil

3.25

2.31

1.2

1.4

38.63

46.34

u/l

—

Cluster headache, wide

261

1.62

2.31

1.3

1.4

24.88

23.66

u/l

0.10

227

Adhesive capsulitis of shoulder

120

911

1.32

2.30

1.3

1.4

29.27

35.22

u/l

1.30

746

Nonalcoholic fatty liver disease

663

1.38

2.29

1.3

1.4

25.82

29.69

u/l

0.48

540

Hypotension

404

1.49

2.29

1.5

1.3

29.70

27.35

u/l

0.17

327

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

469

1.45

2.29

1.4

12.58

14.59

u/l

0.32

412

Other and unspecified injuries of shoulder and upper arm

185

1.75

2.29

1.5

1.4

21.31

21.23

u/l

0.00

153

Alcohol abuse, main dg

120

912

1.32

2.29

1.3

1.4

20.04

21.66

u/l

0.22

759

Diseases of appendix

797

6412

1.11

2.28

1.4

27.84

25.63

u/l

1.10

658

5252

Delivery, wide proxy

347

1560

1.18

2.27

1.4

20.66

22.37

u/l

0.46

298

1275

Superficial injury of forearm

106

793

1.34

2.27

1.4

17.90

21.73

u/l

0.73

660

Androgenic alopecia

2.15

2.27

1.8

1.5

29.51

25.35

u/l

0.22

Viral meningitis, including avohilmo

302

1.57

2.26

1.6

1.3

18.15

21.37

u/l

0.39

249

Injuries to the hip and thigh

302

2281

1.19

2.26

1.5

1.4

26.55

27.42

u/l

0.15

237

1882

Rash and other nonspecific skin eruption

581

1.40

2.25

1.6

1.4

26.70

29.37

u/l

0.34

486

Other bacterial intestinal infections, including avohilmo

184

1480

1.25

2.25

1.4

30.25

26.77

u/l

0.67

149

1215

All dysplastic lesions of the vulva

449

1.47

2.24

1.5

1.4

35.18

30.69

u/l

0.49

369

Acute and subacute iridocyclitis

159

1258

1.27

2.24

1.3

1.4

28.73

27.07

u/l

0.25

136

1033

Maternal care for other conditions predominantly related to pregnancy

404

3409

1.16

2.24

1.3

1.4

22.40

25.50

u/l

1.25

326

2782

Burns and corrosions

122

934

1.31

2.22

1.5

1.4

20.26

21.79

u/l

0.23

784

Fracture of lower leg, including ankle

481

4135

1.14

2.21

1.4

29.16

28.72

u/l

0.10

397

3372

Mild mental retardation

143

1.84

2.20

1.8

1.4

13.59

19.21

u/l

0.63

121

Influenza and pneumonia

1147

6483

1.09

2.18

1.4

25.26

24.99

u/l

0.10

942

5338

Abnormalities of gait and mobility

385

1.49

2.17

1.6

1.3

25.20

27.03

u/l

0.18

317

Speech and linguistic disorders

617

1.37

2.17

1.7

1.4

12.68

12.61

u/l

0.01

539

Pyoderma

101

2.01

2.17

1.5

1.4

37.24

23.67

u/l

0.72

Lyme disease

289

2441

1.19

2.16

1.4

28.75

31.47

u/l

0.64

230

1985

Lyme disease, including avohilmo

289

2441

1.19

2.16

1.4

28.75

31.47

u/l

0.64

230

1985

Spirochaetal infections, other/unspecified, including avohilmo

291

2460

1.19

2.16

1.4

28.98

31.33

u/l

0.52

232

2002

Monoarthritis, not elsewhere classified

235

1.63

2.14

1.3

25.91

27.02

u/l

0.08

204

Other hearing loss

121

900

1.30

2.14

1.4

1.3

26.93

30.86

u/l

0.61

102

738

Superficial injury of hip and thigh

697

1.35

2.13

1.4

20.07

24.35

u/l

0.69

588

Non-allergic asthma (mode), excluding more controls

132

1018

1.29

2.13

1.4

1.3

24.66

27.74

u/l

0.58

114

857

Benign neoplasm of eye and adnexa

503

1.42

2.13

1.3

1.4

38.56

30.13

u/l

1.06

418

LSIL lesion of the vulva

324

1.54

2.12

1.5

1.4

35.26

29.94

u/l

0.51

268

Phlebitis and thrombophlebitis (not including DVT)

180

1456

1.24

2.11

1.4

1.3

26.98

29.89

u/l

0.59

146

1184

Atopic conjunctivitis

364

1.50

2.11

1.4

1.3

24.50

22.60

u/l

0.16

309

Mental retardation

211

1.66

2.10

1.7

1.4

12.84

19.33

u/l

1.09

183

Congenital malformations of the nervous system

183

1.72

2.10

1.4

16.01

19.96

u/l

0.33

158

Mixed disorders of conduct and emotions

183

1.72

2.10

1.5

1.4

7.24

8.17

u/l

0.18

164

Contusion of other and unspecified parts of foot

422

1.46

2.09

1.6

1.4

13.00

20.64

u/l

2.65

359

Disorders of muscles

606

1.38

2.09

1.4

1.3

28.66

26.98

u/l

0.16

508

Other spirochaetal diseases, including avohilmo

296

2514

1.18

2.09

1.4

28.92

31.21

u/l

0.51

235

2048

Psoriasis vulgaris

143

1128

1.27

2.09

1.3

25.41

27.42

u/l

0.34

121

927

Bilateral sagittal split ramus osteotomy operation

333

1.52

2.08

1.4

23.51

23.97

u/l

0.03

285

Pustulosis palmaris et plantaris

245

1.61

2.08

1.2

1.4

30.42

30.70

u/l

0.02

205

Cluster headache, strict, including avohilmo

423

1.46

2.08

1.3

1.4

28.91

23.12

u/l

0.65

356

Malignant neoplasm of oropharynx

2.93

2.08

1.2

1.3

38.63

44.28

u/l

—

Vitamin B12 deficiency anaemia

300

1.54

2.07

1.4

1.3

29.94

31.57

u/l

0.12

250

Nontoxic diffuse goitre

146

1.80

2.07

1.4

1.3

26.38

30.93

u/l

0.30

119

Open wound of forearm

506

1.41

2.07

1.5

1.4

16.30

19.58

u/l

0.54

425

Separation of retinal layers (serosa)

161

1.75

2.06

1.3

26.19

25.28

u/l

0.05

124

Other erythematous conditions

184

1.70

2.05

1.4

1.3

31.47

28.29

u/l

0.15

150

COPD, hospital admissions 3, with asthma pneumonia sepsis

497

1.38

2.05

1.3

25.12

31.19

u/l

1.10

404

Malignant neoplasm of base of tongue, including Hilmo

4.05

2.05

1.7

1.2

15.95

32.99

u/l

—

Viral meningitis

286

1.55

2.05

1.6

1.3

18.53

21.66

u/l

0.36

236

Insulin, intermediate and long-acting

358

2981

1.16

2.04

1.3

1.4

21.23

25.92

u/l

2.41

280

2438

Orchitis and epididymitis

139

1.80

2.04

1.3

1.2

13.76

12.76

u/l

0.12

112

Certain conditions originating in the perinatal period

100

669

1.33

2.04

1.6

1.4

11.60

12.83

u/l

0.24

586

Covid-19 confirmed case

278

2352

1.18

2.03

1.5

1.4

26.11

24.03

u/l

0.50

242

1925

Crohn disease (strict definition, require KELA)

475

1.42

2.03

1.4

20.54

20.74

u/l

0.02

403

Temporal arteritis

2.12

2.03

1.4

1.3

31.97

34.70

u/l

0.14

Benign neoplasm of urinary organs

177

1.71

2.02

1.2

1.4

30.80

29.89

u/l

0.04

144

Corneal ulcer

168

1357

1.24

2.02

1.5

1.4

29.27

24.82

u/l

0.88

141

1121

Contact with sharp glass

287

1.55

2.01

1.4

32.27

17.95

u/l

1.75

243

Fracture of foot, except ankle

258

2175

1.19

2.01

1.3

1.4

27.85

25.52

u/l

0.49

207

1793

Symptoms and signs involving emotional state

224

1.62

2.01

1.6

1.4

23.30

20.20

u/l

0.21

193

Vitreous haemorrhage

384

1.46

2.01

1.4

1.3

27.30

27.09

u/l

0.01

318

Superficial injury of thorax

110

844

1.31

2.00

1.4

17.91

24.63

u/l

1.91

700

Benign neoplasm of breast

121

942

1.29

1.99

1.3

29.72

31.21

u/l

0.18

775

Other spirochaetal diseases

290

2471

1.18

1.99

1.4

28.75

31.38

u/l

0.61

230

2010

Appendicitis, broad definition

787

6405

1.10

1.99

1.3

1.4

27.88

25.62

u/l

1.12

649

5246

Other and unspecified injuries of wrist and hand

264

1.57

1.99

1.6

1.3

20.20

20.81

u/l

0.04

223

Complications predominantly related to the puerperium

410

3589

1.15

1.99

1.3

1.4

25.48

24.70

u/l

0.18

327

2937

Other orthopaedic follow-up care

288

1.54

1.98

1.5

1.3

26.67

26.68

u/l

0.00

235

Osteomyelitis

209

1.63

1.98

1.6

1.3

15.26

24.36

u/l

1.08

166

Crohn's disease NAS

444

1.43

1.97

1.3

1.4

26.67

21.62

u/l

0.62

372

Urolithiasis

183

1495

1.23

1.97

1.4

1.3

25.33

25.95

u/l

0.09

143

1224

Non-allergic asthma (mode)

132

1030

1.27

1.97

1.4

1.3

24.66

27.87

u/l

0.61

114

868

Other disorders of Eustachian tube

202

1.65

1.97

1.4

1.3

18.13

23.72

u/l

0.60

167

Personal history of certain other diseases

187

1.68

1.96

1.5

1.4

10.88

12.90

u/l

0.25

160

Pedal cyclist injured in transport accident

205

1696

1.21

1.96

1.4

20.59

24.39

u/l

1.10

163

1403

Presbyopia

666

1.35

1.96

1.4

39.31

33.44

u/l

0.52

534

Postprocedural musculoskeletal disorders, not elsewhere classified

241

1.58

1.95

1.5

1.3

37.05

35.24

u/l

0.11

192

Calculus of kidney and ureter

175

1426

1.23

1.94

1.3

24.75

26.05

u/l

0.21

137

1166

Cluster headache, wide,, including avohilmo

430

1.43

1.92

1.3

1.4

28.91

23.58

u/l

0.58

363

Maternal care for known or suspected abnormality of pelvic organs

516

3093

1.13

1.92

1.4

21.76

26.87

u/l

3.32

437

2540

Disorders of iron metabolism

2.08

1.92

1.3

30.66

26.01

u/l

0.18

Follicular cysts of skin and subcutaneous tissue

144

1151

1.26

1.92

1.4

25.50

28.19

u/l

0.50

123

949

Giant cell arteritis with polymyalgia rheumatica

2.06

1.91

1.4

1.3

31.97

35.90

u/l

0.22

Tooth agenesis EXCLUDE clefts and syndromes

364

1.47

1.91

1.6

1.4

17.62

15.74

u/l

0.20

316

Viral infections of the central nervous system

464

1.41

1.91

1.6

1.4

18.70

24.02

u/l

0.95

385

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

239

2012

1.19

1.90

1.3

1.4

24.99

25.89

u/l

0.16

197

1660

Other heart diseases, wide

1064

5922

1.09

1.90

1.4

27.42

25.81

u/l

0.82

876

4855

Ulcerative colitis (strict) with PSC

0.00

1.90

0.0

1.5

—

18.14

—

Acute nasopharyngitis (common cold)

527

1.38

1.90

1.4

1.3

22.05

19.30

u/l

0.32

430

Malignant neoplasm of rectum

188

1.65

1.90

1.5

1.3

43.17

32.51

u/l

0.66

131

Dislocation, sprain and strain of joints and ligaments of thorax

204

1.63

1.90

1.3

1.4

24.02

22.70

u/l

0.07

166

Atrial septal defect, secundum type

173

1.69

1.89

1.4

1.3

25.79

19.61

u/l

0.40

147

Nonischemic cardiomyopathy

291

1.52

1.88

1.3

31.87

27.00

u/l

0.39

239

Anterior Iridocyclitis

162

1316

1.23

1.87

1.3

1.4

29.21

27.66

u/l

0.24

139

1081

Malignant neoplasm of digestive organs, including Hilmo

158

936

1.24

1.87

1.3

31.04

34.22

u/l

0.52

125

684

Autoimmune hyperthyroidism

534

1.38

1.87

1.4

1.3

30.33

27.11

u/l

0.32

441

Malignant neoplasm of tonsil, including Hilmo

2.67

1.87

1.2

1.3

38.63

42.06

u/l

—

MS-disease / Multiple Sclerosis

102

785

1.31

1.87

1.3

1.4

29.09

24.30

u/l

0.76

659

Lichen planus

559

1.36

1.86

1.4

1.3

39.36

33.82

u/l

0.64

451

Chronic tubulo-interstitial nephritis

174

1.68

1.86

1.6

1.4

42.78

30.83

u/l

0.97

141

Combinations of oral blood glucose lowering drugs

122

959

1.27

1.86

1.3

1.4

24.73

31.57

u/l

1.82

777

Mental retardation, wide definition

219

1.60

1.85

1.7

1.4

12.84

19.74

u/l

1.18

190

Acute gastritis

293

1.51

1.84

1.3

25.30

30.34

u/l

0.41

243

Caught, crushed, jammed or pinched in or between objects

326

1.48

1.84

1.3

23.30

20.06

u/l

0.25

274

Adverse effects, not elsewhere classified

230

1938

1.19

1.84

1.4

22.56

24.83

u/l

0.48

194

1589

Coeliac disease

111

865

1.29

1.84

1.4

26.24

25.97

u/l

0.03

717

Visual field defects

359

1.45

1.83

1.8

1.4

26.15

26.91

u/l

0.05

296

Inflammatory diseases of the central nervous system

485

1.39

1.82

1.5

1.3

22.73

24.87

u/l

0.24

399

Personal history of risk-factors, not elsewhere classified

1.94

1.82

1.7

1.4

3.85

15.02

u/l

5.33

Crohn disease (strict definition, require KELA, min 2 HDR)

469

1.40

1.81

1.4

20.68

20.59

u/l

0.01

398

conjunctival degenerations and deposits

2.07

1.81

1.1

1.3

35.61

32.28

u/l

—

Injury of nerves at wrist and hand level

207

1.61

1.80

1.2

1.3

24.32

20.79

u/l

0.24

169

Asthma/COPD (KELA code 203)

1014

6241

1.09

1.80

1.4

23.39

25.47

u/l

1.38

837

5135

Hyperlipidaemia, other/unspecified

160

1170

1.23

1.80

1.3

30.71

31.62

u/l

0.13

122

963

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

707

1.32

1.79

1.4

13.78

16.46

u/l

0.51

606

Pustular psoriasis

263

1.53

1.79

1.2

1.4

29.81

30.18

u/l

0.02

220

Graves disease, strict definition

131

1047

1.26

1.79

1.3

30.16

27.60

u/l

0.36

106

860

Congenital deformities of hip

146

1.73

1.78

1.3

1.5

27.39

17.17

u/l

0.60

125

Parkinson's disease, strict definition, excluding more controls

171

1.64

1.78

1.2

37.76

36.90

u/l

0.05

150

Heterophoria

642

1.33

1.78

1.4

26.71

22.01

u/l

0.51

537

Hydrocele

161

1.68

1.77

1.1

1.3

5.82

12.23

u/l

4.43

133

Mucosal proctocolitis

990

0.74

1.77

1.3

24.12

23.12

u/l

0.10

830

Strabismus

264

2252

1.17

1.77

1.4

21.84

25.19

u/l

0.97

212

1857

Type 1 diabetes, strict definition, subgroup 1

639

0.68

1.76

1.2

1.4

16.01

18.51

u/l

0.27

546

Alcohol withdrawal state with delirium

185

1.63

1.75

1.4

1.3

23.79

25.09

u/l

0.07

144

Malignant neoplasm of oropharynx, including Hilmo

2.52

1.74

1.2

1.3

38.63

42.06

u/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

507

1.37

1.73

1.6

1.4

26.96

28.58

u/l

0.16

417

Benign neoplasm: Choroid

257

1.53

1.73

1.3

1.4

37.20

31.09

u/l

0.46

210

Other and unspecified injuries of head

347

1.45

1.73

1.3

17.09

24.97

u/l

1.37

285

All dysplastic lesions of the vagina

250

1.54

1.72

1.5

1.3

28.91

27.99

u/l

0.06

209

Lichen sclerosus et atrophicus

689

1.31

1.72

1.4

1.3

30.34

34.38

u/l

0.60

557

Molar incisor enamel hypoplasia, with caries

2.69

1.71

2.6

1.4

9.91

5.63

u/l

—

Blood alcohol or alcohol intoxication level

148

1.71

1.4

31.39

19.33

u/l

0.64

125

Subacute thyroiditis

226

1.56

1.71

1.7

1.3

22.11

27.60

u/l

0.48

193

Injuries involving multiple body regions

234

1.55

1.71

1.3

25.71

20.20

u/l

0.51

198

Other inflammatory liver diseases

315

1.47

1.71

1.3

25.31

27.15

u/l

0.13

258

Benign neoplasm: Skin of eyelid, including canthus

742

1.30

1.71

1.4

1.3

32.80

33.10

u/l

0.03

608

Other infectious diseases

315

1.47

1.71

1.3

27.76

24.78

u/l

0.22

256

Atopic dermatitis, strict definition

429

3725

1.13

1.70

1.4

20.32

21.42

u/l

0.32

345

3086

Placenta praevia

710

1.31

1.70

1.4

23.07

23.45

u/l

0.04

585

Disorders of lens

339

2406

0.87

1.69

1.3

34.15

36.23

u/l

0.46

270

1933

Glomerular disorders in diseases classified elsewhere

458

1.38

1.69

1.4

30.02

22.53

u/l

0.79

382

Type 1 diabetes, strict definition

668

0.70

1.69

1.2

1.4

17.33

18.90

u/l

0.15

571

Defect, injury or illness of lumbar spine

2.68

1.69

1.4

1.6

19.40

24.96

u/l

—

Cholecystitis

561

1.34

1.68

1.3

24.74

29.78

u/l

0.72

461

Explicit bacterial Sepsis

391

1.41

1.68

1.5

1.4

21.75

23.38

u/l

0.18

330

Insulin, fast-acting

263

2259

1.17

1.67

1.3

1.4

20.26

23.72

u/l

1.14

207

1854

Lichen planus, including avohilmo

121

966

1.26

1.67

1.4

34.97

32.54

u/l

0.32

103

780

Varicella [chickenpox], including avohilmo

276

1.49

1.66

1.5

1.4

16.14

17.22

u/l

0.10

228

Other deformities of toe(s)

165

1.65

1.6

1.3

22.60

32.89

u/l

1.06

143

Lichen ruber planus, wide definition including periferal and oral lichen planus

151

1237

1.22

1.65

1.4

36.05

33.33

u/l

0.41

131

1007

Chondromalacia

173

1.63

1.65

1.5

1.3

29.16

28.65

u/l

0.02

143

Crohn's disease of small intestine

512

1.36

1.65

1.3

1.4

16.51

21.68

u/l

1.11

430

Laparoscopic right hemicolectomy

127

1.74

1.64

1.5

1.3

45.01

31.02

u/l

0.68

106

Type 1 diabetes, definitions combined

768

0.72

1.64

1.3

1.4

21.09

20.01

u/l

0.10

650

Hemiplegia

261

1.50

1.63

2.0

1.3

31.15

26.33

u/l

0.29

214

Benign neoplasm of ovary

137

1113

1.24

1.63

1.3

1.4

39.39

36.00

u/l

0.55

122

910

Distal bite

300

1.47

1.63

1.4

28.01

16.32

u/l

1.07

260

Bicipital tendinitis

205

1.57

1.62

1.4

1.3

29.82

33.81

u/l

0.21

171

Chronic suppurative otitis media

352

1.43

1.62

1.3

1.4

21.41

20.71

u/l

0.06

298

Other necrotizing vasculopathies

237

1.53

1.62

1.7

1.3

28.06

29.75

u/l

0.10

193

Deep bite that required surgery

121

1.77

1.61

1.2

1.4

18.52

23.23

u/l

0.34

104

Disorders of refraction and accommodation

332

2902

1.14

1.61

1.4

24.60

25.35

u/l

0.14

268

2384

Crushed, pushed or stepped on by crowd or human stampede

549

1.34

1.60

1.5

1.4

18.21

17.00

u/l

0.13

472

Respiratory insufficiency

135

1.70

1.60

1.3

16.32

31.92

u/l

2.69

109

Pervasive developmental disorders excl. Autism + Asperger

1.97

1.60

1.7

1.5

4.10

12.42

u/l

3.48

Dislocation, sprain and strain of joints and ligaments of head

312

1.45

1.60

1.4

32.13

21.97

u/l

0.83

265

Abnormal findings on antenatal screening of mother

165

1372

1.21

1.60

1.5

1.4

17.87

17.62

u/l

0.04

138

1139

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

593

3383

1.11

1.59

1.4

31.22

28.93

u/l

0.86

493

2768

Exposure to other and unspecified inanimate mechanical forces

464

1.36

1.59

1.4

29.61

20.17

u/l

1.36

381

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

3.03

1.58

1.3

1.4

36.50

38.55

u/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

447

1.37

1.58

1.4

27.20

25.98

u/l

0.10

366

Type 1 diabetes, strict (exclude DM2)

763

0.73

1.58

1.3

1.4

21.09

19.69

u/l

0.13

646

Labour and delivery complicated by fetal stress [distress]

530

3107

1.11

1.58

1.3

1.4

17.59

23.47

u/l

5.81

459

2516

Other disorders starting during childhood or adolescence

409

1.39

1.58

1.5

1.4

9.51

10.85

u/l

0.26

359

Traumatic subdural haemorrhage

215

1.52

1.58

1.4

1.3

20.12

30.16

u/l

1.31

187

Congenital malformations of the musculoskeletal system, not elsewhere classified

168

1.64

1.58

1.4

28.75

20.29

u/l

0.62

145

Demyelinating diseases of the central nervous system

113

904

1.26

1.57

1.3

1.4

28.15

25.29

u/l

0.41

754

Impacted maxillary molar

727

1.29

1.57

1.4

14.13

12.18

u/l

0.38

636

Barrett oesophagus

129

1.71

1.56

1.2

1.3

23.49

33.56

u/l

0.83

103

Pneumonia, organism unspecified

905

5730

1.08

1.56

1.4

25.41

26.26

u/l

0.35

742

4697

Procedures for purposes other than remedying health state

192

1.58

1.55

1.1

1.3

35.27

28.16

u/l

0.50

159

Amblyopia ex anopsia

240

1.51

1.55

1.3

1.4

18.51

18.94

u/l

0.03

203

Papulosquamous disorders

306

2678

1.14

1.55

1.3

1.4

29.13

30.46

u/l

0.30

256

2180

Multiple delivery

122

987

1.24

1.55

1.3

1.4

31.81

30.56

u/l

0.14

107

777

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

871

5422

1.08

1.55

1.4

25.30

26.68

u/l

0.60

695

4455

Coronary artery bypass grafting

359

0.66

1.54

1.2

1.4

28.80

22.58

u/l

0.45

287

Peripheral artery operations in Hilmo

256

1.49

1.54

1.3

1.4

37.58

26.30

u/l

0.87

211

Other puerperal infections

156

1297

1.21

1.53

1.3

1.4

17.65

18.71

u/l

0.18

122

1081

Other disorders of nervous system

257

1.49

1.53

1.5

1.3

38.10

31.97

u/l

0.46

210

Alzheimer’s disease, strict definition

261

0.59

1.53

1.3

40.91

37.70

u/l

0.13

210

Other complications of labour and delivery, not elsewhere classified

227

1725

1.17

1.52

1.4

13.19

16.28

u/l

1.45

204

1421

Insulin, combination of fast acting with intermediate-acting or long-acting

413

3340

1.12

1.52

1.3

1.4

21.00

25.42

u/l

2.40

326

2735

Left ventricular outflow tract obstruction (LVOTO), broad definition

519

1.33

1.52

1.3

1.4

28.57

26.41

u/l

0.23

426

Malignant neoplasm of vulva

2.62

1.52

1.7

1.2

54.99

41.00

u/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

374

1.40

1.52

1.4

27.06

25.23

u/l

0.16

306

Other disorders of pigmentation

225

1.52

1.4

1.3

30.35

28.72

u/l

0.09

186

Astigmatism

416

1.38

1.52

1.5

1.3

16.98

21.10

u/l

0.49

347

Antepartum haemorrhage, not elsewhere classified

175

1472

1.20

1.52

1.4

23.58

24.91

u/l

0.22

147

1204

Marginal zone B-cell lymphoma, including Hilmo

2.61

1.52

1.6

1.3

35.37

34.42

u/l

—

Childhood asthma (age<16), excluding more controls

170

1110

1.20

1.50

1.2

1.4

12.56

14.91

u/l

0.63

141

960

Explicit bacterial Sepsis, including avohilmo

400

1.38

1.50

1.5

1.4

21.75

23.28

u/l

0.17

337

Poisoning by narcotics and psychodysleptics [hallucinogens]

101

1.80

1.50

1.9

1.3

30.26

13.06

u/l

—

Other condition

123

999

1.24

1.50

1.4

21.29

24.58

u/l

0.57

103

827

Hallux rigidus

564

1.32

1.49

1.4

1.3

43.94

39.53

u/l

0.42

474

Secondary hypertension

336

1.41

1.49

1.4

18.78

25.12

u/l

0.84

275

Allergic purpura

202

1.55

1.49

1.6

1.3

18.73

22.97

u/l

0.37

169

Benign leiomyoma with endometriosis

135

1108

1.22

1.49

1.4

31.84

35.33

u/l

0.55

112

906

Open wound of hip and thigh

186

1.57

1.49

1.6

1.3

20.68

17.97

u/l

0.16

156

Actinic keratosis

101

728

1.26

1.49

1.4

1.3

40.89

36.31

u/l

0.57

592

Ankylosing spondylitis, ICD10

574

1.31

1.48

1.3

1.4

22.28

26.27

u/l

0.60

475

Other blood glucose lowering drugs, excl. Insulins

418

1.37

1.48

1.2

1.4

23.80

37.43

u/l

2.40

348

Childhood asthma (age<16)

170

1112

1.20

1.48

1.2

1.4

12.56

14.96

u/l

0.65

141

962

Pyoderma gangrenosum

2.26

1.48

1.8

1.4

31.10

21.71

u/l

—

Maternal care for known or suspected disproportion

798

0.74

1.47

1.3

1.4

32.84

29.50

u/l

0.35

660

Crohn disease (strict definition, all UC cases excluded)

360

1.40

1.47

1.4

17.40

20.84

u/l

0.50

303

Oesophageal varices

109

1.75

1.47

1.3

1.4

22.78

28.97

u/l

0.37

Coronary atherosclerosis

222

1631

0.86

1.47

1.3

31.62

34.91

u/l

0.74

180

1321

Injury of eye and orbit

112

903

1.24

1.46

1.4

24.37

22.39

u/l

0.26

759

Iridocyclitis

178

1503

1.19

1.46

1.3

1.4

27.75

27.52

u/l

0.03

153

1230

Malignant neoplasm of prostate

151

1.49

1.45

1.5

1.3

11.00

10.02

u/l

0.18

L04AD Calcineurin inhibitors

611

1.30

1.45

1.4

26.36

24.49

u/l

0.18

502

Benign neoplasm: Cerebral meninges

429

1.36

1.44

1.6

1.4

33.44

36.16

u/l

0.23

349

Cerebrovascular diseases

337

2639

0.88

1.44

1.3

32.02

32.47

u/l

0.08

265

2153

Late syphilis, including avohilmo

1.99

1.44

1.3

1.4

14.93

27.66

u/l

—

Stroke, including SAH

234

1942

0.86

1.43

1.3

33.49

32.70

u/l

0.12

184

1589

Colon adenocarcinoma, helper endpoint

261

1.46

1.43

1.3

26.17

33.74

u/l

0.84

211

Intentional self-harm by sharp object

221

1.51

1.42

1.5

1.4

14.76

14.25

u/l

0.04

189

Other keratitis

106

853

1.25

1.42

1.4

23.17

23.66

u/l

0.05

709

Diabetic maculopathy, excluding more controls

465

1.34

1.41

1.4

1.3

18.00

23.44

u/l

0.60

388

Bacterial, viral and other infectious agents, including avohilmo

561

1.31

1.41

1.4

23.60

21.19

u/l

0.25

462

Budesonide

133

1097

1.22

1.41

1.3

1.4

24.39

25.03

u/l

0.09

109

904

Otosclerosis

313

1.41

1.39

1.2

1.4

31.37

30.88

u/l

0.04

263

Mandibular prognathia AND surgery (LeFortI or BSSO)

2.25

1.39

2.2

1.5

10.32

20.57

u/l

—

Previous suicide attempt

1.83

1.39

1.7

1.4

4.25

16.17

u/l

5.05

Other or unspecified ileus, impaction or obstruction

641

1.28

1.39

1.3

32.99

30.47

u/l

0.29

529

Insulin, fast-acting or short human

263

2298

1.15

1.39

1.3

1.4

20.26

23.65

u/l

1.11

207

1883

Schizotypal disorder

166

1.58

1.38

1.4

20.57

22.24

u/l

0.10

138

Other diseases of liver

144

1200

1.20

1.38

1.3

1.4

24.65

30.56

u/l

1.22

111

982

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1066

6292

1.07

1.38

1.4

25.39

25.51

u/l

0.04

887

5170

Diabetic maculopathy

747

0.76

1.37

1.5

1.4

18.62

16.18

u/l

0.21

626

Infectious mononucleosis

111

903

1.24

1.37

1.3

1.4

15.66

16.74

u/l

0.17

774

Infectious mononucleosis, including avohilmo

111

903

1.24

1.37

1.3

1.4

15.66

16.74

u/l

0.17

774

Rosacea

138

1148

1.21

1.36

1.4

1.3

29.30

28.72

u/l

0.06

108

949

Foreign body entering into or through eye or natural orifice

391

1.36

1.4

21.62

19.94

u/l

0.15

321

Psoriasis

225

1950

1.16

1.35

1.3

1.4

26.22

29.13

u/l

0.76

187

1593

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.94

1.34

1.2

1.4

27.85

26.56

u/l

—

Progressive vascular leukoencephalopathy

0.00

1.34

0.0

1.3

—

35.59

—

Other necrotizing vasculopathies (FG)

183

1.54

1.34

1.9

1.3

31.79

28.42

u/l

0.18

149

Bronchitis, not specified as acute or chronic

409

1.35

1.34

1.1

1.3

15.40

24.18

u/l

2.08

338

Synovial cyst of popliteal space [Baker]

299

1.41

1.33

1.5

1.4

33.28

34.98

u/l

0.11

252

COPD-related respiratory insufficiency

224

1.48

1.33

1.2

1.3

23.85

29.43

u/l

0.49

185

Seborrhoeic keratosis

135

1123

1.20

1.33

1.4

1.3

36.88

35.66

u/l

0.15

121

906

Acute appendicitis

737

6327

1.08

1.32

1.3

1.4

27.66

25.71

u/l

0.86

608

5176

Use of dimethyl fumarate

106

1.74

1.32

1.6

1.3

26.27

21.41

u/l

0.27

130

968

1.21

1.32

1.4

1.3

40.45

35.10

u/l

0.83

106

790

Secondary polycythaemia

1.82

1.32

1.1

1.4

10.60

26.24

u/l

2.61

Failed attempted abortion

210

1.51

1.31

1.7

1.3

22.72

23.54

u/l

0.05

176

Disorder of the sleep-wake schedule

129

1.65

1.31

1.7

1.4

17.93

18.20

u/l

0.01

109

Heart failure and antihypertensive medication

113

597

1.23

1.30

1.3

1.4

30.60

34.22

u/l

0.50

499

Symptoms and signs involving speech and voice

276

2435

1.14

1.30

1.4

31.10

30.89

u/l

0.03

215

2001

Bacterial, viral and other infectious agents

490

1.31

1.30

1.4

24.59

21.39

u/l

0.31

401

Obstructed labour due to malposition and malpresentation of fetus

410

3429

1.11

1.29

1.4

25.48

27.89

u/l

0.76

351

2753

Any dementia, excluding more controls

423

0.73

1.29

1.3

39.46

33.95

u/l

0.33

357

Unspecified acute lower respiratory infection

109

891

1.23

1.29

1.6

1.4

22.97

23.38

u/l

0.05

746

Other arthritis (FG)

265

2333

1.14

1.29

1.4

29.21

28.99

u/l

0.03

216

1926

Congenital malformations of ovaries, fallopian tubes and broad ligaments

758

1.25

1.28

1.4

28.74

24.65

u/l

0.58

630

Artificial joint re-operation

161

1.56

1.28

1.2

1.3

52.83

38.22

u/l

0.84

129

Fracture of lumbar spine and pelvis

103

835

1.23

1.28

1.4

1.3

30.14

26.99

u/l

0.32

690

Other renal tubulo-interstitial diseases

186

1.52

1.27

1.1

1.3

32.43

26.63

u/l

0.33

148

Thiazolidinediones

268

1.42

1.27

1.3

1.4

26.41

35.31

u/l

0.90

219

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

527

1.30

1.27

1.5

1.4

20.36

21.50

u/l

0.13

448

Allergic contact dermatitis due to drugs in contact with skin

138

1.61

1.27

1.3

17.01

27.48

u/l

0.82

118

Ischaemic heart disease, wide definition

349

2400

0.89

1.27

1.3

32.98

35.71

u/l

0.79

290

1931

Other congenital malformations of nervous system

115

1.68

1.27

1.5

1.4

10.51

15.83

u/l

0.54

Streptococcal septicaemia

285

1.41

1.27

1.5

1.3

20.72

23.68

u/l

0.32

233

Other vitreous opacities

186

1.51

1.26

1.5

1.3

40.38

29.64

u/l

0.67

153

Purpura and other haemorrhagic conditions

731

1.25

1.26

1.4

26.31

24.59

u/l

0.18

608

Gonarthrosis,primary

664

3689

1.09

1.26

1.4

33.79

35.72

u/l

0.71

522

2998

Other Crohn's disease

519

1.30

1.26

1.4

23.55

22.44

u/l

0.12

443

Amputation of toe

146

1.58

1.26

1.4

1.3

33.71

25.87

u/l

0.35

117

Exposure to unspecified factor

932

6772

0.93

1.25

1.4

1.3

23.88

25.10

u/l

0.55

749

5591

Other viral diseases

328

2922

1.12

1.25

1.4

20.45

22.60

u/l

0.68

267

2430

LSIL lesion of the vagina

147

1.59

1.24

1.2

1.4

23.57

26.22

u/l

0.13

122

Fibrosis and cirrhosis of liver

278

1.41

1.24

1.3

33.38

30.76

u/l

0.13

227

Varicose veins

382

3198

0.90

1.24

1.3

1.4

38.85

36.42

u/l

0.62

314

2588

Venous complications and haemorrhoids in pregnancy

271

1.42

1.24

1.2

1.4

32.89

22.23

u/l

0.88

226

Autoimmune hepatitis, wide definition

220

1.46

1.23

1.3

22.49

24.33

u/l

0.11

178

Erysipelas, including avohilmo

533

3613

1.09

1.23

1.4

1.3

27.84

30.16

u/l

0.86

429

2923

Acute pancreatitis

107

878

1.22

1.23

1.6

1.3

21.09

28.06

u/l

1.92

711

Injury of muscle and tendon at hip and thigh level

627

1.26

1.23

1.5

1.4

23.72

27.75

u/l

0.55

511

Cerebral aneurysm, nonruptured

451

1.31

1.22

1.3

1.4

32.86

33.19

u/l

0.02

368

Dislocation, sprain and strain of joints and ligaments of knee

694

5815

1.08

1.21

1.3

1.4

23.17

25.16

u/l

0.99

563

4788

Cardiodefibrillation

796

0.78

1.21

1.1

1.3

27.89

28.08

u/l

0.01

646

Benign neoplasm of meninges

478

1.30

1.21

1.6

1.4

34.82

35.89

u/l

0.08

393

Alcohol-induced chronic pancreatitis

180

1.51

1.21

1.4

23.45

23.24

u/l

0.01

139

Benign neoplasm: Skin of ear and external auricular canal

140

1.58

1.20

1.7

1.3

17.12

28.70

u/l

1.49

115

Insulin medication

413

3105

1.10

1.20

1.3

21.00

27.02

u/l

3.94

326

2536

Acute pancreatitis (for exclusion)

107

882

1.22

1.19

1.6

1.3

21.09

27.76

u/l

1.80

720

Hyperplasia of prostate

356

1.27

1.18

1.4

1.3

9.07

11.76

u/l

1.79

296

Urethritis and urethral syndrome

125

1.61

1.18

1.4

1.3

37.15

24.82

u/l

0.80

105

Other disorders of bladder

384

1.33

1.18

1.3

1.4

25.01

26.53

u/l

0.11

322

Skin changes due to chronic exposure to nonionizing radiation

108

806

1.21

1.17

1.4

1.3

39.28

36.11

u/l

0.37

656

Benign neoplasm: Skin of trunk

248

1.42

1.17

1.3

1.4

30.23

24.50

u/l

0.38

206

Aortic valve malfunction, age under 60 years

472

1.30

1.17

1.3

1.4

29.53

27.63

u/l

0.18

385

Reactive arthropathies

499

1.29

1.16

1.4

1.3

29.13

28.68

u/l

0.03

412

Type 1 diabetes

204

1778

1.15

1.16

1.4

18.35

23.00

u/l

1.65

162

1456

Aspergillosis

0.00

1.16

0.0

1.4

—

21.34

—

Infections of genitourinary tract in pregnancy

114

950

1.21

1.15

1.4

24.87

22.34

u/l

0.34

779

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

166

1.51

1.15

1.2

1.4

35.56

27.04

u/l

0.62

137

Diabetic nephropathy, excluding more controls

700

0.79

1.15

1.3

1.4

21.91

18.14

u/l

0.41

570

Aspergillosis, including avohilmo

0.00

1.14

0.0

1.4

—

20.83

—

Infective dermatitis

598

1.26

1.14

1.4

26.87

27.19

u/l

0.03

497

STROKE

347

2588

0.90

1.13

1.4

33.48

33.84

u/l

0.07

276

2103

Personal history of malignant neoplasm

662

1.24

1.13

1.7

1.4

29.99

34.02

u/l

0.53

540

Other obstructed labour

807

1.22

1.13

1.3

1.4

28.66

29.83

u/l

0.13

658

Lung diseases due to external agents

361

1.33

1.12

1.3

28.23

25.98

u/l

0.15

300

Haemangioma, any site

555

1.27

1.12

1.4

31.58

28.82

u/l

0.22

456

Coagulation defects, purpura and other haemorrhagic conditions

157

1348

1.17

1.12

1.5

1.4

22.05

25.05

u/l

0.57

129

1119

Atrial fibrillation and flutter

159

1194

0.86

1.12

1.3

1.4

33.75

35.97

u/l

0.30

132

957

Leiomyoma of uterus

841

4413

1.07

1.11

1.4

31.87

32.82

u/l

0.33

704

3568

Peptic ulcer

2.28

1.11

1.9

1.3

28.34

20.93

u/l

—

Contact with nonpowered hand tool

176

1.48

1.10

1.3

1.4

20.33

18.84

u/l

0.09

142

ILD medications: azathioprine

126

1065

1.19

1.10

1.4

25.56

24.04

u/l

0.20

105

877

DVT of lower extremities

101

836

1.21

1.10

1.4

1.3

27.62

30.28

u/l

0.37

670

Calcaneal spur

1.84

1.10

1.4

1.3

19.65

29.81

u/l

0.60

Thyrotoxicosis with toxic multinodular goitre

243

1.40

1.09

1.3

51.27

34.11

u/l

1.38

202

Contact with other sharp object(s)

504

1.28

1.09

1.4

18.11

19.26

u/l

0.11

425

Other strabismus

224

1971

1.13

1.08

1.5

1.4

21.76

24.50

u/l

0.63

179

1619

Delivery

396

1894

1.10

1.08

1.4

22.45

25.35

u/l

0.99

341

1557

Congenital deformities of feet, including avohilmo

295

1.36

1.08

1.5

1.4

15.01

21.25

u/l

1.00

252

Intermittent heterotropia

451

1.29

1.08

1.6

1.4

21.89

17.91

u/l

0.39

384

Heart failure and bmi 25plus

746

0.82

1.08

1.3

33.51

28.41

u/l

0.67

587

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.88

1.08

1.5

31.51

22.90

u/l

0.22

Car occupant injured in noncollision transport accident

244

1.40

1.08

1.1

1.4

19.71

19.01

u/l

0.05

208

Arnold-Chiari syndrome

105

1.65

1.08

1.6

1.4

11.37

14.56

u/l

0.24

Mental and behavioural disorders due to cannabinoids

202

1.45

1.08

1.3

1.4

11.66

12.26

u/l

0.06

171

Squamous cell neoplasms and carcinoma of cervix

1.96

1.07

1.6

1.4

32.47

29.58

u/l

—

Heart failure and coronary heart disease

690

0.81

1.07

1.4

1.3

29.92

29.40

u/l

0.05

559

Myocardial infarction, strict

114

960

0.84

1.07

1.2

1.3

39.52

29.58

u/l

2.14

773

Malignant neoplasm of prostate, including Hilmo

157

1.39

1.06

1.5

1.2

11.60

9.88

u/l

0.31

101

Major coronary heart disease event excluding revascularizations

188

1419

0.87

1.06

1.3

1.4

36.24

33.65

u/l

0.44

157

1149

Abscess of anal and rectal regions

471

1.28

1.05

1.3

25.50

23.57

u/l

0.17

396

Paralytic ileus and intestinal obstruction

123

1041

1.18

1.05

1.3

31.55

30.96

u/l

0.07

109

862

Nonspecific lymphadenitis

472

1.28

1.05

1.4

32.83

28.83

u/l

0.42

386

Glaucoma

228

2181

0.89

1.04

1.4

1.3

34.45

34.20

u/l

0.04

181

1784

Suggestive for eosinophilic asthma

410

1.30

1.04

1.4

1.3

22.55

27.81

u/l

0.57

333

Ulcer of oesophagus

162

1.49

1.04

1.3

1.4

38.07

29.23

u/l

0.46

130

Streptococcal septicaemia, including avohilmo

297

1.35

1.04

1.5

1.3

20.72

24.40

u/l

0.42

244

Other demyelinating diseases of the central nervous system

376

1.31

1.04

1.1

1.4

27.54

22.89

u/l

0.51

312

Inguinal hernia

273

2023

0.90

1.03

1.4

1.3

24.69

22.40

u/l

0.55

219

1689

Open wound of lower leg

102

852

1.20

1.03

1.4

1.3

21.28

23.85

u/l

0.37

720

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

151

1307

1.16

1.02

1.4

21.97

27.97

u/l

1.82

129

1076

Primary open-angle glaucoma, strict

575

0.76

1.02

1.2

1.3

34.96

36.89

u/l

0.12

469

Dementia

602

0.81

1.02

1.3

31.32

33.86

u/l

0.25

506

Haemangioma and lymphangioma, any site

590

1.24

1.02

1.4

30.78

27.94

u/l

0.23

484

Other heart diseases

571

3440

1.08

1.02

1.4

27.42

27.95

u/l

0.14

468

2826

Mental disorders, not otherwise specified

765

0.79

1.02

1.3

1.4

29.44

23.25

u/l

0.58

648

Congenital malformations of trachea and bronchus

2.02

1.00

1.3

1.5

23.59

30.48

u/l

—

Myelodysplastic syndrome, including Hilmo

2.01

1.00

1.1

36.61

25.75

u/l

—

Other arrhythmias

633

4405

1.07

0.99

1.4

27.88

28.41

u/l

0.14

513

3590

Malignant neoplasm of rectum, including Hilmo

231

1.39

0.99

1.5

1.3

43.17

34.17

u/l

0.55

158

Benign neoplasm: Lower jaw bone

0.00

0.98

0.0

1.3

—

28.89

—

Sequelae of cerebrovascular disease

128

934

1.17

0.98

1.3

36.42

31.01

u/l

0.94

756

severe traumatic brain injury, does not include concussion

665

1.22

0.98

1.5

1.3

13.83

25.68

u/l

5.11

545

Chondropathies

138

1190

1.16

0.97

1.3

24.41

24.13

u/l

0.04

113

979

Benign neoplasm: Liver

207

1.41

0.97

1.5

1.3

27.72

26.18

u/l

0.09

173

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.95

0.97

1.6

1.5

28.66

34.29

u/l

—

Diseases of spleen

1.75

0.97

1.6

1.4

23.72

25.01

u/l

0.04

Gout, unspecified

415

1.28

0.96

1.2

1.3

24.70

23.78

u/l

0.06

340

Type 2 diabetes, wide definition

577

3381

1.08

0.96

1.4

1.3

23.83

34.54

u/l

13.00

457

2756

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

302

1.33

0.96

1.5

1.3

13.51

14.97

u/l

0.12

254

Glomerular diseases

100

841

1.19

0.95

1.4

28.83

24.15

u/l

0.60

702

Mandibular retrognathia AND surgery (BSSO)

251

1.37

0.95

1.3

1.4

20.91

23.75

u/l

0.18

211

Carcinoma in situ of other and unspecified sites

1.78

0.94

1.5

1.4

19.92

27.48

u/l

0.48

Other congenital malformations of the digestive system, including avohilmo

266

1.35

0.94

1.4

28.34

17.92

u/l

1.00

224

Erythema intertrigo

1.62

0.94

1.7

1.4

19.89

24.93

u/l

—

Diffuse large B-cell lymphoma, including Hilmo

1.62

0.93

1.3

1.2

27.35

30.02

u/l

0.13

Diffuse large B-cell lymphoma

1.62

0.93

1.3

1.2

27.35

30.02

u/l

0.13

Diffuse large B-cell lymphoma, helper endpoint

1.62

0.93

1.3

1.2

27.35

30.02

u/l

0.13

Multiple gestation

175

1543

1.14

0.93

1.4

30.56

27.81

u/l

0.44

150

1252

Major anomalies of jaw size

192

1.42

0.93

1.6

1.4

31.00

23.13

u/l

0.53

162

Lesion of plantar nerve

269

1.34

0.92

1.3

1.4

32.92

40.09

u/l

0.55

225

Use of levodopa decarboxylase inhibitor

243

1.36

0.92

1.2

1.3

34.45

31.52

u/l

0.21

200

Pedestrian injured in transport accident

383

1.28

0.92

1.2

1.3

20.04

23.62

u/l

0.36

316

Other specified/unspecified bacterial intestinal infections

304

1.32

0.92

1.2

1.4

27.21

26.44

u/l

0.05

248

Ankylosing hyperostosis [Forestier]

2.16

0.91

1.2

1.4

16.95

24.47

u/l

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1.67

0.91

1.3

47.69

37.09

u/l

—

Chondrocostal junction syndrome [Tietze]

244

1.36

0.91

1.4

1.3

19.52

23.43

u/l

0.41

204

Viral pneumonia

626

1.22

0.91

1.3

1.4

24.60

23.63

u/l

0.10

519

Abnormal spermatozoa

184

1.42

0.91

1.3

19.29

12.84

u/l

0.39

148

Acute appendicitis, no complications

613

5703

1.07

0.91

1.4

26.63

25.49

u/l

0.38

503

4657

Voice disturbances

234

2102

1.12

0.90

1.4

32.14

31.50

u/l

0.09

186

1722

Melanocytic naevi of other and unspecified parts of face

420

1.27

0.90

1.4

18.00

26.53

u/l

1.58

353

Urethral stricture

102

1.57

0.90

1.4

1.3

18.89

20.59

u/l

0.11

Sequelae of injuries of lower limb

600

1.22

0.90

1.5

1.4

24.95

26.68

u/l

0.17

498

Speech disturbances, not elsewhere classified

349

1.29

0.90

1.4

1.3

20.40

26.10

u/l

0.50

288

Bacterial meningitis

168

1.44

0.90

1.1

1.4

25.81

24.99

u/l

0.04

143

Intestinal stricture

154

1348

1.14

0.90

1.4

32.41

30.78

u/l

0.25

133

1095

Other acute skin changes due to ultraviolet radiation

143

1.48

0.90

1.1

1.4

42.26

26.71

u/l

0.85

118

Antenatal screening

392

2016

1.09

0.89

1.4

23.90

30.09

u/l

3.37

345

1592

Respiratory and cardiovascular disorders specific to the perinatal period

114

0.54

0.89

1.3

1.5

5.50

9.84

u/l

—

105

Small cell lung cancer

2.07

0.89

1.0

1.3

26.93

35.84

u/l

—

Small cell lung cancer, including Hilmo

2.07

0.89

1.0

1.3

26.93

35.84

u/l

—

Inflammatory bowel disease

294

2675

1.10

0.89

1.4

24.34

24.75

u/l

0.08

242

2197

Contact with heat and hot substances

306

1.31

0.89

1.4

24.78

20.70

u/l

0.35

255

Fracture of forearm

419

4068

0.92

0.88

1.3

1.4

28.29

29.23

u/l

0.23

325

3362

Other diseases of gallbladder

177

1.42

0.88

1.2

1.3

30.97

30.52

u/l

0.02

142

Respiratory conditions due to other external agents

1.80

0.88

1.3

1.4

39.49

34.41

u/l

—

Varicose veins of other sites

220

1.37

0.87

1.3

30.08

24.02

u/l

0.33

181

Mental and behavioural disorders due to use of other stimulants, including caffeine

229

1.36

0.87

1.4

1.3

17.18

14.97

u/l

0.19

196

Other and unspecified disease of Bartholin gland

161

1.44

0.87

1.3

14.86

27.34

u/l

1.35

137

Other specified/unspecified inflammatory spondylopathies

387

1.27

0.87

1.4

23.97

25.86

u/l

0.18

323

Fracture of femur

600

1.20

0.86

1.5

1.3

41.25

29.90

u/l

1.32

495

Left bundle-branch block

212

1.37

0.86

1.3

27.03

32.62

u/l

0.50

175

Other viral diseases, including avohilmo

465

4280

1.08

0.86

1.4

19.76

23.20

u/l

1.81

375

3522

Endovascular or surgical operations to intracerebral aneurysms

238

1.35

0.86

1.5

1.4

34.31

33.65

u/l

0.04

197

Single delivery by forceps and vacuum extractor

282

1528

1.10

0.85

1.3

1.4

20.71

22.63

u/l

0.54

242

1245

Complications of genitourinary prosthetic devices, implants and grafts

137

1.47

0.84

1.2

1.4

27.40

26.73

u/l

0.03

115

Twin gestation

169

1500

1.13

0.84

1.3

1.4

29.58

27.86

u/l

0.25

145

1222

Azathioprine

126

1095

1.15

0.84

1.4

25.56

23.85

u/l

0.23

105

897

Long labour

424

3333

1.08

0.83

1.4

24.14

26.40

u/l

0.76

360

2687

Polyarthropathies

564

3865

0.94

0.82

1.4

1.3

28.20

26.42

u/l

0.60

455

3205

Stroke, excluding SAH

210

1686

0.90

0.82

1.3

31.60

32.10

u/l

0.07

164

1379

Disorders of orbit

249

1.33

0.82

1.4

29.73

28.40

u/l

0.07

210

Prurigo nodularis

1.56

0.81

1.2

1.4

27.31

27.65

u/l

—

Divergent concomitant strabismus

590

1.21

0.81

1.5

1.4

19.91

27.01

u/l

1.31

482

Gout, idiopatic and unspecified

535

1.22

0.81

1.2

1.3

23.82

25.58

u/l

0.14

437

Other specified/unspecified arthritis

218

1967

1.11

0.80

1.4

1.3

30.56

29.44

u/l

0.18

179

1625

Use of glatiramer acetate

190

1.38

0.80

1.5

1.3

28.68

23.81

u/l

0.31

156

Benign neoplasm: Skin, unspecified

224

1.35

0.80

1.3

1.4

26.58

27.08

u/l

0.03

184

Cramp and spasm

294

1.30

0.80

1.5

1.4

19.04

21.39

u/l

0.24

245

Meningitis

294

1.30

0.80

1.4

1.3

22.56

24.50

u/l

0.17

238

Other assisted single delivery

281

0.70

0.79

1.3

1.4

16.16

25.21

u/l

1.12

236

Kyphosis

1.83

0.79

1.7

1.4

23.92

25.37

u/l

—

Foreign body in ear

131

1.46

0.79

1.2

1.4

9.20

18.78

u/l

—

112

Peripheral arterial reconstruction

268

1.31

0.78

1.4

1.3

32.41

27.46

u/l

0.32

221

Acute tubulo-interstitial nephritis

568

4502

1.07

0.78

1.4

25.27

25.84

u/l

0.16

467

3677

Viral warts, including avohilmo

221

2000

1.11

0.78

1.4

21.78

22.97

u/l

0.23

177

1643

Melanocytic naevi of lower limb, including hip

313

1.28

0.78

1.8

1.4

29.56

24.43

u/l

0.37

261

Other congenital malformations of the digestive system

232

1.33

0.78

1.5

1.4

26.96

17.53

u/l

0.76

196

Superficial frostbite

0.00

0.78

0.0

1.6

—

17.83

—

Use of anticholinesterases

375

0.78

0.77

1.4

1.3

28.65

36.24

u/l

0.73

309

N06DA Anticholinesterases

375

0.78

0.77

1.4

1.3

28.65

36.24

u/l

0.73

309

Other specified/unspecified deforming dorsopathies

140

1.44

0.77

1.3

1.4

27.39

30.04

u/l

0.14

119

Benign neoplasm: Liver/bile ducts

217

1.35

0.77

1.5

1.3

27.72

26.09

u/l

0.10

181

Primary open-angle glaucoma

689

0.82

0.77

1.3

38.02

35.84

u/l

0.15

561

Ulcerative proctitis

466

1.23

0.77

1.3

1.4

24.16

22.71

u/l

0.12

390

Myocardial infarction

132

1050

0.88

0.77

1.3

39.71

30.83

u/l

1.99

111

844

Other congenital malformations of skin, including avohilmo

671

0.82

0.77

1.3

1.4

21.67

24.56

u/l

0.28

562

Paroxysmal tachycardia

202

1511

1.11

0.76

1.4

24.87

28.80

u/l

0.97

164

1238

Renal failure

173

1315

1.12

0.76

1.5

1.3

30.95

27.98

u/l

0.45

144

1072

Small cell lung cancer, helper endpoint

1.77

0.76

1.0

1.3

26.93

35.89

u/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

896

5055

1.05

0.76

1.4

1.3

23.85

30.00

u/l

7.66

718

4144

Infections specific to the perinatal period

1.71

0.76

1.7

1.5

5.48

10.41

u/l

—

Primary biliary cholangitis (PBC)

1.55

0.75

1.4

1.3

48.91

29.71

u/l

—

Carcinoma in situ, bladder

1.70

0.75

1.4

1.3

21.09

24.07

u/l

—

Congenital ovarian cysts

597

1.20

0.74

1.3

1.4

27.53

24.00

u/l

0.38

505

Glaucoma suspect

186

1672

1.11

0.74

1.4

1.3

35.12

34.22

u/l

0.12

148

1366

Perichondritis of external ear

1.64

0.73

1.4

19.10

25.72

u/l

—

Pneumocystosis

1.64

0.73

1.3

40.27

31.14

u/l

—

Pneumocystosis, including avohilmo

1.64

0.73

1.3

40.27

31.14

u/l

—

Mixed conductive and sensorineural hearing loss

451

1.22

0.73

1.3

26.41

30.02

u/l

0.37

376

Other benign neoplasms of connective and other soft tissue

579

1.19

0.73

1.3

1.4

26.10

28.16

u/l

0.21

479

Type 1 diabetes, wide definition, subgroup 1

173

1551

1.12

0.73

1.3

1.4

17.62

22.88

u/l

1.81

138

1275

Dermatographic urticaria

644

1.18

0.73

1.7

1.4

20.59

25.09

u/l

0.57

546

Primary coxarthrosis, bilateral

801

1.16

0.72

1.2

1.3

40.01

36.90

u/l

0.31

648

Exposure to other and unspecified animate mechanical forces

276

0.72

1.2

1.4

32.71

20.47

u/l

0.58

235

Malignant neoplasm of endocrine gland, including Hilmo

480

1.21

0.71

1.7

1.4

32.11

27.72

u/l

0.38

373

Chronic kidney disease

825

1.16

0.71

1.3

36.62

27.16

u/l

1.25

673

Superficial injuries involving multiple body regions

177

1.36

0.71

1.3

1.4

24.20

18.29

u/l

0.42

152

Carbimazole or st.post thyroidectomy, condition for graves disease

215

1956

1.10

0.71

1.3

1.4

30.83

30.07

u/l

0.12

177

1596

Other juvenile arthritis

336

1.26

0.70

1.5

1.3

24.98

16.62

u/l

0.93

289

Maxillary prognathism

1.73

0.70

1.6

1.5

6.66

21.91

u/l

—

Bronchiectasis

203

1.33

0.70

1.3

1.4

24.10

35.68

u/l

0.67

168

Dementia, including avohilmo

661

0.86

0.70

1.3

30.25

33.46

u/l

0.38

555

Toxic effect of ethanol

265

1.29

0.70

1.5

1.3

18.07

17.78

u/l

0.02

226

Other/unspecified rheumatoid arthritis

490

1.21

0.70

1.2

1.3

41.37

32.84

u/l

0.85

402

Postmenopausal osteoporosis with pathological fracture

126

1.43

0.70

1.7

1.3

70.98

49.78

u/l

0.72

107

Fracture at wrist and hand level

270

2475

1.09

0.70

1.4

22.22

24.80

u/l

0.70

217

2038

Congenital malformations of heart and great arteries

807

1.16

0.70

1.5

1.4

23.97

20.97

u/l

0.43

683

Neovascular glaucoma

142

0.63

0.69

1.6

1.4

14.09

24.30

u/l

—

119

Glaucoma secondary to other eye disorders

142

0.63

0.69

1.6

1.5

14.09

25.50

u/l

—

120

Eustachian salpingitis and obstruction

833

1.16

0.69

1.3

1.4

16.45

22.10

u/l

1.50

693

Atrial septal defect

211

1.32

0.69

1.5

1.4

22.25

20.03

u/l

0.14

179

Generalized epilepsy

310

1.26

0.69

1.4

1.3

14.79

19.96

u/l

0.65

266

Sequelae of injuries of upper limb

555

1.19

0.69

1.3

1.4

30.51

26.94

u/l

0.33

458

Herpesviral [herpes simplex] infections, including avohilmo

317

2940

1.08

0.68

1.3

1.4

24.93

25.44

u/l

0.10

249

2401

Other general symptoms and signs

388

1.23

0.68

1.5

1.3

29.31

23.18

u/l

0.49

323

Gout, FINNGEN

625

1.18

0.68

1.3

1.4

24.51

25.84

u/l

0.11

509

Disorders of vitreous body

303

2666

1.08

0.68

1.4

1.3

35.32

36.88

u/l

0.30

232

2164

Diabetic retinopathy, strict definition

100

1016

0.87

0.68

1.3

1.4

20.87

18.73

u/l

0.25

844

Peripheral artery disease

118

820

1.14

0.67

1.4

1.3

32.03

28.90

u/l

0.43

652

COPD, hospital admissions 1, only main diagnosis

716

1.15

0.67

1.2

1.3

27.49

30.81

u/l

0.49

576

Thoracic aortic aneurysm

347

1.24

0.67

1.2

1.3

29.58

23.01

u/l

0.56

283

Other and unspecified disorders of vitreous body

239

2142

1.09

0.67

1.4

1.3

38.43

39.53

u/l

0.17

180

1726

Abnormal blood-pressure reading, without diagnosis

249

1.29

0.67

1.3

1.4

28.86

25.04

u/l

0.22

205

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.50

0.67

1.3

1.5

7.68

16.16

u/l

2.22

Bursitis of shoulder

119

1.44

0.67

1.4

1.3

26.17

30.25

u/l

—

103

Delirium, not induced by alcohol and other psychoactive substances

249

1.28

0.66

1.6

1.3

22.24

28.27

u/l

0.74

207

Other ulcerative colitis

412

1.22

0.66

1.3

1.4

23.60

21.79

u/l

0.18

342

Other diseases of pericardium

145

1.38

0.66

1.7

1.3

35.61

24.69

u/l

0.72

113

Sleep disorders, other/unspecified

313

1.25

0.65

1.6

1.3

29.00

20.56

u/l

0.68

270

Epiphora

103

1.46

0.65

1.3

1.4

25.14

28.84

u/l

—

283

1.25

0.65

1.3

41.90

40.73

u/l

0.07

229

Seropositive rheumatoid arthritis, strict definition

905

0.86

0.65

1.4

1.3

33.32

31.54

u/l

0.13

733

Cleft lip, lip and palate or palate

128

0.62

0.64

1.1

1.4

12.88

17.59

u/l

—

108

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

359

1.23

0.64

1.3

1.4

27.64

29.22

u/l

0.10

289

Sulfonylureas

495

1.17

0.64

1.2

1.3

23.23

34.01

u/l

2.40

404

Otitis media, unspecified

112

911

1.13

0.63

1.5

1.4

12.63

16.64

u/l

1.26

101

787

Non-ischemic cardiomyopathy

103

717

1.14

0.63

1.2

1.3

31.93

30.82

u/l

0.12

581

Endocrine disorders, other/unspecified

103

0.58

0.62

1.3

12.10

26.58

u/l

—

Helminthiases

104

0.57

0.62

1.3

1.4

22.77

20.98

u/l

—

Other diseases of oesophagus

333

1.23

0.62

1.3

22.94

27.74

u/l

0.35

276

Acute renal failure

627

1.17

0.62

1.6

1.4

28.46

27.34

u/l

0.10

517

Iron deficiency

343

1.23

0.61

1.4

1.3

9.60

19.00

u/l

4.69

297

Bullous disorders

218

1.29

0.60

1.7

1.3

30.37

26.71

u/l

0.20

178

Malignant neoplasm of endocrine gland

417

1.20

0.60

1.6

1.4

31.30

27.92

u/l

0.26

320

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

245

1.27

0.59

1.2

1.3

25.49

27.37

u/l

0.12

203

Pilonidal cyst

621

1.16

0.59

1.4

18.48

19.66

u/l

0.15

520

Benign neoplasm: Kidney

131

1.38

0.59

1.3

1.4

19.08

30.39

u/l

0.91

109

Metabolic disorders

851

5321

0.96

0.59

1.4

1.3

28.46

28.79

u/l

0.10

697

4348

Defects in the complement system

1.53

0.59

1.4

31.33

22.09

u/l

—

Optic neuritis

400

1.21

0.58

1.4

26.90

23.24

u/l

0.34

339

Other respiratory disorders and diseases

621

1.16

0.58

1.3

25.11

29.23

u/l

0.50

506

Other diseases of the respiratory system

621

1.16

0.58

1.3

25.11

29.23

u/l

0.50

506

Diseases of arteries, arterioles and capillaries (FINNGEN)

766

0.88

0.58

1.4

30.62

33.35

u/l

0.33

620

Chronic nephritic syndrome

162

0.68

0.58

1.1

1.4

33.35

26.22

u/l

0.25

133

Carcinoma in situ of cervix uteri

169

1540

1.10

0.58

1.3

1.4

19.08

20.83

u/l

0.33

124

1280

Mandibular retrognathia

583

1.17

0.58

1.5

1.4

25.65

21.75

u/l

0.39

495

Granulomatous disorders of skin and subcutaneous tissue

184

1.31

0.58

1.4

1.3

24.08

23.01

u/l

0.06

153

Reactive arthropathies, FINNGEN

437

1.19

0.58

1.4

28.74

24.26

u/l

0.35

359

Blepharospasm

1.73

0.58

1.0

1.3

24.48

32.32

u/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.72

0.57

1.0

1.3

63.77

40.41

u/l

—

Multiple myeloma

1.72

0.57

1.0

1.3

63.77

40.41

u/l

—

Iridocyclitis in diseases classified elsewhere

1.44

0.57

1.4

16.65

24.85

u/l

0.68

Unspecified lump in breast

125

1389

0.90

0.56

1.2

1.4

34.61

32.54

u/l

0.26

107

1141

Parkinson's disease, including avohilmo

301

1.23

0.56

1.2

1.3

34.96

33.00

u/l

0.14

247

Varus deformity, not elsewhere classified

1.46

0.56

1.5

31.31

24.31

u/l

—

Aortic aneurysm

466

1.18

0.56

1.2

1.4

26.91

22.37

u/l

0.46

381

Benign neoplasm: Spinal meninges

1.63

0.56

1.3

1.4

42.10

38.12

u/l

—

Benign neoplasm: Adrenal gland

320

1.22

0.55

1.3

1.4

26.08

32.86

u/l

0.64

265

Communicating hydrocephalus

1.55

0.55

1.9

1.3

28.45

29.49

u/l

—

Pedal cyclist injured in noncollision transport accidents

813

1.13

0.55

1.4

18.01

23.73

u/l

1.07

678

Aneurysms, operations, SAH

747

1.14

0.55

1.3

36.82

33.82

u/l

0.33

602

Rheumatoid arthritis, including avohilmo

233

2512

0.93

0.55

1.4

32.15

32.00

u/l

0.02

187

2049

Type 1 diabetes, wide definition

177

1620

1.09

0.55

1.3

1.4

17.96

22.99

u/l

1.67

141

1329

Localized adiposity

1.60

0.55

1.7

1.4

10.18

35.67

u/l

—

All chronic kidney diseases

334

2497

1.07

0.55

1.4

29.67

26.10

u/l

0.97

285

2049

135

1221

1.11

0.55

1.6

1.4

24.41

25.54

u/l

0.15

112

986

Other and unspecified disorders of white blood cells

195

1.29

0.54

1.6

1.4

34.16

23.70

u/l

0.68

161

Hypoplasia of dental enamel

1.58

0.54

2.0

1.5

11.02

6.30

u/l

—

Seropositive rheumatoid arthritis, wide

137

1511

0.91

0.54

1.4

1.3

31.71

32.62

u/l

0.11

104

1241

Diverticular disease of intestine

468

2759

1.06

0.54

1.4

1.3

33.77

35.68

u/l

0.58

369

2246

Benign lipomatous neoplasm of other sites/unspecified

303

1.22

0.54

1.3

1.4

33.85

30.51

u/l

0.22

252

Degenerative macular diseases

303

1.22

0.54

1.5

1.3

26.90

33.92

u/l

0.55

249

Melanoma in situ of lower limb, including hip

1.55

0.53

1.8

1.4

43.22

37.78

u/l

—

Congenital malformations of the urinary system, including avohilmo

350

1.20

0.52

1.5

1.4

16.69

21.91

u/l

0.55

297

Adalimumab

883

1.12

0.52

1.2

1.4

21.95

24.40

u/l

0.37

737

Tic and related disorders

1.43

0.52

1.1

1.3

22.29

12.90

u/l

—

Ulcer of lower limb, not elsewhere classified

396

1.19

0.52

1.4

1.3

24.23

27.80

u/l

0.37

325

Adult respiratory distress syndrome

1.51

0.51

1.5

29.82

27.56

u/l

—

Rheumatoid arthritis

193

1850

0.92

0.51

1.4

1.3

32.86

33.23

u/l

0.05

150

1526

Other and/or unspecified nontoxic goitre

397

1.19

0.51

1.3

33.98

34.54

u/l

0.04

332

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

226

1.21

0.50

1.2

1.4

35.05

38.64

u/l

0.25

198

Ectropion of eyelid

1.46

0.50

1.3

18.03

22.05

u/l

—

Complications of the puerperium, not elsewhere classified

637

0.86

0.50

1.4

22.13

24.04

u/l

0.19

536

L04AA Selective immunosuppressants

184

1699

1.08

0.50

1.3

1.4

31.00

27.89

u/l

0.59

154

1399

Single spontaneous delivery

378

1885

1.06

0.49

1.4

24.64

25.46

u/l

0.18

320

1548

Organic, including symptomatic, mental disorders

158

1017

1.09

0.49

1.4

1.3

27.37

30.84

u/l

0.72

127

839

Myotonic disorders

1.57

0.49

1.3

1.4

28.56

23.68

u/l

—

Other/unspecified seropositive rheumatoid arthritis

136

1490

0.91

0.49

1.4

1.3

31.82

32.67

u/l

0.10

103

1223

Carcinoma in situ of skin of trunk

1.56

0.49

1.7

1.4

45.10

26.64

u/l

—

Viral warts

746

1.13

0.49

1.6

1.4

18.21

22.18

u/l

0.58

627

Other disorders of cornea

483

1.16

0.48

1.4

36.60

29.41

u/l

0.87

395

Psoriatic arthropathies

586

1.15

0.48

1.2

1.3

23.72

31.62

u/l

1.54

490

Disorders in reading

119

1.35

0.48

1.4

18.04

12.30

u/l

0.34

104

Herpesviral [herpes simplex] infections

103

927

1.11

0.48

1.4

1.3

22.71

26.33

u/l

0.66

769

Angina pectoris

185

1327

0.92

0.48

1.3

1.4

32.28

34.25

u/l

0.33

145

1077

Carcinoma in situ of skin

199

1.26

0.47

1.4

31.59

31.41

u/l

0.01

163

Percutaneous Coronary Intervention

514

2981

1.05

0.47

1.4

32.17

35.77

u/l

1.55

423

2403

Disorders of vitreous body and globe

306

2725

1.06

0.47

1.4

1.3

35.05

36.65

u/l

0.32

235

2216

Ischaemic Stroke, excluding all haemorrhages

186

1478

0.93

0.47

1.3

30.64

32.06

u/l

0.22

147

1211

Other osteochondropathies

438

1.17

0.47

1.2

1.4

26.04

22.58

u/l

0.31

361

Other and unspecified hydrocephalus

1.48

0.47

3.3

1.3

8.59

29.74

u/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

485

1.16

0.47

1.4

19.02

22.92

u/l

0.41

413

Other endocrine disorders

243

1.22

0.47

1.5

1.3

9.38

17.72

u/l

2.22

209

Other metabolic disorders

134

1225

1.10

0.46

1.6

1.3

31.48

29.15

u/l

0.30

115

1013

Valvular heart disease excluding rheumatic fever

221

1470

1.07

0.46

1.4

34.06

30.31

u/l

0.81

179

1213

Poisoning by medicine, drug-induced

1.39

0.46

1.9

1.4

16.11

24.76

u/l

0.81

Parkinson's disease

291

1.20

0.46

1.2

1.3

35.93

33.02

u/l

0.22

239

Hypertensive Renal Disease

1.43

0.46

1.0

1.3

30.93

28.43

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

136

1483

0.92

0.45

1.4

1.3

31.82

32.59

u/l

0.09

103

1216

Other congenital malformations of face and neck

219

1.24

0.45

1.3

1.4

22.34

20.52

u/l

0.11

183

Syphilis, including avohilmo

103

1.36

0.45

1.5

1.3

29.07

23.04

u/l

—

Syphilis

103

1.36

0.45

1.5

1.3

29.08

23.04

u/l

—

Burns and corrosions confined to eye and internal organs

183

1.26

0.45

1.9

1.3

19.23

23.14

u/l

0.27

152

Other and unspecified coagulation defects

422

1.16

0.45

1.5

1.4

16.55

22.61

u/l

0.93

354

Habit and impulse disorders

112

1.35

0.45

1.5

1.4

32.81

19.44

u/l

—

Molar incisor enamel hypoplasia

297

1.19

0.44

1.6

1.4

21.78

12.03

u/l

0.93

260

Injury of muscle and tendon at lower leg level

809

1.11

0.44

1.3

1.4

23.29

24.65

u/l

0.16

669

Bleeding

552

3708

1.04

0.44

1.5

1.4

26.58

29.71

u/l

1.41

450

3029

Hallux valgus (acquired)

273

1837

1.06

0.44

1.4

1.3

37.80

37.11

u/l

0.11

209

1515

Acute peritonitis

229

1.23

0.43

1.4

1.3

30.30

24.59

u/l

0.29

189

Vascular disorders of the intestines

130

1.31

0.43

1.5

1.3

39.77

30.39

u/l

0.40

111

Other superficial mycoses

166

1.27

0.43

1.2

1.4

16.66

20.14

u/l

0.26

140

Aphakia

1.62

0.43

1.0

1.5

14.38

18.08

u/l

—

Pneumonias (Asthma/COPD co-morbidities)

1017

6438

1.03

0.43

1.4

25.28

25.55

u/l

0.10

834

5300

Coronary revascularization (ANGIO or CABG)

513

2982

1.04

0.43

1.4

32.20

35.76

u/l

1.52

422

2404

Cerebrovascular diseases (FINNGEN)

228

1703

0.94

0.42

1.3

1.4

31.46

33.89

u/l

0.46

176

1381

Non-rheumatic valve diseases

219

1462

1.07

0.42

1.4

34.23

30.39

u/l

0.83

178

1208

Coxarthrosis [arthrosis of hip](FG)

274

1997

0.94

0.42

1.3

32.84

36.35

u/l

0.86

214

1637

Other and unspecified disorders of psychological development

1.39

0.42

1.3

1.4

6.72

11.75

u/l

—

Exclusion endpoint for clefts

140

1.29

0.41

1.7

1.4

10.78

17.35

u/l

1.73

118

Hereditary ataxia

1.52

0.41

1.0

1.5

49.18

25.54

u/l

—

All pneumoniae

1025

6462

1.03

0.41

1.4

25.59

25.44

u/l

0.05

842

5316

Maternal care for cervical incompetence

305

1.18

0.41

1.4

21.92

21.96

u/l

0.00

257

Other diseases of biliary tract

277

1.19

0.41

1.3

29.10

31.99

u/l

0.18

227

Gout

567

1.12

0.40

1.3

24.51

28.33

u/l

0.39

476

Tibial collateral bursitis [Pellegrini-Stieda]

1.34

0.40

1.1

1.5

51.45

35.12

u/l

—

Congenital malformations of the circulatory system

109

967

1.10

0.40

1.5

1.4

22.54

22.36

u/l

0.02

811

Other disorders of optic disc

1.37

0.40

2.7

1.4

20.09

23.53

u/l

0.18

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

985

6365

1.03

0.40

1.4

25.29

25.80

u/l

0.19

809

5232

Other viral diseases, not elsewhere classified

169

1569

1.07

0.40

1.5

1.4

20.97

23.67

u/l

0.62

140

1296

Sub-endpoint used in defining T1D endpoints

208

1920

1.07

0.40

1.4

18.38

22.10

u/l

1.21

166

1578

Cyst of Bartholin Gland

390

1.16

0.39

1.4

36.55

26.53

u/l

0.84

335

Benign neoplasm: Spinal cord

1.32

0.39

1.3

1.4

31.84

26.42

u/l

—

Ulcerative colitis

206

1934

1.07

0.39

1.4

26.49

24.67

u/l

0.36

170

1596

Open wound of ankle and foot

588

1.12

0.39

1.2

1.4

23.28

20.29

u/l

0.35

495

Specific development disorders of speech and language

322

1.17

0.39

1.5

1.4

11.96

12.89

u/l

0.10

283

Dementia in other diseases classified elsewhere

106

1.32

0.39

1.2

1.3

29.46

30.76

u/l

—

Tick-borne viral encephalitis, including avohilmo

1.40

0.38

1.2

1.4

25.40

30.72

u/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

120

1106

1.09

0.38

1.4

23.79

24.54

u/l

0.09

918

Congenital deformities of feet

197

1.22

0.38

1.5

1.4

19.33

19.91

u/l

0.03

168

Postprocedural endocrine and metabolic disorders, not elsewhere classified

126

1165

1.08

0.37

1.6

1.3

32.03

29.08

u/l

0.38

108

959

Alzheimer disease, excluding more controls

160

0.81

0.37

1.5

1.3

42.20

39.16

u/l

0.12

146

Atrophic disorders of skin

125

1156

1.08

0.37

1.4

1.3

25.59

32.13

u/l

1.74

101

946

Congenital malformations of eye, ear, face and neck

506

1.13

0.36

1.3

1.4

17.83

18.93

u/l

0.11

432

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

123

1138

1.08

0.36

1.4

25.59

25.46

u/l

0.01

945

Juvenile arthritis (FINNGEN)

403

1.14

0.36

1.4

1.3

25.74

16.31

u/l

1.24

344

Other congenital malformations of female genitalia

121

0.74

0.36

2.8

1.3

10.94

16.58

u/l

—

101

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.43

0.35

1.0

1.2

61.78

35.79

u/l

—

Primary biliary cholangitis, wide definition

1.32

0.35

1.4

1.3

54.49

28.53

u/l

—

Other coagulation defects

593

1.12

0.35

1.7

1.4

16.74

23.96

u/l

1.33

499

Other diseases of pancreas

282

1.17

0.35

1.5

1.3

36.12

31.55

u/l

0.29

229

Diseases of arteries, arterioles and capillaries

293

2254

0.95

0.35

1.3

28.99

29.79

u/l

0.14

244

1854

Dacryoadenitis

1.37

0.34

1.3

1.5

24.63

21.02

u/l

—

Other congenital malformations, including avohilmo

115

1241

0.92

0.34

1.4

20.58

23.41

u/l

0.46

1038

Other fall from one level to another

164

1537

1.07

0.34

1.4

1.3

18.40

20.21

u/l

0.37

138

1282

Benign neoplasm of bone and articular cartilage

604

1.11

0.34

1.5

1.4

26.37

25.66

u/l

0.06

502

Abscess of Bartholin gland

302

1.16

0.34

1.5

1.4

19.83

22.24

u/l

0.21

262

Other malignant neoplasms of skin (=non-melanoma skin cancer)

145

1054

0.93

0.34

1.3

37.84

36.03

u/l

0.25

118

774

Other retinal disorders

315

2503

0.96

0.34

1.4

28.42

29.39

u/l

0.18

247

2055

Other appendicitis

567

1.11

0.33

1.5

1.4

28.53

27.37

u/l

0.10

472

Ulcer of vagina/vulva

219

1.19

0.33

1.7

1.4

24.67

19.49

u/l

0.38

191

Other specified/unspecified hearing loss

331

1.15

0.33

1.5

1.4

29.59

27.32

u/l

0.16

274

Struck by thrown, projected or falling objec

303

1.16

0.33

1.2

1.3

11.91

18.35

u/l

1.78

246

Valvular operations

328

0.85

0.32

1.2

1.3

22.85

23.38

u/l

0.03

268

Other specified and unspecified disorders of conjunctiva

1.28

0.32

1.2

1.5

7.35

24.16

u/l

—

Secondary thrombocytopenia

1.28

0.32

1.3

1.5

67.47

28.66

u/l

—

Sacrococcygeal disorders, not elsewhere classified

229

1.18

0.32

1.2

1.4

23.71

26.99

u/l

0.20

190

Coxarthrosis, primary, with hip surgery

164

1430

1.06

0.32

1.3

36.04

37.98

u/l

0.27

131

1167

Colectomy operation

588

1.11

0.32

1.3

1.4

32.68

29.55

u/l

0.29

483

Other salmonella infections

174

1.21

0.31

1.0

1.3

54.72

26.19

u/l

1.60

142

Tumor necrosis factor alpha inhibitors

162

1526

1.06

0.31

1.3

1.4

21.73

24.67

u/l

0.69

141

1260

Malignant neoplasm of thyroid gland

399

1.13

0.31

1.6

1.4

30.47

28.41

u/l

0.13

305

Ptosis of eyelid

399

1.13

0.31

1.4

1.3

21.99

32.24

u/l

1.41

330

Parkinson's disease, strict definition

258

1.16

0.30

1.2

1.3

37.76

32.20

u/l

0.46

211

Crowding of teeth, including avohilmo

100

766

1.08

0.30

1.4

13.88

14.52

u/l

0.09

668

6-mercaptopurine

277

1.16

0.30

1.3

16.55

16.45

u/l

0.01

231

Other disorders of the musculoskeletal system and connective tissue

724

1.09

0.30

1.4

1.3

32.47

31.07

u/l

0.14

589

Blepharochalasis

137

1284

1.07

0.30

1.4

1.3

37.37

39.62

u/l

0.30

111

1044

Myeloproliferative diseases

277

1.16

0.30

1.2

1.3

27.73

28.32

u/l

0.03

228

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

121

1095

1.07

0.30

1.5

1.4

21.05

21.98

u/l

0.12

100

916

Oral lichen planus

120

1.25

0.30

1.7

1.3

38.95

31.46

u/l

0.40

100

Septal defects

383

1.13

0.29

1.6

1.4

18.64

19.81

u/l

0.10

327

Allergic conjunctivitis

647

6396

0.97

0.29

1.4

23.89

26.53

u/l

1.33

524

5265

Poor fetal growth

235

2243

1.05

0.29

1.4

17.43

21.08

u/l

1.40

197

1852

Perioral dermatitis

241

1.17

0.29

1.7

1.3

20.37

21.63

u/l

0.08

200

Benign mammary dysplasia

910

0.92

0.29

1.4

1.3

32.63

33.82

u/l

0.11

742

Congenital malformations of cardiac septa

398

1.12

0.29

1.6

1.4

18.00

19.41

u/l

0.14

340

Other/unspecified disorders of vestibular function

176

1.20

0.29

1.4

1.3

29.75

26.12

u/l

0.18

146

Other disorders of white blood cells

260

1.16

0.28

1.6

1.3

34.06

25.35

u/l

0.54

216

Overexertion and strenuous or repetitive movements

607

0.90

0.28

1.4

20.98

25.11

u/l

0.54

509

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

129

1176

1.07

0.28

1.5

1.4

20.47

22.43

u/l

0.32

108

980

Unspecified jaundice

140

0.78

0.28

1.5

1.4

15.98

27.23

u/l

1.31

110

Primary gonarthrosis, bilateral

239

1912

1.05

0.27

1.4

1.3

35.70

39.01

u/l

0.76

192

1546

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

223

1.17

0.27

1.4

22.36

17.07

u/l

0.45

191

Nonhereditary hypogammaglobulinemia

1.24

0.27

1.4

1.5

35.40

24.32

u/l

—

Diseases caused by chlamydiae, including avohilmo

187

1.18

0.27

1.6

1.4

34.41

27.88

u/l

0.36

157

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.70

0.26

1.2

1.3

25.56

18.62

u/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

892

5511

1.02

0.26

1.4

30.28

28.17

u/l

1.03

730

4491

Papillary adenocarcinoma of thyroid gland

291

1.14

0.26

1.6

1.4

34.57

28.72

u/l

0.35

226

AV-block

378

1.11

0.26

1.4

1.3

21.04

26.58

u/l

0.55

310

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

617

6059

0.97

0.26

1.4

1.3

24.01

26.52

u/l

1.18

498

4987

Pacemaker

811

0.93

0.25

1.4

1.3

32.91

28.45

u/l

0.46

660

Other diseases caused by chlamydiae, including avohilmo

188

1.18

0.25

1.6

1.4

34.41

27.74

u/l

0.37

158

Ulcerative colitis, NAS

112

1053

1.06

0.25

1.4

1.3

26.30

23.84

u/l

0.36

875

Other congenital malformations

781

1.08

0.25

1.5

1.4

21.71

22.33

u/l

0.06

661

Biological medication for rheuma

177

1687

1.05

0.25

1.3

1.4

22.22

24.41

u/l

0.49

153

1382

Malignant neoplasm of thyroid gland, including Hilmo

435

1.11

0.25

1.6

1.3

31.62

28.54

u/l

0.21

333

Tooth eruption problems

160

1624

0.95

0.25

1.3

1.4

13.36

13.61

u/l

0.05

144

1400

Other cataract

219

1558

1.04

0.24

1.4

1.3

31.98

34.64

u/l

0.56

178

1258

Hypoplasia of dental enamel , including avohilmo

281

1.13

0.24

1.6

1.4

20.30

12.13

u/l

0.71

247

Focal brain injury

170

1.18

0.24

1.5

1.4

11.41

24.12

u/l

1.97

143

Caries in Clefts patients

0.74

0.24

1.0

1.5

15.68

15.76

u/l

—

Whooping cough, including avohilmo

161

1.19

0.24

1.6

1.4

32.69

20.07

u/l

0.68

137

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

161

1142

0.95

0.24

1.3

38.27

35.85

u/l

0.38

132

841

Other degenerative diseases of the nervous system

137

945

1.06

0.24

1.3

1.4

30.43

30.33

u/l

0.01

101

790

Impetigo

350

1.12

0.24

1.6

1.4

15.24

20.08

u/l

0.60

293

Retinal detachment with retinal break

444

0.90

0.24

1.3

35.45

30.43

u/l

0.35

366

Other and unspecified haemorrhagic conditions

0.70

0.24

1.5

10.08

24.65

u/l

—

Adjustment and management of implanted device

402

0.90

0.24

1.5

1.3

26.41

27.29

u/l

0.04

313

Coxarthrosis

263

1763

0.96

0.24

1.3

31.63

36.75

u/l

1.53

205

1453

Ulcerative colitis (strict definition, all Crohn cases excluded)

105

1116

0.94

0.24

1.4

1.3

24.48

23.04

u/l

0.18

928

Acute hepatitis B, including avohilmo

1.36

0.23

1.0

1.4

17.12

29.69

u/l

—

Other specified congenital malformation syndromes affecting multiple systems

115

1.22

0.23

1.7

1.4

12.23

18.57

u/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1053

0.94

0.23

1.3

1.4

25.15

26.01

u/l

0.10

869

Heart failure, strict

160

1167

0.95

0.23

1.3

31.83

30.11

u/l

0.26

129

955

Adenocarcinoma and papillary adenocarcinoma of stomach

1.32

0.23

1.2

1.3

28.60

32.93

u/l

—

Gonarthrosis, primary, with knee surgery

254

1902

1.04

0.23

1.3

37.12

39.48

u/l

0.51

198

1542

Glucosamine medication

121

1021

0.95

0.23

1.3

39.06

41.32

u/l

0.29

839

Injury of muscle and tendon at forearm level

1.24

0.23

1.3

1.4

9.35

21.79

u/l

2.05

Unspecified fall

367

3493

1.03

0.22

1.4

25.62

25.63

u/l

0.00

286

2867

Neurofibromatosis, type 1

1.25

0.22

1.0

1.3

7.66

22.20

u/l

—

Rheumatic valve diseases

1.25

0.22

2.0

1.5

34.08

30.35

u/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

917

0.94

0.22

1.3

1.4

24.11

25.33

u/l

0.15

759

Congenital malformations of the urinary system

324

1.11

0.22

1.4

1.3

18.75

20.86

u/l

0.15

274

Accident to watercraft causing other injury

0.00

0.22

0.0

1.4

—

15.24

—

Toxic effect of pesticides

0.00

0.22

0.0

1.7

—

24.30

—

Reimbursement for rheumatic diseases

481

4659

1.03

0.21

1.4

27.99

29.24

u/l

0.35

391

3801

Benign neoplasm of middle ear and respiratory system

286

1.12

0.21

1.3

37.27

27.26

u/l

0.88

236

Other benign neoplasm of uterus: Corpus uteri

1.19

0.21

1.0

1.6

38.08

31.00

u/l

—

Congenital malformation of biliary tract

0.00

0.21

0.0

1.1

—

19.64

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.21

0.0

1.7

—

13.17

—

Discitis, unspecified

1.19

0.21

1.2

1.4

51.82

27.81

u/l

—

Diabetic nephropathy

721

0.93

0.21

1.3

1.4

21.91

18.36

u/l

0.38

592

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.6

—

15.98

—

Burn and corrosion confined to eye and adnexa

154

1.17

0.21

1.9

1.3

23.75

21.26

u/l

0.12

131

Osteomalacia

1.17

0.21

1.4

56.58

18.53

u/l

—

Fall on same level involving ice and snow

489

4768

1.03

0.21

1.4

26.29

28.44

u/l

0.73

397

3892

All-cause Heart Failure

157

1142

0.96

0.21

1.3

32.26

30.06

u/l

0.34

127

934

Injuries to unspecified part of trunk, limb or body region

566

1.08

0.20

1.5

1.4

23.57

22.53

u/l

0.11

477

Other inflammation of eyelid, including avohilmo

501

5129

0.98

0.20

1.4

23.09

25.25

u/l

0.82

411

4202

Congenital malformations of pulmonary and tricuspid valves

1.26

0.20

2.0

1.4

12.40

14.56

u/l

—

Accidental poisoning by and exposure to pesticides

0.00

0.20

0.0

1.9

—

22.39

—

Myopia

134

1404

0.95

0.20

1.4

24.70

22.81

u/l

0.22

107

1175

Benign neoplasm: Other and unspecified parts of small intestine

1.23

0.20

1.7

1.5

6.27

38.11

u/l

—

ILD, hospital admissions

386

0.91

0.20

1.2

1.4

28.97

30.57

u/l

0.12

318

Melanocytic naevi of eyelid, including canthus

1.20

0.20

1.0

1.5

37.42

28.43

u/l

—

Abnormal serum enzyme levels

105

960

1.06

0.19

1.4

28.46

22.22

u/l

0.96

792

Childhood allergy (age < 16)

173

1369

1.04

0.19

1.4

7.09

7.93

u/l

0.47

142

1191

Retinal vascular occlusion

250

1.12

0.19

1.4

1.3

42.19

32.61

u/l

0.70

204

Hypertensive Heart Disease

408

1.08

0.19

1.3

33.77

30.89

u/l

0.22

340

Other and unspecified injuries of abdomen, lower back and pelvis

1.23

0.19

1.5

1.4

9.20

19.88

u/l

1.30

Hyperprolactinaemia, drug-induced

1.14

0.19

2.0

1.5

18.75

33.10

u/l

—

Renal tubulo-interstitial diseases

783

5835

0.98

0.19

1.4

27.85

25.67

u/l

1.01

650

4769

Atrial fibrillation and flutter with reimbursement

613

0.95

0.18

1.3

35.94

37.94

u/l

0.18

500

Scissor bite

183

1.14

0.18

1.3

1.5

32.06

13.41

u/l

1.10

158

Pre-eclampsia or poor fetal growth

498

4854

1.02

0.18

1.3

1.4

21.01

25.36

u/l

2.86

415

3972

Protozoal diseases, including avohilmo

119

1.18

0.17

1.3

38.64

28.23

u/l

0.55

102

Ulcerative rectosigmoiditis

610

1.07

0.17

1.3

1.4

29.75

24.56

u/l

0.58

502

Hard cardiovascular diseases

617

3714

0.98

0.17

1.4

32.22

34.07

u/l

0.67

503

3001

IBD patients in KELA-register

206

1993

1.03

0.17

1.4

23.81

23.23

u/l

0.10

177

1647

Complications specific to multiple gestation

0.76

0.17

1.6

1.4

6.58

24.58

u/l

—

Sensorineural hearing loss

455

2965

1.02

0.17

1.3

31.04

33.57

u/l

0.80

367

2410

Dialysis, with operation codes

436

1.08

0.17

1.5

1.4

31.73

24.14

u/l

0.63

356

Faecal incontinence

407

1.08

0.17

1.4

1.3

24.33

35.54

u/l

1.34

328

Macular cyst

0.72

0.17

1.8

1.3

36.38

33.13

u/l

—

Retinal vascular disorders

253

1.11

0.16

1.4

1.3

42.19

32.54

u/l

0.71

207

Cardiomyopathy

536

0.93

0.16

1.4

23.01

26.83

u/l

0.43

437

Other superficial mycoses, including avohilmo

105

1003

1.05

0.16

1.4

19.09

21.57

u/l

0.42

845

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

137

1424

0.96

0.16

1.4

26.26

23.88

u/l

0.39

117

1175

Insulin, fast-acting (human)

116

1112

1.04

0.16

1.3

1.4

17.42

21.69

u/l

0.89

927

Benign neoplasm: Long bones of lower limb

235

1.11

0.15

1.3

1.4

22.88

21.45

u/l

0.06

199

Acute epiglottitis

0.77

0.15

1.3

1.4

12.55

21.05

u/l

—

Other or ill-defined heart diseases

216

1.11

0.15

1.3

23.11

22.89

u/l

0.01

175

Other interstitial pulmonary diseases

390

0.92

0.15

1.2

1.4

28.68

30.18

u/l

0.12

322

Seropositive rheumatoid arthritis

137

1414

0.96

0.15

1.4

1.3

31.71

33.57

u/l

0.24

104

1167

Ulcerative colitis (strict definition, require KELA)

127

1320

0.96

0.15

1.3

1.4

25.84

23.49

u/l

0.37

110

1091

Macular pucker

361

1.08

0.15

1.6

1.3

40.54

35.93

u/l

0.22

297

Idiopathic gout

178

1.12

0.15

1.2

1.3

14.48

23.64

u/l

0.73

144

Benign neoplasm of major salivary glands

400

1.08

0.15

1.2

1.4

20.37

29.39

u/l

1.37

329

Diabetes, insulin treatment (Kela reimbursement)

908

5326

1.01

0.15

1.4

1.3

23.77

29.77

u/l

7.49

728

4366

Other immunodeficiencies

1.10

0.15

1.4

33.29

23.60

u/l

—

Calcific aortic valvular stenosis, including rheumatic fever

493

0.94

0.15

1.3

28.14

29.89

u/l

0.15

400

Foreign body in genitourinary tract

0.81

0.14

1.7

1.4

24.73

20.63

u/l

—

Unspecified abortion

576

1.06

0.14

1.5

1.4

33.41

36.69

u/l

0.34

467

D07AA Corticosteroids, weak (group I)

148

1427

1.04

0.14

1.4

21.16

21.94

u/l

0.13

131

1196

Interstitial lung disease endpoints

389

0.93

0.14

1.2

1.4

28.68

30.36

u/l

0.13

321

Interstitial lung disease

389

0.93

0.14

1.2

1.4

28.68

30.36

u/l

0.13

321

Emergency coronary revascularization (for ACS)

516

3057

1.02

0.14

1.4

1.3

32.24

35.63

u/l

1.43

425

2464

Other diseases of intestine

615

1.06

0.14

1.3

25.29

31.87

u/l

0.81

506

Second line medication for Crohn's disease

521

5113

1.02

0.14

1.4

27.59

27.54

u/l

0.01

432

4180

All kidney diseases

964

6536

0.99

0.14

1.4

27.25

25.07

u/l

1.19

794

5375

Protozoal diseases

112

1.16

0.14

1.3

41.47

27.70

u/l

0.77

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

123

1277

0.96

0.14

1.3

26.10

23.19

u/l

0.47

107

1057

L04AX Other immunosuppressants

497

4879

1.02

0.14

1.4

28.03

27.99

u/l

0.01

412

3982

Acute lymphadenitis

421

1.07

0.14

1.5

1.3

29.59

20.15

u/l

0.85

354

Nephropathy related operations

431

1.07

0.14

1.6

1.4

31.25

24.00

u/l

0.59

351

Other disorders of eyelid

226

2076

1.03

0.14

1.3

32.20

35.98

u/l

0.93

184

1711

Premature separation of placenta [abruptio placentae]

315

0.92

0.13

1.7

1.4

32.80

27.43

u/l

0.39

266

Injuries to the shoulder and upper arm

672

5256

0.99

0.13

1.3

1.4

25.15

27.54

u/l

1.10

538

4310

Psoriatic arthropathies, ICD10

637

1.05

0.13

1.2

1.3

23.72

29.24

u/l

0.92

520

Dilated cardiomyopathy

286

1.08

0.13

1.5

1.3

20.94

23.51

u/l

0.20

235

Presence of cardiac and vascular implants and grafts

123

872

1.04

0.13

1.2

1.4

29.41

27.71

u/l

0.19

718

Fracture of shoulder and upper arm

188

1929

0.97

0.13

1.3

26.02

28.14

u/l

0.36

147

1598

Operations 2 for CAVS

490

0.94

0.12

1.3

28.14

30.02

u/l

0.16

398

Calcific aortic valvular stenosis, diagnosis (helper)

490

0.94

0.12

1.3

28.14

30.02

u/l

0.16

398

Heart failure,strict

157

1062

1.03

0.12

1.3

31.92

30.36

u/l

0.22

127

872

Other viral diseases, not elsewhere classified, including avohilmo

297

2890

1.02

0.12

1.4

19.53

23.69

u/l

1.77

241

2395

Cardiomyopathies, Primary/intrinsic

316

1.08

0.12

1.5

1.3

20.83

25.53

u/l

0.47

257

Acute bronchiolitis

347

1.07

0.12

1.4

1.5

10.31

10.70

u/l

0.05

306

Inflammatory bowel disease, strict (require KELA)

206

2010

1.03

0.12

1.4

23.81

23.30

u/l

0.09

177

1656

Unspecified privation

610

1.05

0.12

1.5

1.4

13.29

24.07

u/l

4.25

511

Certain zoonotic bacterial diseases, including avohilmo

143

1.12

0.11

1.3

47.39

24.16

u/l

—

123

Benign neoplasm: Parotid gland

337

1.07

0.11

1.2

1.3

21.75

28.01

u/l

0.73

275

Seronegative rheumatoid arthritis

588

0.95

0.11

1.3

39.54

31.42

u/l

0.79

484

Hernia

806

5412

0.99

0.11

1.4

1.3

28.97

28.11

u/l

0.29

650

4412

Other/unspecified enthesopathies, not elsewhere classified

406

1.06

0.11

1.4

28.31

32.92

u/l

0.34

342

Ulcerative enterocolitis

221

1.09

0.11

1.2

1.4

24.35

22.03

u/l

0.11

183

Injuries to the elbow and forearm

635

5504

0.99

0.10

1.3

1.4

25.00

26.71

u/l

0.67

492

4533

Other hammer toe(s) (acquired)

557

1.04

0.10

1.3

39.82

43.51

u/l

0.36

471

Meniscus derangement

398

2599

1.02

0.10

1.4

1.3

32.03

32.25

u/l

0.04

326

2148

Other psoriatic arthropathies

623

1.04

0.10

1.2

1.3

22.90

29.56

u/l

1.18

508

Unstable angina pectoris

724

0.97

0.10

1.3

1.4

29.29

30.39

u/l

0.10

577

Cardiomyopathy (excluding other)

339

1.06

0.10

1.4

1.3

19.90

25.22

u/l

0.59

276

Other secondary gonarthrosis

197

0.91

0.10

1.1

1.3

33.79

31.82

u/l

0.06

158

Basal cell carcinoma, including Hilmo

156

1082

0.98

0.09

1.4

1.3

38.40

36.14

u/l

0.34

130

799

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

281

1.07

0.09

1.3

28.26

21.67

u/l

0.51

238

Diabetic neuropathy

460

0.95

0.09

1.3

1.4

18.70

21.74

u/l

0.27

384

Intracerebral haemorrhage

262

1.07

0.09

1.2

1.3

39.01

28.46

u/l

0.69

213

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.11

0.09

1.3

1.4

22.80

14.14

u/l

—

Sequelae of infectious and parasitic diseases, including avohilmo

429

1.05

0.09

1.4

25.12

26.20

u/l

0.09

350

Calcific aortic valvular stenosis

493

0.96

0.09

1.3

27.57

29.83

u/l

0.20

401

Calcific aortic valvular stenosis, operated

493

0.96

0.09

1.3

27.57

29.83

u/l

0.20

401

Arthropathic psoriasis

695

1.04

0.08

1.2

1.4

24.72

29.67

u/l

0.80

564

ILD, hospital admissions 1, main diag only

339

0.94

0.08

1.3

1.4

27.89

30.72

u/l

0.22

276

Dermatopolymyositis (FG)

1.05

0.08

1.3

28.75

27.88

u/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.03

0.08

1.3

1.4

22.80

14.06

u/l

—

Major coronary heart disease event

532

3145

1.01

0.08

1.4

1.3

32.69

35.35

u/l

1.01

441

2533

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.82

0.08

1.2

1.5

6.50

8.25

u/l

—

Benign neoplasm of brain and other parts of central nervous system

312

1.06

0.08

1.7

1.3

17.82

26.95

u/l

1.25

259

Other specified and unspecified disorders of eyelid

0.83

0.08

1.2

1.4

12.16

30.51

u/l

—

Other disorders of kidney and ureter

489

1.04

0.08

1.4

22.03

29.24

u/l

0.95

404

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.84

0.07

1.7

1.4

6.55

15.01

u/l

—

Contact with lifting and transmission devices, not elsewhere classified

0.83

0.07

1.5

1.4

21.06

24.04

u/l

—

Myasthenia gravis

0.82

0.07

1.7

1.4

19.32

27.34

u/l

—

Ischemic heart diseases

562

3377

0.99

0.07

1.4

32.10

34.92

u/l

1.18

464

2726

Retinal detachments and breaks

156

1530

1.02

0.07

1.4

1.3

38.90

33.29

u/l

1.00

118

1243

Sequelae of other and unspecified infectious and parasitic diseases

402

1.05

0.07

1.4

26.28

25.63

u/l

0.05

328

Personal history of other diseases and conditions

134

1361

0.98

0.07

1.4

19.37

21.08

u/l

0.30

117

1132

Tic disorders

0.87

0.07

1.0

1.4

14.77

16.54

u/l

—

Supervision of normal pregnancy

353

1989

1.01

0.07

1.4

25.22

30.17

u/l

2.11

298

1567

Cleft palate

0.82

0.07

1.1

1.4

14.40

17.15

u/l

—

Other salmonella infections, including avohilmo

245

1.06

0.07

1.1

1.3

46.45

23.84

u/l

1.37

204

Psoriatic and enteropathic arthropathies

748

1.03

0.07

1.2

1.3

23.29

29.21

u/l

1.16

614

Other embolism and thrombosis

620

1.03

0.07

1.4

1.3

20.36

29.99

u/l

1.88

506

Motorcycle rider injured in other and unspecified transport accidents

334

1.05

0.06

1.4

1.3

10.33

15.90

u/l

1.04

281

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

403

1.04

0.06

1.4

26.28

25.66

u/l

0.05

329

Loose body in joint

0.84

0.06

1.1

1.3

33.65

23.80

u/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

226

1.06

0.06

1.3

12.27

19.22

u/l

0.67

191

5-aminosalicylic acid

178

1751

1.02

0.06

1.4

25.27

24.33

u/l

0.15

156

1429

Hypertensive heart and/or renal disease

460

1.03

0.06

1.3

33.37

31.22

u/l

0.18

387

Transient ischemic attack

210

1647

1.02

0.06

1.4

1.3

33.90

33.99

u/l

0.01

167

1346

Transient global amnesia

236

1.06

0.06

1.3

26.39

40.92

u/l

1.01

192

Disorders of eyelid in diseases classified elsewhere

197

1.07

0.06

1.2

1.4

41.23

24.95

u/l

1.10

162

Hereditary corneal dystrophies

121

0.91

0.06

1.5

1.4

39.20

30.49

u/l

0.51

Basal cell carcinoma

150

1005

1.02

0.06

1.4

1.3

37.75

35.84

u/l

0.27

125

741

Atherosclerosis, excluding cerebral and coronary sclerosis

683

0.98

0.05

1.4

1.3

29.62

29.60

u/l

0.00

552

Pedal cyclist injured in collision with motor vehicle

188

1.06

0.05

1.3

1.4

14.14

19.15

u/l

0.39

156

Degeneration of macula and posterior pole

128

1005

0.98

0.05

1.4

1.3

36.00

34.32

u/l

0.19

108

823

Pre-eclampsia

274

2769

0.99

0.05

1.3

1.4

22.98

28.73

u/l

2.53

226

2243

Subarachnoid haemorrhage

356

1.04

0.05

1.3

1.4

43.61

32.63

u/l

1.11

288

Pyogenic granuloma

110

0.91

0.05

1.3

1.4

31.62

22.02

u/l

—

Accidental poisoning by and exposure to alcohol

110

1.09

0.05

1.6

1.4

28.64

14.64

u/l

1.00

Sequelae of infectious and parasitic diseases

426

1.03

0.05

1.4

25.26

25.92

u/l

0.05

347

Bacterial pneumoniae

220

1952

0.99

0.04

1.4

22.92

26.46

u/l

1.04

191

1612

400

1.03

0.04

1.3

37.96

38.91

u/l

0.07

332

Benign neoplasm: salivary glands, exclude unknown (D119)

377

1.03

0.04

1.2

1.4

21.15

29.06

u/l

1.05

308

Myocardial infarction, without ST-elevation

800

0.98

0.04

1.3

39.55

29.50

u/l

1.72

648

Gestational [pregnancy-induced] hypertension

425

4211

1.01

0.04

1.3

1.4

21.40

25.05

u/l

1.81

363

3433

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

702

4396

1.01

0.04

1.4

16.05

22.39

u/l

8.91

595

3617

Other (seronegative) rheumatoid arthritis, wide

103

1013

1.02

0.04

1.3

38.47

31.37

u/l

1.05

829

Retinal breaks without detachment

795

0.98

0.04

1.6

1.4

40.67

33.84

u/l

0.78

641

Other abortion

111

1.08

0.04

1.6

1.4

31.24

20.05

u/l

0.71

Methotrexate

885

1.02

0.03

1.4

1.3

30.87

29.84

u/l

0.11

718

Coxarthrosis, primary

246

2059

0.99

0.03

1.3

35.25

37.83

u/l

0.51

191

1659

Other respiratory diseases principally affecting the interstitium

482

0.97

0.03

1.3

36.14

31.11

u/l

0.44

398

Other disorders of veins

347

3391

1.01

0.03

1.4

30.49

33.07

u/l

0.71

271

2744

Other obstetric conditions, not elsewhere classified

709

4491

1.00

0.03

1.4

16.88

22.81

u/l

7.20

602

3697

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

120

1185

1.01

0.03

1.4

23.79

23.48

u/l

0.04

984

Anisometropia and aniseikonia

171

1.05

0.03

1.3

39.72

24.29

u/l

0.51

140

Tubulo-interstitial nephritis, not specified as acute or chronic

360

1.03

0.03

1.2

1.4

30.46

26.13

u/l

0.32

298

Excessive earwax

400

3604

1.01

0.03

1.4

27.14

28.29

u/l

0.29

322

2958

Total colectomy operation

231

1.04

0.02

1.3

1.4

20.82

22.50

u/l

0.11

192

Total colectomy

231

1.04

0.02

1.3

1.4

20.82

22.50

u/l

0.11

192

Injury of unspecified body region

410

1.02

0.02

1.5

1.3

23.07

22.20

u/l

0.07

340

Bacterial pneumonia (organism specified)

241

2167

1.01

0.02

1.4

23.54

26.57

u/l

0.86

209

1790

Bacterial pneumonia, not elsewhere classified

205

1812

0.99

0.02

1.4

23.92

26.48

u/l

0.61

177

1496

Embedded teeth, including avohilmo

979

1.01

0.02

1.3

1.4

15.74

15.82

u/l

0.01

847

Acute appendicitis, with complications

124

1229

1.01

0.02

1.3

32.56

29.04

u/l

0.55

105

1008

Etanercept

529

0.98

0.02

1.3

1.4

24.20

24.93

u/l

0.07

442

Gout, strict definition

342

1.02

0.01

1.1

1.3

20.93

23.79

u/l

0.22

277

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

123

1220

1.01

0.01

1.4

25.59

24.31

u/l

0.16

1012

Glomerulonephritis

442

1.02

0.01

1.4

1.3

32.10

24.99

u/l

0.62

361

Infections of breast associated with childbirth

492

1.02

0.01

1.4

21.81

21.02

u/l

0.06

416

Pre-eclampsia or eclampsia

289

2879

1.00

0.01

1.3

1.4

23.80

28.95

u/l

2.18

239

2332

Myeloproliferative diseases (CML excluded)

243

1.03

0.01

1.2

1.3

32.82

29.37

u/l

0.19

197

Sulfasalazine

224

2248

1.00

0.01

1.3

1.4

27.51

27.96

u/l

0.07

185

1830

Other disorders of ear

787

5088

1.00

0.00

1.3

1.4

29.58

29.06

u/l

0.15

642

4157

Oesophagitis

204

1.03

0.00

1.4

35.54

26.38

u/l

0.55

168

Conductive and sensorineural hearing loss

514

3405

1.00

0.00

1.3

1.4

31.35

32.14

u/l

0.20

414

2769

Other diseases of arteries and capillaries

396

0.98

0.00

1.2

1.3

47.47

27.46

u/l

2.14

327

112

0.95

0.00

1.7

1.5

10.35

7.07

u/l

0.31

Use of rivastigmine

174

1.03

0.00

1.4

1.2

13.72

40.89

u/l

4.78

143

UC patients in KELA-register (code 208), prior to 1994

179

1.01

0.00

1.3

1.4

38.82

33.77

u/l

0.24

150

Viral conjunctivitis, including avohilmo

329

1.00

0.00

1.2

1.4

20.71

22.67

u/l

0.15

275

Other disorders of breast and lactation associated with childbirth

235

1.02

0.00

1.5

1.4

15.05

13.93

u/l

0.08

206

Periodontal disease, other/unspecified

142

0.99

0.00

1.6

1.3

31.25

26.74

u/l

0.21

124

Nontraumatic intracranial haemmorrhage

591

1.00

0.00

1.2

1.3

40.98

32.51

u/l

0.97

480

Muscle strain

198

1.01

0.00

1.4

1.3

39.49

25.04

u/l

0.63

166

Generalized epilepsy, strict definition

161

0.99

0.00

1.5

1.3

6.84

19.27

u/l

—

135

Burn and corrosion of shoulder and upper limb, except wrist and hand

105

1.05

0.00

1.5

1.4

21.86

22.65

u/l

0.03

Other maltreatment syndromes

185

1.03

0.00

1.5

1.4

15.06

20.20

u/l

0.37

152

Complications following abortion and ectopic and molar pregnancy

215

1.02

0.00

1.3

45.62

35.81

u/l

0.43

182

Drug-induced myopathy

0.00

0.0

1.1

—

38.16

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.6

—

34.22

—

Other congenital malformations of spinal cord

0.00

0.0

1.5

—

33.78

—

Traumatic secondary and recurrent haemorrhage

0.00

0.0

1.7

—

36.52

—

Other cystitis, drug-induced

0.00

0.0

1.0

—

40.12

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.0

1.1

—

24.20

—

Myiasis, including avohilmo

0.00

0.0

2.0

—

26.14

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

1.9

—

14.96

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

38.80

—

Combined immunodeficiencies

0.98

-0.00

2.0

1.5

35.36

28.98

u/l

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

18.64

—

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.9

—

43.36

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.4

—

37.87

—

Taeniasis, including avohilmo

0.00

-0.00

0.0

1.8

—

10.56

—

Folliculitis decalvans

0.00

-0.00

0.0

1.6

—

43.89

—

Explicit viral Sepsis

0.00

-0.00

0.0

1.0

—

42.72

—

Abscess of mediastinum

0.00

-0.00

0.0

1.5

—

26.17

—

Alpha thalassaemia

0.00

-0.00

0.0

2.0

—

16.97

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.6

—

26.78

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

1.2

—

47.50

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

2.0

—

31.96

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.8

—

21.74

—

Diffuse (eosinophilic) fasciitis

0.00

-0.00

0.0

1.7

—

28.50

—

Myiasis

0.00

-0.00

0.0

2.0

—

26.14

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

1.4

—

36.68

—

Other disorders originating in the perinatal period

0.92

-0.00

1.2

1.4

32.28

22.05

u/l

—

Explicit viral Sepsis, including avohilmo

0.00

-0.00

0.0

1.4

—

28.99

—

Pemphigus foliaceus

0.00

-0.00

0.0

1.3

—

46.15

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.6

—

22.76

—

Sequelae of poliomyelitis

0.00

-0.00

0.0

1.7

—

23.11

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.5

—

43.62

—

Hirsprung

0.00

-0.00

0.0

1.4

—

5.48

—

Acne keloid

0.00

-0.00

0.0

1.5

—

16.73

—

Congenital glaucoma

0.00

-0.00

0.0

1.2

—

30.82

—

Tic and related disorders

1.01

-0.00

1.1

1.5

22.29

15.80

u/l

—

Migraine with aura, drug-induced

0.96

-0.00

1.6

1.4

22.20

28.78

u/l

—

Dermatopolymyositis

0.97

-0.00

1.3

1.4

28.75

27.69

u/l

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.8

—

37.80

—

Bacterial vaccines

0.00

-0.00

0.0

1.0

—

31.65

—

Forearm

0.00

-0.00

0.0

1.0

—

31.36

—

Inflammation of lacrimal passages (chronic)

0.96

-0.00

1.6

1.3

6.54

29.05

u/l

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.8

—

37.06

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.8

—

19.18

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.0

—

17.96

—

Exclusion endpoint for supernumerary teeth

1.01

-0.00

1.2

1.4

11.34

15.26

u/l

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

2.0

—

27.43

—

Other/unspecified crystal arthropathies

0.00

-0.00

0.0

1.4

—

38.58

—

Other injuries of lower limb, level unspecified

0.98

-0.00

1.2

1.5

28.58

23.82

u/l

—

Chronic hepatitis NAS

1.00

-0.00

1.3

1.5

24.28

26.59

u/l

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.4

—

30.26

—

Haemophilus septicemia

0.00

-0.00

0.0

1.3

—

26.11

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.6

—

21.42

—

Secondary lactase deficiency

0.00

-0.00

0.0

1.4

—

11.42

—

Benign neoplasm: Pancreas

0.99

-0.00

2.1

1.3

44.40

32.19

u/l

—

Other disorders following mastoidectomy

0.00

-0.00

0.0

1.0

—

22.68

—

Birth trauma

1.02

-0.00

1.4

3.84

15.44

u/l

—

Acute disseminated encephalitis/encephalomyelitis

0.00

-0.00

0.0

1.7

—

41.17

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.3

—

6.73

—

Other changes in lacrimal passages

0.00

-0.00

0.0

1.6

—

23.48

—

Right ventricular outflow tract obstruction

0.98

-0.00

2.2

1.5

6.20

13.35

u/l

—

Cerebral amyloid angiopathy

0.00

-0.00

0.0

1.4

—

41.41

—

Cryoglobulinemia

0.00

-0.00

0.0

1.0

—

9.80

—

Intrauterine hypoxia

0.00

-0.00

0.0

1.0

—

23.78

—

Normal-pressure hydrocephalus

1.00

-0.00

1.7

1.3

18.95

32.80

u/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follitropin [Units/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS